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Abstract 
This project focuses on the characterisation of two separate aspects of 
Trypanosoma brucei cell biology; the degradative process of autophagy and a 
specific cysteine peptidase from the metacaspase family. 
Autophagy is a widely conserved intracellular mechanism for the degradation of 
long lived proteins and organelles, that requires the formation of an 
autophagosome (double membrane bound vesicle) around cargo destined for the 
lysosome.  The molecular machinery involved in autophagy has been well 
characterised in yeast and bioinformatic screens have identified many of the 
core components in T. brucei.  However, beyond bioinformatics there is limited 
experimental evidence to support the presence of functional autophagy in T. 
brucei.     
A key component of the autophagic pathway is ATG8, a ubiquitin-like protein 
that is incorporated into the autophagosome membrane.  To investigate 
autophagy in T. brucei the three candidate ATG8 genes (ATG8.1 Tb927.7.5900, 
ATG8.2 Tb927.7.5910 and ATG8.3 Tb927.7.3320) were fused with yellow 
fluorescent protein (YFP) and expressed in bloodstream form and procyclic form 
T. brucei cultured parasites.  Fluorescent microscopy was used to monitor the 
formation of YFP-labelled autophagosomes, which enabled the evaluation of the 
autophagic response towards a variety of different stimuli.  We provide the first 
direct experimental evidence confirming a functional autophagy pathway in T. 
brucei and show that it is induced in response to nutrient starvation in the 
procyclic form and neuropeptide treatment in the bloodstream form and can be 
blocked by the classical autophagy inhibitor wortmannin.  Characterisation of 
the T. brucei ATG8 family revealed that ATG8.1 and ATG8.2 appear to operate 
as ‘ATG8-like’ proteins, whereas ATG8.3 behaves atypically, possibly functioning 
as an ATG12 protein.  Furthermore, targeted RNAi downregulation of the 
predicted T. brucei ATG3 (Tb927.2.1890) caused a reduction in cell growth.  The 
vital role of ATG3 in the autophagy pathway suggested that the process was 
required for normal procyclic form growth.  
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The second focus of the project was metacaspase 4 (Tb927.10.2440) which 
belongs to the metacaspases (MCAs), cysteine peptidases of the caspase family 
found in plants, fungi and protozoa, but absent from mammals.  Of the five 
MCAs possessed by T. brucei, only MCA2, MCA3 and MCA5 contain the conserved 
histidine cysteine catalytic dyad.  MCA1 and MCA4 are predicted to contain key 
substitutions within their active sites, raising interesting questions regarding 
potential peptidase activity and functions.  The exact role of the T. brucei 
metacaspases remains largely unknown, with MCA2 , MCA3 and MCA5 appearing 
to function in association with RAB11 positive endosomes, although 
independently of the known recycling functions of these endosomes  (Helms et 
al. 2006).        
To develop our understanding of the MCA family in T. brucei a study into the 
function of MCA4 was undertaken.  An antibody was raised against MCA4 and 
western blotting of cell lysate revealed that MCA4 expression occurred only in 
bloodstream form T. brucei.  Interestingly MCA4 localised to the flagellar 
membrane, appearing in a linear array of punctate structures.  Dual acylation is 
known to mediate flagellar membrane association in T. brucei and was 
implicated in MCA4 targeting following bioinformatic predictions and subsequent 
experimental confirmation of MCA4 palmitoylation using an acyl-biotin exchange 
reaction.   
MCA4 contains a non-canonical active site residue (serine-219) in the position of 
the predicted conserved active site cysteine.  Activity assays using purified 
recombinant protein revealed that full length MCA4 was unable to autoprocess 
and was inactive.  However, MCA4 peptidase activity could be detected 
following proteolytic activation with MCA2.  Interestingly, removal of the MCA4 
active site serine by mutagenesis (MCA4S219G) did not abolish activity of the 
processed enzyme, revealing an alternative nucleophile was capable of 
contributing to activity.  Furthermore, mutation of the active site serine to 
cysteine, produced a constitutively active peptidase capable of autolytic 
processing in a calcium dependent manner.    
Following these key findings the role of MCA4 in the T. brucei lifecycle was 
investigated by RNAi and genetic knockout.  Rapid depletion of MCA4 by RNAi 
caused a block in cytokinesis followed by cell death, nevertheless the generation 
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of MCA4 null mutant parasites (∆mca4) was possible.  A role for MCA4 in 
mammalian infection was revealed by monitoring infection progression in mice.  
Deletion of MCA4 increased host survival and parasite virulence could be 
restored by the ectopic re-expression of MCA4 in ∆mca4 parasites.  However, re-
expression of MCA4 lacking both serine-219 and cysteine-218 (potential 
alternative nucleophile provider) failed to restore ∆mca4 parasite virulence, 
which confirmed the necessity of enzymatic activity for MCA4 function. 
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Definitions and abbreviations 
 
aa   amino acid 
bp   base pair 
ATG   autophagy related gene 
Biotin-HPDP  (N-(6-(Biotinamido)hexyl)-3'-(2'-pyridyldithio)-propionamide  
BLEO   bleomycin / phleomycin 
BSD   blasticidin 
BSA   bovine serum albumin 
BSF   bloodstream form T. brucei 
CMA   chaperone mediated autophagy 
CPA / B  cysteine peptidase A / B  
CHAPS   3-(3-Cholamidopropyl)dimethylammonio-1-propanesulfonate 
DABCO  4-diazabicyclo[2.2.2]octane 
DAPI   4,6-diamidino-2-phenylindole (nucleic acid stain)            
DMSO   dimethyl sulfoxide 
DNA   deoxyribonucleic acid 
DTT   dithiothreitol 
EDTA   ethylene diamine tetra acetic acid 
ER   endoplasmic reticulum 
EF-1α   elongation factor 1α 
FACS   fluorescence activated cell sorting 
FCS   fetal calf serum 
FT   flow through 
GABARAP  γ-aminobutyric-acid-type-A (GABAA)-receptor associated 
protein  
GATE-16        Golgi-associated ATPase enhancer of 16kDa 
GFP   green fluorescent protein 
GPI   glycosylphosphatidylinositol 
HA   human influenza hemagglutinin  
HIS   histamine 
HYG   hygromycin B 
HRP   horseradish peroxidase 
IPTG   isopropyl-β-D-thiogalactopyranoside 
IFT   intraflagellar transport 
K   kinetoplast 
Kb   kilo base 
kDa   kilo Dalton 
LC MS/MS  liquid chromatograph tandem mass spectrometry 
LB   Luria bertani medium 
λ (λEx / λEm)  wavelength (excitation λ / emission λ) 
µ   micro 
m   milli / metre 
M   molar 
MCA   metacaspase 
mRNA   messenger ribonucleic acid 
n   nano 
N   nucleus 
NEM   n-ethylmaleimide 
NEO   neomycin  
nt   nucleotide 
NP40   octylphenyl-polyethylene glycol 
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OD   optical density 
PCD   programmed cell death 
PCR   polymerase chain reaction 
PBS   phosphate buffered saline 
PE   phosphatidylethanolamine 
PLD   phospholipase D 
RNA   ribonucleic acid 
RNAi   ribonucleic acid interference 
rRNA   ribosomal ribonucleic acid 
SEM   scanning electron microscopy 
SERA   serine repeat antigen 
SDS-PAGE  sodium dodecyl sulphate polyacrylamide gel electrophoresis 
TEM   transmission electron microscopy  
UV   ultra violet 
UTR   untranslated region  
V   volts 
VIP   vasoactive intestinal peptide 
v/v   volume to volume 
w/v   weight to volume 
WHO    world health organisation 
YFP      yellow fluorescent protein 
Z-RR-AMC     benzyloxycarbonyl-arginine-arginine-7-amino-4- 
methylcoumarin 
 
 
Amino acid abbreviations 
 
A        alanine (Ala)  
C cysteine (Cys) 
D  aspartic acid (Asp) 
E  glutamic acid (Glu) 
F  phenylalanine (Phe) 
G  glycine (Gly) 
H  histidine (His) 
I  isoleucine (Ile) 
K  lysine (Lys) 
L  leucine (Leu) 
M  methionine (Met) 
N  asparagine (Asn) 
P  proline (Pro) 
Q  glutamine (Gln) 
R  arginine (Arg) 
S  serine (Ser) 
T  threonine (Thr) 
V  valine (V) 
W  tryptophan (Trp) 
X  any amino acid 
Y  tyrosine (Tyr) 
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1  General introduction 
The work presented in this PhD thesis covers several aspects of biology relating 
to the protozoan parasite Trypanosoma brucei.  The general introduction is 
intended to provide background information about the parasite that will be of 
direct relevance to the research discussed in sections 3, 4 and 5.  
1.1 Human African Trypanosomiasis 
Human African trypanosomiasis (also known as sleeping sickness) is a potentially 
fatal disease caused by the protozoan parasite T. brucei.  The causative agents 
of this disease (African trypanosomes) are classified into two subspecies that are 
located in distinct geographical regions of Africa.  T. brucei gambiense is 
responsible for endemic chronic infections occurring in central and western 
regions of sub-Saharan Africa and T. brucei rhodesiense causes an acute form of 
the disease in east and southern Africa.  A third subspecies T. brucei brucei only 
infects domestic and wild animals but not humans (Brun et al. 2010).  
The impact of these parasites is widespread across sub-Saharan Africa with the 
World Health Organisation (WHO) estimating millions of people are at risk in 36 
countries (http://www.who.int/).  Due to the inherent difficulties associated 
with maintaining thorough surveillance programmes over large areas covering 
multiple developing countries, it is impossible to know the true human cost.  
However, the WHO estimate that there are currently between 50,000 and 70,000 
new cases per year (http://www.who.int/mediacentre/factsheets/fs259/en/).  
The devastating impact on human life combined with an unquantified toll on 
domestic livestock mean the African trypanosomes cause a stifling burden on the 
socio-economic development of effected communities represent a significant 
challenge for the international community.   
T. brucei is an extracellular parasite transmitted between mammalian hosts by 
the blood feeding tsetse fly (genus Glossina) (Figure 1-1).  Accordingly, the 
geographical distribution of the disease is intrinsically linked to the range of the 
vector and thus restricted to regions of sub-Saharan Africa.  Following infection 
from either T. brucei gambiense or T. brucei rhodesiense the clinical symptoms 
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of human African trypanosomiasis present in two main phases.  During the initial 
phase of the disease parasites proliferate and colonise the haemolymphatic 
system.  The second phase (meningo-encephalitic stage) is characterised by 
invasion of the central nervous system and is associated with the more severe 
disease symptoms. 
 
Figure 1-1 Hosts cycles of T. brucei. 
From Field et al. 2009.  Diagram depicting the T. brucei lifecycle showing tsetse fly vector 
transmitting parasites between different hosts.     
  
 
In the absence of treatment infections from both of the human infective 
subspecies are fatal.  T. brucei gambiense parasites cause a chronic infection 
persisting in a patient for an average period of three years (Checchi et al. 2008), 
where as T. brucei rhodesiense infections are acute, with patient death typically 
occurring within months (Odiit et al. 1997).  The symptoms associated with the 
initial phase of the disease include general fever and headaches, these are often 
associated with a flu-like illness which delays formal diagnosis.  The latter phase 
of the disease can be accompanied with bipolar behavioural changes, 
dysregulation of the circadian rhythm leading to fragmentation of sleeping 
patterns, coma and ultimately death (Brun et al.  2010). 
The current therapeautics used to treat human African trypanosomiasis have 
many limitations:  they require lengthy and complex dosing regimens with 
concurrent high levels of patient care due to frequent adverse reactions.  
Furthermore, the drugs used to treat the second stage of the disease are linked 
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to particularly severe complications that can often be lethal (Barrett et al. 
2007).  The limitations of the current therapeutics combined with emerging 
incidence of drug resistance, highlights the urgent need for the development of 
new prevention and treatment options.   
In the context of this devastating disease a large volume of research has been 
developed focusing on the characterisation of the fascinating biology of the 
African trypanosomes.  The use of powerful genetic manipulation techniques 
combined with the wealth of information provided by the sequenced genomes of 
several trypanosome species (http://tritrypdb.org) could eventually help to 
develop new strategies to combat this disease.      
1.2 T. brucei cell cycle 
At different points during the T. brucei lifecycle the parasites are required to 
colonise the host environment which relies on the rapid proliferation of 
individual cells.  The replication of T. brucei parasites broadly follows the same 
scheme as the mammalian cell cycle.  However, an important aspect of T. 
brucei cell division is the coordinated replication and segregation of numerous 
single copy organelles (e.g. nucleus, mitochondrion, kinetoplast, Golgi, basal 
body/flagellum complex) with added complexity provided by the independent 
replication of nuclear and mitochondrial (kinetoplast) DNA (Hammarton 2007; 
McKean 2003; Sherwin et al. 1989).  To ensure successful cell division, the 
organelles are replicated and separated in a precise and ordered manner that 
occurs during specific phases of the cell cycle (Figure 1-2). 
Following the commitment to divide, cells first produce a new basal body which 
is capable of nucleating the daughter flagellum (Sherwin et al.  1989).  Shortly 
afterwards, the Golgi is replicated and localises next to the new basal body and 
the new endoplasmic reticulum exit site (He et al. 2004).  Kinetoplast DNA 
replication commences slightly ahead of the nucleus and takes a shorter amount 
of time, consequently the kinetoplast DNA is segregated before nuclear 
replication and segregation are complete (Sherwin et al.  1989).  In procyclic 
form cells one nucleus (N) is positioned between both kinetoplasts (K) (giving the 
formation KNKN), whereas in bloodstream form the two nuclei remain close to 
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each other (leading to KKNN formation).  Cytokinesis occurs after mitosis and 
follows a unidirectional cleavage furrow moving from the anterior of the cell to 
the posterior (Hammarton et al. 2007; McKean 2003).  Due to the highly ordered 
pattern of cell division, the labelling of cells with appropriate stains, such as 
DAPI, allows for the accurate determination of the cell cycle stage.     
 
Figure 1-2 Cell cycle of T. brucei. 
Adapted from McKean 2003.  The major events of the cell cycle are illustrated for PCF T. brucei.  
The highly ordered duplication and segregation of single copy organelles is depicted along with the 
stages of the cell cycle. 
 
1.3 Trypanosome cell biology 
T. brucei exist as extracellular parasites that are adapted to survive in two very 
different host environments (Figure 1-1).  A complex lifecycle involving 
numerous developmental forms ensures that the parasites are optimally adjusted 
for survival within each host (summarised in Figure 1-4 and discussed in more 
detail in section 1.4).  The parasites replicating in the tsetse fly exist as multiple 
lifecycle forms (detailed in section 1.4.2) which are broadly referred to as 
procyclic form (PCF) due to the possession of a surface glycoprotein coat 
comprised of procyclins (Acosta-Serrano et al. 1999).  The T. brucei lifecycle 
stage found in mammals are known as bloodstream form (BSF) parasites and are 
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covered in a dense protein coat comprised of variant surface glycoprotein (VSG) 
(Johnson et al. 1977).  In both lifecycle stages the morphology of the parasites is 
broadly similar characterised by a vermiform shape tapering at both ends.  This 
distinct shape is directed by a spiralled network of over 100 subpellicular 
microtubules, that run along the axis of the cell beneath the plasma membrane 
(Sherwin et al.  1989).  
The trypanosomatids have many characteristic features typical of eukaryotic 
cells.  However, their long independent evolution (Dacks et al. 2008) has been 
accompanied by the development of several unusual organelles and features of 
cell biology.   
 
Figure 1-3 Diagram depicting T. brucei. 
(Diagram adapted from http://www.sanger.ac.uk/Projects/T_brucei/Tryp.cartoon.shtml).  Illustration 
depicting general organisation of bloodstream form T. brucei cell.  Major cellular structures are 
indicated.      
 
Perhaps the most apparent feature of the T. brucei cell is the highly motile 
flagellum.  This organelle originates from the basal body at the posterior end of 
the parasite, emerging from the cell body through a specialised invagination in 
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the plasma membrane called the flagellar pocket (Figure 1-3) (Field et al. 2009; 
Ralston et al. 2009).  The flagellum is comprised of several prominent structures 
including the axoneme and the paraflagellar rod (PFR).  In common with most 
other eukaryotes the T. brucei axoneme consists of nine outer microtubule 
doublets encircling a single pair of central mircotuble filaments (Ralston et al.  
2009).  The PFR is an unusual flagella structure that is formed from a large 
paracrystalline filament that runs alongside the axoneme (Ralston et al.  2009).  
The precise role of the PFR is unknown, although it appears essential for 
flagellar function as PFR disruption causes defects in cell motility (Bastin et al. 
1998) and cytokinesis in BSF cells (Broadhead et al. 2006), which culminates in a 
loss of infectivity in mouse models (Griffiths et al. 2007).    
The flagellum is surrounded by its own membrane and is attached to the exterior 
of the cell body via a series of transmembrane junctions known as the flagellar 
attachment zone (Kohl et al. 1998).  The flagellum follows a helical path around 
the outside of the cell body with a portion freely extending away from the 
extreme anterior end of the cell.  T. brucei motility is generated by the 
propagation of bihelical waves of rotation (left-handed and right-handed helical 
motion) travelling along the flagellum, separated by a region known as a kink 
(Rodriguez et al. 2009).  The flagellum is central to maintaining correct cellular 
function and pathogenicity, with many critical roles directly linked to motility 
(Broadhead et al.  2006; Griffiths et al.  2007; Ralston et al. 2006b; Ralston et al. 
2006a).   
Several fundamental aspects of T. brucei biology are centred on the flagellar 
pocket.  The plasma membrane surrounding this site is free from the 
subpellicular microtubule network and consequently represents the only cellular 
site capable of endocytosis and exocytosis (Field et al.  2009).  This leads to a 
highly polarized endomembrane system, with the secretory and endocytic 
organelles predominantly located between the nucleus and kinetoplast.  The 
endoplasmic reticulum exists as an elongated structure that runs along the 
length of the cell body from the flagellar pocket to the anterior tip.  Excluding 
the unusual polarization, the endomembrane system of T. brucei is broadly 
similar to other eukaryotes.  Indeed representative genes for many protein 
families known to be involved in vesicle transport have been identified in the T. 
brucei genome (Ackers et al. 2005; Berriman et al. 2005). 
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To mediate against the effects of the mammalian host immune system T. brucei 
use two mechanisms that are both heavily reliant on the flagellar pocket and 
endosomal system.  Mammalian anti-VSG antibodies bind to the surface of T. 
brucei and can effectively kill the parasites by complement.  One survival 
method employed by T. brucei involves the periodic switching of the VSG surface 
molecule type to continually evade the host immune response (see section 1.4.1) 
(Vickerman 1978).  A second survival mechanism involves the clearance of 
surface bound anti-VSG antibodies.  This is thought to be mediated by 
hydrodynamic forces exerted on the swimming parasites that force the anti-VSG 
antibodies bound to VSG towards to the posterior end of the cell and into the 
flagellar pocket (Engstler et al. 2007).  The high endocytic rate in BSF cells 
ensures that anti-VSG antibody/VSG complexes are rapidly endocytosed by 
RAB5A containing vesicles from the early endosomal system (Pal et al. 2003; Pal 
et al. 2002).  The anti-VSG antibody/VSG complexes are separated and anti-VSG 
is degraded while intact VSG is trafficked back to the surface via RAB11 positive 
recycling endosomes (Grunfelder et al. 2003; Pal et al.  2003).  Interestingly the 
enzymes used to selectively degrade anti-VSG antibody are unknown.  RAB11 
recycling endosomes were found to colocalise with the metacaspase cysteine 
peptidases MCA2, MCA3 and MCA5, however simultaneous deletion of these MCAs 
failed to impact on the ability of the null mutant parasites to degrade anti-VSG 
or recycle VSG (Helms et al.  2006). 
Given that the flagellar pocket represents only 5 % of the cell surface of T. 
brucei, it does not appear to significantly impede upon rates of trafficking.  
Indeed BSF T. brucei are capable of turning over (endocytosis and recycling back 
to the surface) their entire pool of cell surface VSG in 12.5 minutes (Engstler et 
al. 2004b).  Interestingly endocytosis rates are approximately 10 fold higher in 
BSF than PCFs, which might reflect the inherent requirement of BSF cells for 
increased internalisation and degradation in response to the mammalian immune 
system (Natesan et al. 2007).       
Unlike many eukaryotes that contain hundreds of individual mitochondria T. 
brucei contains one single elongated mitochondrion that extends the length of 
the cell body (Figure 1-3).  Contained within the mitochondrion is the 
kinetoplast, a disc-like organelle made of the mitochondrial DNA.  The 
kinetoplast is a complex structure uniquely comprised of a large network of 
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interlocked circular DNA molecules; thousands of minicircles are interlocked 
with 20 to 30 maxicircles (Chen et al. 1995).  The maxicircles all have identical 
genetic sequences and predominantly encode for the mitochondrial proteins.  
Minicircles are heterogenous in sequence and encode for guide RNAs which serve 
as templates for editing maxicircle transcripts (Stuart et al. 2005).  The 
kinetoplast is physically connected to the flagellar basal body complex through a 
series of filaments and the outer mitochondrial membrane (Ogbadoyi et al. 
2003).  
Another interesting feature of T. brucei is the compartmentalisation of select 
metabolic systems into small vesicular structures called glycosomes (Michels et 
al. 2006).  The containment of distinct repertoires of metabolic enzymes allows 
for their rapid turnover which facilitates parasite adaptation in response to 
changing host environments (Herman et al. 2008).  In BSF T. brucei the 
mitochondrion is suppressed and the glycosomes are filled with glycolytic 
enzymes (90% of glycosome protein content) (Michels et al.  2006).  Oxidative 
phosphorylation of glucose yields more ATP than glycolysis, however the 
abundant and constant supply of glucose in mammalian blood, means that the 
parasites can effectively rely on a simplified metabolism and thus use glycolysis 
alone to generate ATP (Michels et al.  2006).  In the tsetse fly sugar availability is 
changeable and predominantly very low, however amino acids (proline and 
threonine) are abundant and serve as a more reliable substrate for energy 
generation.  Consequently PCF parasites have a more complex metabolism,  
involving a functional mitochondrion and more extensive glycosomal metabolic 
networks (Michels et al.  2006).      
T. brucei parasites also contain acidocalcisomes, which are distinct organelles 
involved in the sequestration and storage of polyphosphates, calcium and other 
cations (Moreno et al. 2003).  In T. brucei the exact role of these small vesicles 
is not clear, although their surface membrane contains calcium and proton 
pumps, which has lead to the suggestion they are involved in calcium signalling 
and could facilitate survival during periods of stress (Docampo et al. 2005; 
Moreno et al.  2003).                
Depending on the developmental form of the parasite the morphological 
arrangement of several key cellular features is changed.  Trypomastigote 
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parasites are characterised by a kinetoplast and flagellar pocket positioned at 
the posterior end of the cell with a centrally located nucleus (Field et al.  2009).  
In epimastigotes cells the kinetoplast and flagellar pocket are located to the 
anterior side of the centrally located nucleus (Field et al.  2009).  
1.4 T. brucei life cycle 
1.4.1 T. brucei development in the mammalian host 
During the T. brucei lifecycle the parasite must inhabit the contrasting and 
challenging environments of the mammalian and insect host (Figure 1-1).  The 
parasite is ingested/transmitted by the tsetse fly (genus Glossina) while taking a 
blood meal during feeding.  In mammals the transmitted parasites initially form 
a lesion (chancre) at the site of the bite, where they multiply before gaining 
access to the host blood stream.  Here parasites exist as rapidly dividing long 
slender trypomastigotes that differentiate via an intermediate stage into non 
proliferative short stumpy trypomastigotes (Figure 1-4)(Newton 1968).  The long 
slender form is perfectly adapted to exploit the glucose rich environment of the 
mammalian blood and rapidly divides increasing parasitemia to aid colonisation 
of the host. 
 
Figure 1-4 Lifecycle of T. brucei  
Diagram from (Lee et al. 2007b).  Schematic representing simplified lifecycle of T. brucei showing 
best studied forms from the insect and mammalian host stage.     
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Following adequate proliferation the long slender trypomastigotes are replaced 
by the short stumpy form.  This differentiation event is suspected to be induced 
by an as yet unknown parasite signal, referred to as the stumpy induction factor 
(Vassella et al. 1997).  The accumulation of non proliferative short stumpy forms 
at peak parasitemia, prolongs survival within the mammalian host and maximises 
the chance of successful transmission.  The prospects of short stumpy survival in 
the tsetse fly are further increased by the reactivation of the mitochondrial 
respiratory chain, which ensures pre-adaptation to the glucose limited 
environment of the tsetse fly (Michels et al.  2006; Priest et al. 1994).  Thus, 
stumpy form T. brucei are a prerequisite for the efficient transmission from the 
mammalian to the insect host.   
To protect BSF cells from the antagonistic host environment they are coated 
with a densely packed monolayer of variant surface glycoprotein (VSG), which is 
comprised of more than 107 variable VSG molecules per cell (Cross 1975).  
Following infection the VSG coat on the surface of the parasite is quickly 
recognised by the host immune system and a specific antibody response is raised 
to neutralise and clear the parasites by complement, thus decreasing 
parasitemia.  However in the mammalian host, a subpopulation of trypanosomes 
arise by changing their surface coat through the expression of different VSG 
molecules, in a process known as antigenic variation (Vickerman 1978).  Through 
the periodic switching of the surface VSG coat the parasite can evade successive 
immune responses and persist within the host.  The cyclical waves of T. brucei 
parasitemia that are typically observed in chronic T. brucei infections, therefore 
arise from an interplay between the host immune system and parasite derived 
factors (Lythgoe et al. 2007).    
1.4.2 T. brucei development in the tsetse fly host 
Parasites that are fully transformed and adapted to live in the tsetse fly vector 
are called procyclic form (PCF) cells.  When the tsetse fly feeds on an infected 
mammal the resulting blood meal can contain both long slender and short 
stumpy parasites.  Rapid differentiation of the BSF parasites must take place to 
ensure PCF cells can prevail in the tsetse mid gut.  The transformation to PCF 
parasites is believed to be triggered by the reduced temperature of the tsetse 
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fly mid gut, decreasing from 37oC of the mammalian blood to 20oC, the average 
ambient temperature during peak tsetse fly feeding (Engstler et al. 2004a).  
Additionally, experiments have shown that BSF to PCF differentiation occurs 
from those cells in the G0 or G1 phase of the cell cycle (Matthews et al. 1994; 
Ziegelbauer et al. 1990).  Short stumpy cells are arrested in the G0/G1 position 
of the cell cycle and possess a pre-adapted metabolism; this therefore makes 
them ideal candidates to rapidly start the differentiation process and attempt 
colonisation of the tsetse fly mid-gut.  
Once in the tsetse fly parasites must undergo a complex development cycle 
involving several different lifecycle stages and considerable parasite movement 
between distinct internal compartments of the tsetse fly (Figure 1-5)(Van den 
Abbeele et al. 1999).  Despite all the efforts of T. brucei to (pre-) adapt to their 
new environment, two to three days post feeding approximately 99% of the 
ingested parasites are eliminated by the tsetse fly, with the remaining surviving 
population fully differentiated into PCF cells (Van den Abbeele et al.  1999).  
Differentiation to PCF cells occurs rapidly and is accompanied by the shedding of 
the VSG coat and its subsequent replacement with a new surface protein coat 
comprised of procyclin (Ziegelbauer et al.  1990).   
In a short space of time the reduced population of PCF cells undergoes vigorous 
growth and establishes a robust stable population in the midgut.  As midgut 
colonisation progresses (posterior to the anterior direction) there is a concurrent 
physical elongation of parasites, with long trypomastigote forms (also known as 
mesocyclic trypomastigotes, displayed in Figure 1-5) found near the 
proventriculus at 6 days post infection (Van den Abbeele et al.  1999).  These 
cells enter the proventriculus and migrate into the tsetse foregut and proboscis, 
where they undergo further complex differentiation (Figure 1-5).  The long 
trypomastigotes cells replicate their DNA and reposition the kinetoplast and 
basal body to a location anterior of nucleus (thus becoming long epimastigote 
forms) and subsequently finish mitosis and divide asymmetrically producing long 
and short daughter cells (Van den Abbeele et al.  1999).  The flagella of the short 
daughter epimastigotes prohibits efficient movement, thus it is proposed that 
attached asymmetrically dividing cells are propelled to the salivary gland using 
the flagellar of the long epimastigote.  Once in the salivary gland, cell 
separation occurs and the short epimastigote attaches to the salivary gland wall 
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and further develops into metacyclic forms ready for retransmission into a 
mammalian host (Van den Abbeele et al.  1999).   
 
Figure 1-5 Development of T. brucei in the tsetse fly.   
Adapted from Van den Abbeele et al., 1999.  Light microscopy images of the different 
morphological stages of T. brucei isolated from the tsetse fly vector.  Scale bar represents 10 µm. 
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As illustrated in this introduction T. brucei is subject to numerous challenges 
arising from the pressures exerted by hostile host environments.  Consequently 
the parasite has evolved a complex lifecycle that encompasses drastic and varied 
alterations to help ensure survival.  Given the widespread burden inflicted by 
the disease causing forms of T. brucei it is evident that the parasite is extremely 
successful and increased efforts are needed to gain a more detailed 
understanding of the complex biology of this parasite.  The research presented 
in this PhD focuses on two different topics:    
Autophagy is a degradative process used by eukaryotic cells to break down and 
recycle their own components in the lysosome.  In light of the complex cellular 
remodelling that occurs during the T. brucei lifecycle and the contrasting host 
environments occupied, we speculate that autophagy could be exploited by the 
parasites to enable efficient adapatation and survival.  In section 3 autophagy is 
introduced in detail and results generated depicting the characterisation of this 
process in T. brucei are presented and discussed. 
In section 4 the focus is turned to T. brucei MCA4.  The MCAs are cysteine 
peptidases that are only found in plants, fungi and protozoa but are absent from 
mammals (detailed introduction in section 4).  To provide a more complete 
understanding of the T. brucei MCAs, a detailed investigation into MCA4 was 
performed focusing on in vivo characterisation combined with in vitro analysis of 
the recombinant enzyme. 
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2 Methods 
2.1 Bacteria: strains and culture 
2.1.1 Bacteria strains 
For standard plasmid transformation and preparation, competent host strains 
with low endonuclease activity were used to ensure high quality DNA.  The strain 
typically used was E. coli XL1-Blue (genotype recA1 endA1 gyrA96 thi-1 hsdR17 
supE44 relA1 lac, tetracycline resistant) (Stratagene).   
When working with restriction endonucleases sensitive to DNA methylation (e.g. 
BclI) a methyltransferase free host strain was used; E. coli dam-/dcm- 2925 (New 
England Biosciences).  Due to the low transformation efficiency of these cells 
they were not used as primary hosts for the transformation of ligation reactions.  
For the expression of recombinant proteins different E. coli strains were used, 
each selected following optimisation specific to the individual protein 
expressed.  The strains used were: E. coli BL21 (DE3) (Novagen) and E. coli BL21 
(DE3) Rosetta (Novagen).  DE3 strains contain an IPTG-inducible T7 RNA 
polymerase gene and are specifically designed for high level expression of 
proteins using compatible vectors such at the pET system (Novagen).  E. coli 
(DE3) Rosetta harbour a plasmid encoding for rare E. coli tRNAs and 
consequently are optimised for bacterial expression of proteins containing 
unusual codons.    
2.1.2 Bacterial transformations 
Heat shock transformation was used to introduce plasmids into competent E. coli 
cells.  Aliquots of competent E. coli (strain XL1-Blue) were thawed on ice and 
mixed with 1 µl purified plasmid or 5 µl ligation reaction mix and incubated on 
ice for 30 minutes.  Cells were heat shocked in a 42oC water bath and returned 
to ice for 5 minutes, before plating onto Luria Bertani (LB) agar plates 
supplemented with appropriate antibiotics.   
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2.1.3 Bacterial culture and storage 
Following plasmid transformation into an E. coli host strain, the cells were 
spread onto LB-agar plates supplemented with the appropriate antibiotics 
(ampicillin 100 µg ml-1, kanamycin 50 µg ml-1, or chloramphenicol 40 µg ml-1) and 
incubated overnight at 37oC.  Individual colonies were used to inoculate liquid 
cultures as necessary.  For long term storage of bacteria 0.5 ml of an overnight 
culture was mixed with an equal volume of 2 % (w/v) peptone and 40 % (v/v) 
glycerol and stored at -80oC. 
2.1.4 Production of competent E. coli cells     
Competent E. coli cells were prepared using rubidium chloride treatment.  
Briefly, a single colony of the required E. coli strain was inoculated into 5 ml LB 
broth and grown overnight at 37oC.  The following day the culture was diluted 
1:1000 into 50 ml of fresh LB broth and grown at 37oC until the optical density 
reached 0.6 (at 600 nm).  The culture was cooled on ice for 10 minutes and 
centrifuged at 2000 g for 15 minutes at 4oC.  The cell pellet was gently 
resuspended in 16 ml chilled RF1 buffer (100 mM rubidium chloride, 50 mM 
MnCl2.4H2O, 30 mM potassium acetate, 10 mM CaCl2, 15 % glycerol, adjusted to 
pH 5.8 using acetic acid) and incubated on ice for 15 minutes before repeat 
centrifugation.  The cell pellet was resuspended in 4 ml of ice cold RF2 buffer 
(10mM MOPS pH 6.8, 10 mM rubidium chloride, 75 mM CaCl2, 15 % glycerol 
adjusted to pH 6.8 with NaOH) and maintained on ice for 1 hour, before snap 
feezing aliquots in an ethanol-dry ice bath.  Competent cell aliquots were stored 
at -80oC.    
2.2 Molecular biology techniques 
2.2.1 Polymerase chain reaction 
Polymerase chain reactions (PCR) were performed in a PCR Express machine 
(Hybaid).  Standard PCRs were performed with Taq polymerase (New England 
Biolabs), however for cloning work high-fidelity proof-reading enzymes were 
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used: Pfx50 (Invitrogen), PfuTurbo (Stratagene) and Phusion (Finnzymes).  All 
polymerases were used according to manufacturers’ guidelines.   
In general PCR reactions were composed of the following constituents: template 
DNA (100 ng genomic DNA or 100pg plasmid DNA), 2.5 µl of appropriate 10 x PCR 
mix (1.13 mg ml-1 BSA, 450 mM Tris pH 8.8, 110 mM ammonium sulphate, 45 mM 
MgCl2, 68.3 mM β-mercaptoethanol, 44 µM EDTA pH 8.0, 10 mM dCTP, 10 mM 
dATP, 10 mM dGTP, 10 mM dTTP), 5 pmol of each primer, 1 unit of Taq 
polymerase and autoclaved distilled water to a final volume of 25 µl.  Typically 
the PCR machine was programmed for an initial denaturation step of 95°C for 5 
minutes, followed by 30 cycles of: denatuartion 95°C for 30 seconds; annealing 
at [Tm of primers] -2°C for 30 seconds; extension at 72°C for Taq polymerase, 
30 seconds per 0.5 kb of sequence.  The PCR conditions were optimised for each 
reaction adjusting primer annealing temperature, elongation time and extension 
temperature as required.  
All oligonucleotide primers were designed using Vector NTI software package 
(Invitrogen) and produced by Eurofins MWG Operon (Ebersberg, Germany).  
Details of oligonucleotide primers listed in Table 2-1 and Table 2-2. 
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Table 2-1 Oligonucleotides used in this study. 
Targeted gene (tritrypDB identifiers in brackets) or description is indication with the appropriate 
sequence information and where used endonuclease restriction enzyme sites (underlined). 
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Table 2-2 Oligonucleotides used in this study (continued). 
Targeted gene (tritrypDB identifiers in brackets) or description is indication with the appropriate 
sequence information and where used endonuclease restriction enzyme sites (underlined), second 
restriction site coloured red. 
 
2.2.2  DNA gel electrophoresis 
DNA gel electrophoresis was typically carried out in a 1 % gel (w/v) made from 
agarose (UltraPure, Invitrogen) in 0.5 x TRIS borate buffer (TBE) (20 mM Tris, 20 
mM boric acid, 0.5 mM EDTA, pH 7.2).  The agarose solution was solubilised in 
TBE buffer by briefly boiling in a microwave.  Once cool 1 µg ml-1 of SYBR Safe 
DNA stain (Invitrogen) was added and the gel was cast.  DNA samples were 
prepared with 6 x DNA loading dye (0.25 % (w/v) bromophenol blue, 0.25 % (w/v) 
xylene cyanol FF, 30 % (v/v) glycerol) and electrophoresed in Life Technologies 
Horizon gel tanks at 100 V.  For reference, a 1 kb DNA ladder (Invitrogen) was 
used at 0.5 µg per lane.  To visualise nucleic acids gels were exposed to U.V. 
light, using a BioRad Gel-Doc imager and Quantity One software.  When the DNA 
was destined for use in cloning or transfection it was visualised using a 
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DarkReader blue light transilluminator and extracted from the agarose gel using 
a Gel Extraction kit (Qiagen) according to the manufacturer’s instructions.  
2.2.3 Cloning PCR products 
The subcloning vectors pGEM-T-Easy (Promega) and TOPO (Invitrogen) were used 
to establish stable vectors containing PCR products.  Typically, after high fidelity 
proof reading PCR, the product was incubated at 72°C for 15 minutes with 0.5 
units of Taq polymerase (A-tailing step).  A 2 µl aliquot of the PCR product was 
ligated into the pGEM-T-Easy or TOPO vector according to manufacturers’ 
instructions.  Ligated plasmids were transformed into heat-shock competent E. 
coli XL1-Blue cells.  Successful transformants were selected on LB agar plates 
containing 50 µg ml-1 of ampicillin and insertion of a PCR product was assessed 
by a concurrent blue/white colony screen stemming from 0.5 mM IPTG and 80 µg 
ml-1 X-gal previously applied to surface of LB plates.  Integration of the PCR 
product was confirmed by PCR screen of 10 white colonies, picked using a sterile 
tooth pick and inoculated into 5 µl of distilled water.  PCR was run as standard 
except the DNA was replaced with 5 µl colony/water mix and the denaturation 
step increased to 10 minutes.  Vector specific primers (pGEM-T-Easy T7 and SP6; 
TOPO M13 Forward and Reverse) spanning the cloning site were used to verify 
the presence of an appropriate sized insert.  Where necessary the PCR product 
was sequenced.  
2.2.4 Restriction endonuclease digestion 
Nucleic acids (plasmid and genomic DNA) were digested using restriction 
endonucleases from New England Biolabs.   Digestion reactions were performed 
as recommended by the manufacturer, with restriction endonuclease(s) used 
with the optimum reaction buffer (New England Biolabs), supplemented with BSA 
where appropriate.  Digested DNA was visualised by agarose gel electrophoresis 
and if required, purified using a Gel Extraction kit (Qiagen) according to the 
manufacturer’s instructions.         
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2.2.5 Ligation 
Ligation of DNA was performed using T4 DNA ligase and T4 ligase buffer (New 
England Biolabs) in reactions as per the manufacturer’s instructions.  Typically 
digested plasmid and DNA insert were purified using a Gel Extraction kit (Qiagen) 
and added to 10 µl ligation reaction in different ratios (insert:vector, 1:3, 3:1, 
1:1) and incubated overnight at 16oC.  For blunt-ended ligations digested vectors 
were treated with CIP (calf intestinal alkaline phosphatase, New England 
Biolabs) to prevent self religation.  Following ligation 2 µl of the reaction was 
transformed into competent E. coli cells and selected using the appropriate 
antibiotic.  Correct ligation was verified by colony PCR (using insert and vector 
specific primer pairs) or by plasmid purification and restriction digest analysis. 
2.2.6 Sequencing 
All DNA sequencing was performed by the Sequencing Service of the University of 
Dundee (www.dnaseq.co.uk).  The sequence data were analysed using the 
Vector NTI applications ContigExpress and AlignX (Invitrogen).  
2.3 Plasmid generation 
All plasmids described in this study are detailed in Table 2-3, and specific details 
regarding their construction listed below.  All oligonucleotide primers were 
designed using sequence information provided by tritrypDB or geneDB 
(http://tritrypdb.org or http: http://www.genedb.org).  Plasmids generated are 
listed in Table 2-3.  
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Table 2-3 Plasmids used in this study. 
Plasmids generated for use in this study, including target gene (with tritrypDB identifier in bracket), 
plasmid backbone and brief description.  Drug resistance listed, stating bacterial then trypanosome 
resistance markers.  Plasmid generation described in section 2.3.     
 
2.3.1 In situ fluorescent tagging of T. brucei ATG8.1 
The native T. brucei ATG8.1 (Tb927.7.5900) locus was modified to include N-
terminal human influenza hemagglutinin (HA) and green fluorescent protein 
(GFP) epitope tags, using a PCR-based strategy as described by Shen et al 2001.  
Briefly, OL2304 and OL2305 were designed to amplify an HA:GFP cassette 
(including blasticidin drug resistance) from pGL1466.  The oligos also introduced 
80 base-pairs (bp) additions to each flank, corresponding to the genomic 
sequence immediately up- and downstream of the T. brucei ATG8 start codon 
and were used to target the epitope tag and drug resistance marker to the 
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correct locus.  The 1899 bp PCR product was amplified using high fidelity PfX50 
and cloned into the TOPO vector generating pGL1810.  The construct was 
verified by sequencing and for transfection pGL1810 was digested with EcoRV.    
2.3.2 Recombinant protein expression plasmids 
T. brucei MCA4 was amplified from genomic DNA (strain 427) using Pfx50 
(Invitrogen) with OL2329 (NdeI) and OL2330 (XhoI), with the added restriction 
sites indicated in brackets.  The resulting product was cloned into TOPO and 
sequenced before excision using NdeI and XhoI (New England Biolabs) and ligated 
into the pET-28a(+) E. coli protein expression vector (pGL655), pre-digested with 
NdeI and XhoI.  The resulting plasmid was named pGL1697. 
The same procedure was repeated with ATG8.1 (Tb927.7.5900) amplified from 
T. brucei genomic DNA (strain 427), using primers OL2775 (NheI) and OL2776 
(XhoI).  The generated RNAi plasmid was named pGL2115. 
2.3.3 RNAi constructs 
The MCA4 RNAi target fragment was identified using the TrypamoFAN: RNAit 
target selection script (http://trypanofan.path.cam.ac.uk/software/RNAit).  
The identified 469 bp fragment of T. brucei MCA4 was amplified from genomic 
DNA (strain 427) by PCR using Pfx50 (Invitrogen) with primers OL2312 (BamHI) 
and OL2313 (HindIII), with the added restriction sites in brackets.  The resulting 
product was cloned into TOPO and sequenced before excision and ligation into 
pGL571, pre-digested with BamHI and HindIII.  The resulting plasmid was named 
pGL1695.  
The same procedure was repeated with a 500 bp fragment of T. brucei ATG3 
(Tb927.2.1890) amplified from T. brucei genomic DNA (strain 427), using primers 
OL3668 (HindIII) and OL3669 (BamHI).  The generated RNAi plasmid was named 
pGL2065. 
To prepare the RNAi plasmids for transfection they were digested with NotI.  
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2.3.4 MCA4 knockout constructs 
The 5’ and 3’ flanks of MCA4 (Tb927.10.2440) were amplified by PCR from 
genomic DNA (strain 427) with Phusion (Finnzymes) and the primer pairs OL3245 
(NotI) / OL3246 (XbaI) and OL3247 (ApaI) / OL3248 (ApaI and XhoI), respectively.  
The restriction sites added by each oligonucleotide are indicated in brackets.  
The resulting fragments were cloned separately into pGEM-T-Easy and confirmed 
by sequencing.  The 5’ and 3’ flanks were excised using NotI/XbaI and ApaI/XhoI 
and sequentially ligated into pGL1689, first pre-digested with NotI/XbaI and 
secondly with ApaI/XhoI.  The resulting construct was the named pGL1986, the 
NEO MCA4 knockout construct.  Exchange of resistance genes was achieved by 
excising the HYG gene from pGL1688 using BmgBI and BglII and cloning this into 
pGL1986 pre-digested with BmgBI and BglII, generating pGL1985 the HYG MCA4 
knockout construct.  For transfection into T. brucei pGL1986 and pGL1985 were 
digested with NotI and XhoI.      
2.3.5 MCA4 re-expression construct 
To switch the HYG resistance gene of pGL1742 site directed mutagenesis was 
used to introduce specific restriction sites (NdeI and BclI) flanking the HYG gene, 
which was subsequently excised using NdeI and BclI (New England Biosciences) 
and replaced with the BSD gene.  The resulting construct was digested with XhoI 
and BamHI (removing YFP tag) and the MCA4 gene was cloned in using the same 
restriction sites, producing pGL2067.   
2.3.6 Tagging of genes expressed from ectopic locus 
The plasmids used to for the ectopic expression of epitope tagged genes are 
described in detailed by Kelly et al., 2007. 
ATG8.1 (Tb927.7.5900) was amplified from genomic DNA (strain 427) by PCR 
with Pfx50 (Invitrogen) using primers OL2621 (HindIII) and OL2622 (BamHI), the 
added restriction sites are in brackets.  The resulting fragment was cloned into 
TOPO and sequenced before ligation into pGL1731, pre-digested with BamHI and 
HindIII.  This created an N-terminal yellow fluorescent protein (YFP) tagged 
ATG8.1 expression construct, named pGL1843.  
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Additional N-terminally tagged YFP expression constructs were prepared by 
following the same procedure for T. brucei ATG8.2 (Tb927.7.5910), using 
primers OL2623 (HindIII) and OL2624 (BamHI), producing pGL1835 and T. brucei 
ATG8.3 (Tb927.7.3320), using primers OL2625 (HindIII) and OL2626 (BamHI), 
producing pGL1836. 
A construct to express MCA4 with 6 HA epitope tags fused to the C-terminus was 
generated as above using primers OL3397 (HindIII) and OL3398 (BamHI and BclI) 
and the plasmid backbone pGL1728.  The resulting construct was named 
pGL2010. 
2.4 Site directed mutagenesis 
To change specific amino acids of proteins expressed from plasmids, targeted 
alterations were made to the nucleotide sequence using the Quick Change 
Mutagenesis Kit (Stratagene), according to manufacturer’s instructions.  All 
mutations were confirmed by DNA sequencing.  
2.5 Preparing DNA for transfection  
DNA used in trypanosome transfections was linearised by digestion with the 
appropriate restriction endonucleases and purified by ethanol precipitation.  The 
digestion reaction volume was estimated and 0.1 volumes of sterile 3 M sodium 
acetate solution pH 5.2, was added and vortex mixed.  A further 2.5 volumes of 
100 % ethanol was added and vortex mixed before incubation at -80°C overnight.  
The solution was centrifuged at 14, 000 g for 20 minutes at 4°C.  The DNA pellet 
was then washed twice in 70 % ethanol and re-suspended in 10 µl sterile 
autoclaved water and stored at -20°C until needed.   
2.6 Southern blotting 
Southern blotting was used to confirm the presence of specific DNA sequences in 
genomic DNA isolated from T. brucei.  Extracted genomic DNA was digested 
overnight using the appropriate enzymes and efficient digestion was verified by 
visualisation of 1 µl of digestion mix run on an agarose gel.  Digested DNA (5 µg) 
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from the different cell lines analysed was electrophoresed at a low voltage in a 
large 0.8 % agarose gel (200 ml) stained with SYBR-Safe DNA stain (Invitrogen).  
To enable subsequent estimation of DNA fragment size, a photograph of the gel 
(exposed to U.V. light) was taken with a ruler alongside to allow correlation of 
the 1 kb DNA ladder bands with the migration distance.  Purines were removed 
from the gel by gentle washing in 0.25 M HCl for 10 minutes, before washing in 
distilled water.  The gel was then immersed in denaturation buffer (1.5 M NaCl, 
0.5 M Tris-HCl, pH 7.0) for 30 minutes and gently agitated before rinsing in 
distilled water.  Finally the gel was incubated in neutralisation buffer (3 M NaCl, 
0.5 M Tris-Hcl, pH 7.0) for 30 minutes and rinsed in distilled water.   
To transfer the DNA onto a nylon membrane (Hybond-N, GE Healthcare) the gel 
was placed onto a blotting paper wick, the ends of which were immersed in 20 x 
SCC buffer (3 M NaCl, 0.3 M sodium citrate pH 7.0).  The membrane was layered 
on top of the gel, with two sheets of blotting paper and excess weighted paper 
towels added to draw the 20 X SCC buffer up the wick.  The transfer was left to 
occur overnight and then the membrane was washed in 2 x SCC buffer before the 
DNA was crosslinked to the membrane in a U.V. Stratalinker 2400 crosslinker 
(Statagene) set at 1200 mJoules.   
The blot was prehybridized and probed overnight with DNA digested out of a 
plasmid (corresponding to either the 5’ flanking region used for MCA4 
replacement, pGL1985 or the MCA4 open reading frame, pGL1697) labelled with 
the Alk-Phos Direct labelling kit (Amersham) as per the manufacturer’s 
instructions.  Signal was detected using CDP-Star detection reagent (Amersham) 
and exposed using a Kodak film imager.  The blot was stripped by incubation in 
0.5 % SDS and re-probed following the same protocol detailed above.  
2.7 Protein biochemistry 
2.7.1 Recombinant protein: expression and purification 
The MCA4 protein expression vector (pGL1697) was transformed into E. coli BL21 
Rosetta cells (Stratagene) and an individual colony used to inoculate a 10 ml 
starter culture of Overnight Express TB Medium (Novagen).  After 10 hours 
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growth the starter culture was used to inoculate 300 ml of pre-warmed 
Overnight Express TB Medium which was incubated overnight at 37oC with 
shaking at 220 rpm.  The following morning the cells were harvested by 
centrifugation at 4500 g for 20 minutes and the pellet frozen at -20oC until 
required.  
The cell pellet was thawed on ice and lysed in 40 ml of Bacterial Protein 
Extraction Reagent (B-PER) (Pierce) supplemented with 10 µg ml-1 DNAse 1 
(Sigma) and incubated on a rotary shaker at 4oC for 30 minutes.  The solution 
was fractionated by high-speed centrifugation at 16,000 g for 20 minutes and the 
soluble fraction was filtered through a 0.2 µM filter (Ministart) and stored on ice.  
The recombinant HIS tagged protein was then purified from the soluble fraction 
by immobilised metal ion affinity chromatography on a column packed with 
Metal Chelate-20 (Poros) operated by the BioLogic DuoFlow purification system 
(Bio-Rad).  All buffers used were stored on ice before and during purification.  
The column was equilibrated with equilibration buffer (50 mM NaH2PO4, 300 mM 
NaCl and 0.5mM imidazole, pH 8.0) before loading of the soluble fraction at 5 
ml/minute.  Contaminating proteins were removed from the column with wash 
buffer (50 mM NaH2PO4, 300 mM NaCl, 20 mM imidazole) and the bound proteins 
were released and eluted in 1 ml fractions using elution buffer (50 mM NaH2PO4, 
300 mM NaCl,  0.5 M imidazole pH 8.0).  Peak fractions were pooled and buffer 
exchanged into 50 mM Tris pH 8 using a PD10 column (GE Healthcare) and for 
long term storage 150 mM NaCl was added.  The protein purity was assessed by 
SDS-PAGE and quantified using the BCA Protein Assay (Pierce) as per 
manufacturer’s guidelines. 
The same protocol was followed for the expression of T. brucei ATG8.1 
(pGL2115) except the using a modified wash buffer (50 mM NaH2PO4, 300 mM 
NaCl, 40 mM imidazole, pH 8.0) and changing the storage buffer to 50 mM Tris, 
150 mM NaCl pH 5.5. 
2.7.2 MCA4 antibody production and purification 
Recombinant MCA4 was purified as described above and used as an antigen to 
produce a specific polyclonal antibody.  Two chickens were immunised with 
recombinant MCA4 (four 250 µl inoculations of 1 mg ml-1 protein over the course 
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of four months) at the Scottish National Blood Transfusion Service (Penicuik, 
Midlothian) and all eggs laid after the third injection were collected 
(approximately 50 per chicken) along with pre-immune egg yolks.  The egg yolks 
were separated and stored at -20oC before purification of total IgY using the 
Eggcellent IgY Purification kit (Pierce). 
2.7.3 ATG8.1 antibody production  
Recombinant ATG8.1 was purified as described above and used as an antigen to 
produce a specific polyclonal antiserum.  One rabbit was immunised with 
recombinant ATG8.1 (four 250 µl inoculations of 1 mg ml-1 protein over the 
course of three months) at the Scottish National Blood Transfusion Service 
(Penicuik, Midlothian) and the pre-immune serum along with three bleeds were 
collected and stored at -20oC. 
2.7.4 Antibody affinity purification 
In a 5 ml polypropylene column (Pierce), approximately 2.5 mg of purified 
recombinant MCA4 or ATG8 protein was covalently linked to 1 ml of AminoLink 
Coupling Gel (Pierce) according to the manufacturer’s protocol and equilibrated 
with 10 ml of PBS.  4 ml of anti-ATG8 rabbit antiserum (3rd bleed) was diluted 
1:1 with PBS, whereas purified anti-MCA4 IgY was already resuspended in PBS.  
The protein/AminoLink resin was incubated overnight at 4oC in a 50 ml conical 
tube with the antiserum/total IgY.  The resin was transferred back to the 5 ml 
polypropylene column and washed in 12 ml of PBS before eluting bound 
antibodies with in multiple 1 ml fractions of Immunopure IgG elution buffer 
(Pierce).  The pH of eluted samples was immediately neutralised by the addition 
of 50 µl of 1M Tris pH 9.  The various elution fractions were then quantified by 
measurement of their OD at λ = 280 nm.  The peak fractions were pooled and 
concentrated using a Vivaspin 2 ultrafiltration unit (10,000 MWCO, Vivascience), 
at 4000 g.  The concentrate was then washed 3 times with 2.5 ml of PBS, and 
finally time with 2.5 ml of PBS + 0.05 % (w/v) sodium azide, before 
concentrating to final volume of 1 ml.  The aliquots were stored at 4oC. 
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2.7.5 Protein electrophoresis (SDS-PAGE)         
Whole cell extracts and purified recombinant protein were separated by SDS-
PAGE (sodium dodecyl phosphate polyacrylamide gel electrophoresis).  Typically 
12 % or 15 % (w/v) polyacrylamide gels were used, with a layer of 5 % stacking 
gel cast on top to help load and focus samples before full separation in the 
resolving gel.  Samples were mixed in 2 x SDS-PAGE loading buffer (20 % (v/v) 
glycerol, 2.5 % (w/v) SDS, 0.05 % (w/v) bromophenol blue, 0.2 M Tris-HCl pH 6.8, 
20 mM DTT) and denatured by boiling at 100oC for 4 minutes.  Electrophoresis 
was performed in XCell SureLock Mini Cell chambers (Invitrogen) with SDS-PAGE 
running buffer (2.5 mM Tris, 19.2 mM glycine and 0.01 % (w/v) SDS).  The voltage 
was set at 100 V while samples were in the stacking gel, then increased to 180 V 
as samples progressed through the resolving gel.  With each gel, 2 µg of protein 
marker (Pre-stained Protein Marker Broad Range, New England Biolabs) was run 
as a reference to estimated molecular weight of protein samples.   
Where stated polyacrylamide gels were prepared containing 6 M urea by 
dissolving appropriate weight of urea powder in the Tris and acrylamide solution 
aided by gentle heating.  The remaining components of the gel were added 
before casting as standard. 
2.7.6 Coomassie staining of SDS-PAGE 
Protein gels were simultaneously fixed and stained by immersion in Coomassie 
stain solution (2.5 % (w/v)  Coomassie Brilliant Blue R-250, 45 % (v/v) methanol, 
10 % acetic acid) for 1 hour at room temperature.  Gels were destained with 
several changes of destain solution (10 % (v/v) methanol, 10% (v/v) acetic acid) 
until optimum staining/background resolution was observed, following which 
they were washed in several changes of distilled water and photographed on the 
Gel-Doc 2000 (Biorad). 
2.7.7 Western blotting  
To analyse by western blot, samples were separated by SDS-PAGE and 
transferred by ‘wet’ transfer to nitrocellulose membrane (Hybond-C, Amersham 
Biosciences) in an X-Cell II Blot Module (Invitrogen).  The inner chamber was 
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filled with transfer buffer (20 % (v/v) methanol, 20 mM Tris, 15 mM glycine) and 
efficient protein transfer was ensured by using adequate support pads and filter 
paper pre-soaked in transfer buffer.  Transfer was performed at 30 volts for 1 
hour with the outer chamber filled with water to maintain a cool temperature.  
After transfer the membrane was saturated with a blocking solution of 5 % 
powdered milk (Marvel) in TBST buffer (25 mM Tris-HCl pH 8, 120 mM NaCl, 0.1 % 
Tween-20) for at least 1 hour followed by incubation with the appropriate 
antibodies diluted in blocking solution.  Following primary and secondary 
antibody application the membrane was washed three times for 5 minutes in 
blocking solution.  All secondary antibodies used were conjugated to horse 
radish peroxidase (HRP) and labelled proteins were revealed by applying an ECL 
(enhanced chemiluminescence) substrate (SuperSignal West Pico 
Chemiluminescent Substrate or West Femto Maximum Sensitivity Substrate, 
Pierce) to the membrane according to manufacturers’ instructions.  
Chemiluminescence was visualised by exposing the western blot on photographic 
film processed in a Kodak film processor.  
2.7.8 Co-immunoprecipitation experiments 
To immunoprecipitated MCA4 and any associated proteins pre-immune IgY and 
affinity purified anti-MCA4 were coupled to Carbolink resin (Pierce) according to 
manufacturer’s instructions. 
4.5 x 109 wild type T. brucei (strain 427) cells were purified from rat blood using 
DE52 cellulose (Whatman) and lysed in 4.5 ml of ice cold lysis buffer (50 mM 
Tris-HCl pH 7.4, 150 mM NaCl, 0.2% (v/v) NP40, 0.5 % (w/v) CHAPS, 1.5 x Roche 
Protease Inhibitor Cocktail) before centrifugation at 100,000 g for 45 minutes at 
4oC.  Supernatant was transferred to a fresh tube and pre-cleared with 200 µl 
pre-immune IgY Carbolink resin, incubated on rotary shaker at 4oC for 2 hours.  
The pre-clear step was repeated after centrifugation recovery of pre-immune IgY 
Carbolink.  The supernatant was divided and 100 µl of anti-MCA4 Carbolink resin 
was added to the experimental sample and 100 µl of pre-immune IgY Carbolink 
added to control sample, before overnight incubation at 4oC on a rotary shaker.  
The following day the resin was separated from the supernatant using 
microcentrifuge spin cups (Pierce) and washed with lysis buffer (repeated x3) 
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and PBS (repeated x3).  Precipitated material was released in 8 separate 100 µl 
fractions of elution buffer (100 mM glycine pH 2.6) and immediately neutralised 
with 10 µl Tris pH 9.0.  Where indicated samples (excised band from SDS-PAGE) 
were analysed by mass spectrometry at the Sir Henry Wellcome Functional 
Genomics Facility (SHWFGF).  Samples were digested with trypsin and analysed 
by electrospray ionisation mass spectrometry on a Q-STAR Pulsar I hybrid MS/MS 
system.  Resulting data was analysed by SHWFGF using Applie Biosystems Analyst 
QS (v1.1) software and the automated Matrix Science Mascot Daemon server 
(v2.2.06) and all identifications were assigned by the Mascot search engine.   
2.8 Acyl-biotin exchange 
To detect MCA4 palmitoylation an acyl biotin exchange assay was used as 
previously described by Emmer and co-workers (Emmer et al. 2009).  Two 
samples each comprised of 1.2 x109 BSF T. brucei cells were pelleted and 
washed twice in PBS before suspension in 2.5 ml of lysis buffer 1 (50 mM Tris-HCl 
pH7.4, 150 mM NaCl, 5 mM EDTA, 1.5 x Roche Protease Inhibitor Mix*, 10 mM 
NEM *(n-ethylmaleimide, Sigma), * always added just prior to use).  Cells were 
lysed by adding 0.5 ml of 10 % Triton X-100 and incubated for 1 hour at 4oC on a 
rotary shaker.  Intact cells and nuclei were pelleted by low speed centrifugation 
for five minutes at 800 g at 4oC.   
Supernatants were transferred to fresh 50 ml tubes for methanol-chloroform 
precipitation.  To each 3 ml lysate fraction 12 ml methanol, 4.5 ml chloroform, 9 
ml distilled water were added sequentially before vortex mixing and 
centrifugation at 6000 g for 20 minutes at 4oC.  The upper phase was aspirated 
and 9 ml methanol was added before further vortex mixing and centrifugation at 
6000 g for 10 minutes at 4oC.  Supernatant was aspirated and the protein pellets 
air-dried for 5 minutes.   
The pellets were resuspended in 600 µl solubilisation buffer 1 (50 mM Tris-HCl 
pH7.4, 5 mM EDTA, 4 % SDS, 10 mM NEM) and incubated at 37oC for 10 minutes 
with occasional vortex mixing.  Samples were diluted with 2.4 ml lysis buffer 2 
(50 mM Tris-HCl pH7.4, 150 mM NaCl, 5 mM EDTA, 1.5 x Roche Protease Inhibitor 
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Mix, 10 mM NEM, 0.2 % Triton X-100) and incubated overnight at 4oC on a rotary 
shaker.   
NEM was removed by three rounds of methanol chloroform precipitation, as 
described above but with the protein pellet from round 1 and 2 suspended in 750 
µl solubilisation buffer 2 (50 mM Tris-HCl pH7.4, 5 mM EDTA, 4 % SDS) and diluted 
with 2.25 ml lysis buffer 3 (50 mM Tris-HCl pH7.4, 150 mM NaCl, 5 mM EDTA, 1.5 x 
Roche Protease Inhibitor Mix, 0.2 % Triton X-100).  Following the third and final 
methanol precipitation the protein pellets were resuspended in 600 µl 
solubilisation buffer 2.  
To the experimental sample 2.4 ml of hydroxylamine-label reagent (200 µM 
biotin-HPDP (Pierce), 700 mM hydroxylamine (Sigma) pH 7.4, 5 mM EDTA, 0.2 % 
Triton X-100 amd 1.5 x Roche Protease Inhibitor Mix) was added and an 
equivalent volume of Tris-label reagent (200 µM biotin-HPDP, 50 mM Tris pH 7.4, 
5 mM EDTA, 0.2 % Triton X-100 amd 1.5 x Roche Protease Inhibitor Mix) was 
added to the control sample.  Both samples were incubated for 1 hour at room 
temperature on a rotary shaker.  The excess labelling reagent was removed by 
three rounds of methanol chloroform precipitation, as for the NEM removal step 
but the final pellets were resuspended in 150 µl 2 % SDS buffer (50 mM Tris-HCL 
pH7.4, 5 mM EDTA, 2 % SDS), with 30 µl collected to represent input samples. 
Biotinylated proteins were then precipitated using streptavidin agarose.  Excess 
SDS was diluted out of the remaining samples by adding 2.28 ml lysis buffer 3 
and incubating for 30 minutes on a rotary shaker.  Particulates were removed by 
pulse centrifugation at 14, 000 g for 30 seconds and supernatant transferred to 
fresh tubes containing streptavidin agarose prewashed in precipitation wash 
buffer (50 mM Tris-HCl pH7.4, 150 mM NaCl, 5 mM EDTA, 1.5 x Roche Protease 
Inhibitor Mix, 0.2 % Triton X-100, 0.1 % SDS) and incubated for 90 minutes at 
room temperature.  The streptavidin beads were washed 5 times in precipitation 
wash buffer and bound proteins were eluted by incubation with elution buffer 
(50 mM Tris-HCl pH7.4, 150 mM NaCl, 5 mM EDTA, 1.5 x Roche Protease Inhibitor 
Mix, 0.2 % Triton X-100, 0.1 % SDS, 1 % β-mercaptoethanol). 
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2.9 MCA4 processing reactions 
2.9.1 Autocatalytic processing 
10 µg of purified recombinant MCA4 or MCA4S219C was incubated in a reaction 
buffer (50mM Tris-HCl, pH 8, 150 mM NaCl, 5 mM DTT) with and without 10 mM 
CaCl2 for 1 hour at 37
oC.  The extent of autocatalytic processing was monitored 
by SDS-PAGE.  
2.9.2 MCA2 processing of MCA4 
10 µg of purified MCA4 was incubated with increasing amounts of purified 
recombinant MCA2 (0, 1, 10 and 100 ng) in reaction buffer (50mM Tris-HCl, pH 8, 
150 mM NaCl, 5 mM DTT, 10 mM CaCl2) for 1 hour at 37
oC.  The extent of 
processing was monitored by SDS-PAGE. 
2.9.3 N-terminal Edman degradation 
To sequence the N-terminus of processing products reactions were set up as 
described in section 2.9.1and 2.9.2 and separated on NuPAGE Novex 10 % Bis-Tris 
gels (Invitrogen) with MOPS running buffer (Invitrogen).  A PVDF membrane 
(Hybond-P, Amersham Biosciences) was prepared by briefly soaking in 100 % 
methanol before washing in distilled water for 10 minutes followed by 
equilibration in transfer buffer (20 % (v/v) methanol, 20 mM Tris, 15 mM glycine) 
for 10 minutes.  Prior to transfer the Bis-Tris gel was also soaked in transfer 
buffer for 20 minutes.  The protein was transferred to PVDF membrane by ‘wet’ 
transfer in an X-Cell II Blot Module (Invitrogen) at 30 V for 1 hour.  The inner 
chamber was filled with transfer buffer and the outer filled with water.  The 
membrane was stained (0.1 % (w/v) Coomassie Brilliant Blue R-250, 50 % (v/v) 
methanol, 1 % (v/v) acetic acid) for 1 minute and destained (40 % (v/v) 
methanol, 10 % (v/v) acetic acid), followed by extensive washing in distilled 
water.  The blot was air dried and the appropriate bands were excised using a 
sterile scalpel blade and sent to the University of Dundee, MRC Protein 
Phophorylation Unit, to carry out the N-terminal Edman degradation reaction. 
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2.10 Activity assays 
Proteolytic activity of purified recombinant MCA4 was assessed by measuring the 
hydrolysis of synthetic fluorogenic substrates.  All assays were run in clear 
bottom 96 well plates and typically contained the following components (unless 
stated otherwise): 2 µg purified enzyme, reaction buffer (50mM Tris-HCl, pH 8, 
150 mM NaCl, 5 mM DTT and 10 mM CaCl2), 10 µM substrate (e.g. Z-RR-AMC) and 
distilled water to 200 µl.  All assays were run in triplicate and included ‘no-
enzyme’ controls.  
Fluorescence was read every 2 minutes for maximum of 3 hours in an EnVision 
Multilabel Reader (Perkin Elmer, Beaconfield, UK) at excitation wavelength (λEx) 
of 355 nm and emission wavelength (λEm) of 460 nm using the general mirror.  
The fluorescence readings were analysed using Microsoft Excel.  Where indicated 
peptidase inhibitors were added to the reaction at the concentration in 
brackets: leupeptin (100 µM), antipain (100 µM), E64 (10 µM), PMSF (0.5 mM) and 
Pefabloc (2.5 mM).  
For activity assays of processed MCA4, purified recombinant MCA2 was added to 
MCA4 at ratio of 1:100 (e.g. 0.1 µg MCA2 : 10 µg MCA4) and incubated with 
reaction buffer (50mM Tris-HCl, pH 8, 150 mM NaCl, 5 mM DTT and 10 mM CaCl2) 
for 1 hour at 37oC.  Aliquots containing 0.02 µg MCA2 and 2 µg MCA4 were 
removed and added to activity assays as described above and assessed by SDS-
PAGE to check for MCA4 processing. 
2.11 Microscopy 
Fluorescent microscopy images were obtained using an Applied Precision 
DeltaVision Deconvolution microscope system fitted with a CoolSnap HQ camera.  
Image capture and microscope operation was performed using the software 
package SoftWoRx.  Fluorescence was viewed using the FITC filter (λEx 490 nm / 
λEm 528 nm), RD-TR-PE filter (λEx 555 nm / λEm 617 nm), DAPI filter (λEx 360 nm / 
λEm 457  nm) and reference images were obtained using the differential 
interference contrast (DIC) filter.  Exposure time was set to 1 second with the 
transmission level of the neutral filter optimised for each sample and 60 x or 100 
 48 
x oil immersion objectives were used.  Typically 15 Z-stacks were obtained and 
individually deconvolved using the automatic conservative ratio setting before 
projection into one representative image.  To merge images containing multiple 
fluorescent signals Adobe photoshop was used.   
Cell counting for the RNAi induction experiment was performed using a Zeiss 
Axioplan microscope, with images captured by a Hamamatsu ORCA-ER digital 
camera and processed using Openlab version 3.5 software. 
2.11.1 Direct cell fluorescence 
For each slide approximately 1 x 105 T. brucei cells were washed twice in 
trypanosome dilution buffer (TDB) (20 mM Na2HPO4, 2 mM NaH2PO4, 80 mM NaCl, 
5 mM KCl, 1 mM MgSO4, 20 mM glucose, pH 7.4) before fixation in 1 % (w/v) 
paraformaldehyde (Sigma) with concurrent incubation on ice for 15 minutes 
(BSF) or 30 minutes (PCF).  After two further washes in TDB the cell pellet was 
resuspended in 20 µl TDB and evenly spread onto twin frosted end 76 x 26 mm 
microscope slide (BDH) coated in 0.1 % poly-l-lysine (Sigma) and the cells 
allowed to sediment.    
Excess liquid was removed and the cells on each slide were stained with 10 µl of 
1 µg ml-1 4,6-Diamindino-2-phenylindole (DAPI) in mounting solution (PBS, 50 % 
(v/v) glycerol, 2.5 % (w/v) DABCO).  All slides were fitted with a coverslip sealed 
with nail varnish.  
2.11.2 Immunofluorescence analysis 
The protocol used for immunofluorescence analysis was adapted from the 
method published by Field and co-workers (Field et al. 2004).  Briefly, mid-log 
BSF parasites were washed in vPBS (137 mM NaCl, 3 mM KCl, 16 mM Na2HPO4, 3 
mM KH2PO4, 46 mM sucrose, 10 mM glucose, pH 7.6) before fixation on ice in 3 % 
paraformaldehyde for 10 minutes.  The fix solution was diluted out with excess 
vPBS and two further cell washes were performed.  Fixed cells were applied to a 
2 cm2 area outlined in nail varnish, on 0.01 % poly-l-lysine treated microscope 
slides and allowed to sediment.  When required the cells were permeabilised by 
applying 0.1 % (v/v) Triton X-100 in PBS for 10 minutes before washing with PBS 
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and blocking for 1 hour using 20 % (v/v) foetal calf serum (Sigma) in PBS.  The 
primary antibody was then applied (diluted in 20 % (v/v) foetal calf serum in 
PBS) and incubated for 2 hours at room temperature.  Slides were washed three 
times with PBS and the corresponding secondary antibody applied (diluted in 20 
% (v/v) foetal calf serum in PBS) and incubated for 1 hour.  Slides were washed 
three times with PBS, stained with 1 µg ml-1 DAPI in mounting solution and 
sealed with a coverslip and nail varnish. 
Primary antibodies used : affinity purified anti-MCA4 1/400 (chicken) and 
monoclonal anti-HA (Roche) 1/1000 (mouse).  Secondary antibodies used: Alexa 
Fluor 488 (green)-conjugated anti-chicken (Molecular Probes) and Alexa Fluor 
594 (red)-conjugated anti-mouse (Molecular Probes). 
2.11.3 Immuno-electron microscopy 
Immuno-electron microscopy services were provided by the Integrated 
Microscopy Facility at the University of Glasgow, with procedures overseen by Dr 
Laurence Tetley and Ms Margaret Mullin.   
Wild type BSF T. brucei cell pellet was chemically fixed in suspension and 
maintained in 0.2 % (v/v) gluteraldehyde, 2 % (w/v) paraformaldehyde in PBS 
(pH 7.2) on ice for 1 hour.  After fixation the cells were rinsed in PBS and 
embedded in Lowicryl resin using the progressive lowering of the temperature 
method.  Cells were cut into blocks and mounted on metal pins and frozen in 
liquid nitrogen before sectioning with a Leica Ultracut UCT/FCS.  The 
cryosections were blocked with 0.1 M glycine followed by 5 % (w/v) BSA and then 
labelled with affinity purified anti-MCA4 (1:10) and 1.4 nm gold (rabbit) anti-
chicken (1:20) (Aurion).  Cells were contrast stained and the immuno-labelling 
was enhanced by 15 minutes treatment with R-gent (Aurion).  Sections were 
viewed with a LEO 912 transmission electron microscope.  
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2.12 T. brucei cell culture 
2.12.1 General culturing techniques 
T. brucei (strain 427) were grown in culture as bloodstream form (BSF) and 
procyclic form (PCF) parasites.  BSF were grown to a maximum cell density of 1 
x 106 ml-1 at 37°C in 5 % carbon dioxide in HMI-9 media supplemented with 10 % 
heat-inactivated foetal calf serum (FCS), 10 % serum plus and 0.5 µg ml-1 
penicillin-streptomycin solution (Sigma).  PCF T. brucei were grown to a 
maximum cell density of 1 x 107 ml-1 at 27°C in 5 % carbon dioxide in SDM-79 
media supplemented with 10 % FCS and 0.5 µg ml-1 penicillin-streptomycin 
solution (Sigma).  The genetic knockout of MCA4 was performed in BSF T. brucei 
427.  RNAi analysis and the tetracycline induced expression of tagged transgenes 
was performed in BSF 427 13-90 and PCF 427 29-13 cell lines (Wirtz et al. 1999).  
To induce RNAi or transgene expression 1 µg ml-1 tetracycline was added to the 
culture media.   
For all parasite growth analysis, the cell densities of cultures was determined by 
counting the number of cells in 10 µl of culture using an Improved Neubauer 
haemocytometer counting chamber (Weber Scientific).  When monitoring BSF 
parasite growth, cultures were seeded at 1 x105 cells ml-1 and the culture 
density was determined at regular intervals, with cultures passaged back to 1 x 
105 cells ml-1 every 24 hours.  PCF cultures were seeded at 5 x 105 and passaged 
every 72 hours. 
Stabilates of T. brucei were prepared for long term cryopreservation.  Cultured 
cells (mid-log) were pelleted and resuspended in HM19 with 10 % (v/v) glycerol 
(BSF) or SDM79 with 10 % (v/v) glycerol (PCF).  1 ml aliquots were transferred to 
cryovials and stored at -80oC for 24 hours, before transfer to liquid nitrogen 
tanks for long term storage.   
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2.12.2 T. brucei genomic DNA isolation 
Genomic DNA was prepared from cultured T. brucei using the DNeasy Blood and 
Tissue kit (Qiagen), following the Cultured Animal Cell protocol outlined in the 
manufacturer’s instructions.  
2.12.3 BSF transfection   
BSF (strain 427) parasites were cultured as previously described.  For each 
transfection 1 x 107 mid-log cells were harvested by centrifugation at 1500 g for 
10 minutes at 37°C.  The cell pellet was resuspended in 100 µl Human T Cell 
Nucleofector Solution (Lonza), transferred to an electroporation cuvette (Lonza) 
and mixed with 10 µg of linearised DNA.  A control transfection was performed 
following the same method but omitting DNA.  The cuvettes were then pulsed 
once on programme X-001 using the Human T Cell Nucleofector machine (Amaxa) 
and the parasites were immediately transferred to 30 ml of prewarmed 
complete HM19 containing with no selective drugs.  Dilutions of the parasites 
(1:100 and 1:1000) were then plated out into 24 well plates and incubated at 
37°C.  The following day selective drugs were added and clones generally, 
detected after 6 to 8 days.  Drug concentrations used for transgenic BSF T. 
brucei 427: 5 µg ml-1 hygromycin B (Calbiochem), 2.5 µg ml-1 G418 (Calbiochem), 
2.5 µg ml-1  phleomycin (InvivoGen) and 10 µg ml-1 blasticidin (Calbiochem).     
2.12.4 PCF transfection 
PCF (strain 427) parasites were cultured as previously described.  For each 
transfection 3 x 107 mid-log cells were harvested by centrifugation at 600 g for 
10 minutes at 27°C.  The cell pellet was resuspended in 100 µl Human T Cell 
Nucleofector Solution (Lonza) and transferred to an electroporation cuvette 
(Lonza) and mixed with 10 µg of linearised DNA.  A control transfection was 
performed following the same method but omitting DNA.  The cuvettes were 
then pulsed once on programme X-001 using the Human T Cell Nucleofector 
machine (Amaxa).  The parasites were immediately transferred to 10 ml of 
prewarmed SDM79 (15 % (v/v) FCS) without selective drugs and incubated 
overnight at 27°C.  Following recovery the culture was split into three pools and 
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selective drugs added.  Dilutions (1:100 and 1:1000) were prepared using SDM79 
(15 % FCS and appropriate selection drugs), before plating into 96 well plates 
with clones were detected after 14 to 21 days. Drug concentrations used for 
transgenic PCF T. brucei 427: 50 µg ml-1 hygromycin B (Calbiochem), 10 µg ml-1 
G418 (Calbiochem), 10 µg ml-1  zeocin (Calbiochem) and 20 µg ml-1 blasticidin 
(Calbiochem). 
2.13 RNAi induction and analyses 
RNAi was induced by adding 1 µg ml-1 tetracycline to cells passaged to 1 x105 ml-
1 (BSF) or 5 x 105 ml-1 (PCF) and the growth rate was compared to identical non-
induced control lines.  Cells were passaged every 24 hours (BSF) or 72 hours 
(PCF) and tetracycline added to induced cells.  At select time points samples 
were removed from the cultures for further analysis by western blot, 
quantitative real time PCR (RT-PCR), FACS analysis and microscopy of DAPI 
stained cells (<200 cells counted for three replicate cultures).   
2.13.1 RNA isolation and reverse transcriptase (RT) PCR 
For each sample, RNA was isolated from 1.5 x 107 cells using the RNAeasy kit 
(Qiagen) processed in the automated QIAcube (Qiagen) according to 
manufacturer’s instructions, with an added on column DNase -1 (Sigma) 
digestion step.  The integrity of isolated RNA was inspected on a 1 % agarose gel 
made with 1 x UltraPure TAE buffer (Invitrogen) stained with ethidium bromide.  
cDNA was produced from 1 µg of isolated RNA using random hexamer primers 
(Invitrogen) and SuperScript Reverse Transcriptase III (Invitrogen) according to 
manufacturers’ instructions.  To monitor genomic DNA contamination the 
procedure was performed without reverse transcriptase (-RT).     
2.13.2 Quantitative real time PCR  
Real time PCR analysis was performed on both +RT and –RT cDNA samples in 
reactions comprised of following:  1 µl of cDNA, 12.5 µl Power SYBR Green PCR 
Master Mix (Applied Biosystems), 3 µM primer 1,  3 µM primer 2 and 6.5 µl of 
water.  PCR reactions were carried out in triplicate in sealed 96 well plates, 
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using an Applied Biosystems 7500 Real Time PCR machine, with resulting data 
analysed on Applied Biosystems 7500 System Software.  Primers used for real 
time PCR were designed using the Applied Biosystems Primer Express 3.0 
programme and designed to amplify a 50 bp product specific to each target ORF. 
2.13.3 Fluorescence activated cell sorting (FACS)  
To analyse the DNA content of T. brucei, 1.5 x 106 cells were centrifuged at 800 
g for 10 minutes, then washed with TDB, centrifuged once more and 
resuspended in 1 ml of 70% (v/v) methanol in PBS.  Fixed cells were stored at 
4°C.  Prior to FACS analysis, the cells were centrifuged at 800 g at  4°C for 10 
minutes and washed with 10 ml PBS, centrifuged once more and resuspended in 
1ml of PBS supplemented with 10 µg ml-1 propidium iodide (Sigma) and 10 µg ml-1 
RNAse A (Sigma), and incubated at 37°C for 45 minutes, in the dark.  FACS 
analysis was performed on a Becton Dickinson FACSCalibur using the FL2-A 
Forward Scatter (FSC, relative cell size) and the Side Scatter detectors (SSC, cell 
granulometry or internal complexity).  Introduction of the prepared samples into 
the cytometer was automated with a FACS Loader (Worklist manager and Loader 
manager softwares).  For each sample, 10 000 events (cells) were analysed. Data 
interpretation was performed using the CellQuestPro software (BD Bioscience). 
2.13.4 Monitoring autophagy in T. brucei 
Autophagy was monitored by counting the number of autophagosomes labelled 
with YFP-ATG8 in T. brucei cell lines expressing YFP-tagged ATG8 proteins under 
the control of a tetracycline operator.  Autophagosome formation was monitored 
in response to different conditions, with fluorescence microscopy used to count 
the number of autophagosomes per cell for more than 200 cells (repeated for 
three replicate experiments) fixed with 1 % paraformaldehyde.  Transgene 
expression was induced by adding 1 µg ml-1 tetracycline to cultures before 
overnight incubation under standard conditions.   
The basal rate of autophagosome formation was determined in induced PCF cells 
following standard growth in nutrient rich SDM79 supplemented with 
tetracycline.  Starvation induced autophagosome formation was monitored by 
thorough washing and re-suspension of induced PCFs for 2 hours in pre-warmed 
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PBS supplemented with 1 µg ml-1 tetracycline (and wortmannin (Sigma) or 
rapamycin (Sigma) where indicated).  Similarly the basal rate of autophagosome 
formation was determined in induced BSF cells following standard growth in 
nutrient rich HM19 supplemented with tetracycline.  Autophagy induction was 
investigated using rapamycin and vasoactive intestinal peptide (VIP) (American 
Peptide Company).  
2.13.5 T. brucei animal infection 
1 x 105 cultured BSF T. brucei (strain 427) were inoculated into ICR mice by intra 
peritoneal injection and the parasitemia monitored daily by haemocytometer 
cell count of mouse blood taken from a tail vein diluted in 0.83 % ammonium 
chloride.  For infection experiments, groups of four mice were infected with 
trypanosomes taken directly from the same donor mouse.  
For large scale trypanosome purification rats were inoculated with cultured BSF 
T. brucei (strain 427) and culled at peak parasitemia with the maximum blood 
extracted by cardiac puncture (approximately 12 ml obtained per rat).  The 
blood was mixed heparin and purified by anion exchange on DE52 cellulose 
(Whatman) columns. 
2.13.6 Motility analysis 
T. brucei resistance to sedimentation was investigated as a function of cell 
motility.  Wild type BSF T. brucei and ∆mca4 cells were cultured to the same 
mid-log densities.  2 ml of culture was divided equally into 2 cuvettes and the 
OD600 was recorded at 0, 3 and 6 hour time points.  One cuvette was always left 
undisturbed and the other mixed and re-suspended before each optical density 
reading.  Three replicate experiments were performed and sedimentation rates 
determined by subtracting the OD600 of the undisturbed control from the OD600 of 
the resuspended culture.    
2.13.7 Cell fractionation 
The cellular fractionation method was adapted from Liu et al., 2010.  For 
detergent lysis  2 x 107 mid-log BSF cells were washed in vPBS and lysed in 500 µl 
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1% (v/v) Triton X-100, 25mM HEPES, 1mM EDTA pH7.4 for 30 minutes on ice 
before centrifugation at 14,000 g for 5 minutes.  For hypotonic lysis 2 x 107 mid-
log BSF cells were washed in vPBS and lysed in 500 µl 10mM Tris-HCl pH7.4 with 
4 x 15 second blasts in an ice cold sonicating water bath (Fisher Scientific 
FB15047), before centrifugation at 14,000 g for 5 minutes.  For both lysis 
methods, insoluble material in the pellet was solubilised by boiling with 625 µl 1 
x a SDS-PAGE sample buffer for 5 minutes.  The supernatant was prepared for 
electrophoresis by adding 125 µl 4 x SDS-PAGE sample buffer and boiling for 5 
minutes.  1 x 106 cell equivalents were loaded per lane.  
2.13.8 Statistical analysis of data 
Where indicated data were expressed as means ± standard deviation from the 
mean.  P-values were calculated using an unpaired, two-tailed Student’s T-test 
on Microsoft Excel.  Differences were considered significant at a p-value of 
<0.05.  
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3 Autophagy 
3.1 Introduction  
3.1.1 General introduction to Autophagy  
The word autophagy stems from two Greek terms, meaning to eat (‘phagy’) and 
oneself (‘auto’).  It describes a primary intracellular mechanism for the 
degradation of long lived proteins and organelles, which results in the release of 
amino acids back into the cytosol.  Degradation of an organisms own proteins is 
an important part of cellular regulation and development, helping to maintain a 
crucial balance between anabolic and catabolic processes.  Eukaryotic cells use 
two major mechanisms for intracellular protein degradation, the ubiquitin-
proteosomal system and the lysosome (vacuole in yeast).  The ubiquitin-
proteosomal system is the major method for degradation of short lived, damaged 
or misfolded proteins (Hershko et al. 1998).  However, unwanted stable proteins 
or organelles are targeted to the lysosome where they can be degraded and 
recycled.  Autophagy is one of several methods for transporting cargo to the 
lysosome and is a widespread biological process thought to be conserved in a 
diverse range of eukaryotic organisms (Meijer et al. 2007; Rigden et al. 2009).     
The process of autophagy is subdivided into three primary forms that differ in 
mechanism and function: microautophagy, chaperone-mediated autophagy 
(CMA) and macroautophagy, all summarised in Figure 3-1.  Microautophagy is a 
degradation process that occurs directly at the lysosomal surface, during which 
the target cytoplasm or organelle is engulfed by invagination, protrusion, and/or 
septation of the lysosome membrane (Kunz et al. 2004).  CMA is distinct from 
both micro- and macroautophagy pathways because there is no vesicle used to 
target proteins to the vacuole/lysosome.  Instead, chaperone molecules 
recognise a peptide motif (KFERQ-like) present on select cytosolic proteins and 
binds them to the Lamp type 2A receptors located on the lysosomal membrane.  
Thus delivering specific cytosolic proteins to the lysosome on a molecule by 
molecule basis (Bandyopadhyay et al. 2010; Cuervo 2010).  Like 
macroautophagy, CMA can be activated by nutrient starvation.  However, while 
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macroautophagy is activated as an initial response it soon declines, whereas CMA 
is active during prolonged periods of starvation (Dice 2007). 
Macroautophagy is the major form of autophagy and is often referred to simply 
as ‘autophagy’, as will be the case for this work.  The process involves the 
engulfment of cytoplasm or entire organelles into a double-membrane structure, 
called the autophagosome.  The outer membrane of the autophagosome fuses 
with the lysosome, introducing the inner membrane and the bound contents into 
the lysosome.  In this compartment hydrolases degrade and recycle the contents 
into constituent amino acids (Reggiori et al. 2005a).  
 
Figure 3-1 Autophagic degradation by the lysosome. 
Figure taken from (Mizushima et al. 2008).  The three types of autophagy are depicted.  
Macroautophagy cargoes are engulfed in an expanding double membrane structure called the 
phagophore.  The completed vesicle, called the autophagosome, is delivered to the lysosome.  
Microautophagy describes the engulfment of cytosolic components directly by the lysosome, 
mediated by the lysosome membrane.  Chaperone-mediated autophagy occurs without vesicle 
formation, unfolded target proteins are translocated into the lysosome via lysosome–associated 
membrane proteins type 2A (LAMP-2A) and the chaperone hsc70.  Once inside the lysosome 
cargo is degraded by hydrolases and amino acids are released into the cytosol by permeases.             
 
3.1.2 Molecular dissection of autophagy pathway 
The scientific principle of autophagy was originally described over 40 years ago 
(for early review see (de Duve et al. 1966).  Early work was focused on defining 
morphological features, however significant developments in the field of 
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molecular biology have lead to a great understanding of the molecular 
mechanisms behind autophagy.  Due to the complex and sometimes overlapping 
nature of work being carried out in different research labs a universal 
nomenclature was proposed; the genes are named ATG, which stands for 
autophagy-related (Klionsky et al. 2003).  To date over 30 ATG genes have been 
identified, but many more genes and their products are involved in the wider 
field of lysosomal degradation and not directly in autophagy thus retain their 
previous names (Herman et al. 2006; Nakatogawa et al. 2009; Rigden et al.  
2009).  A subset of genes have been identified as essential for all types of 
autophagy and were designated the core ATG genes (Xie et al. 2007), these are 
shown along with the putative T. brucei orthologues in Table 4.  Much of the 
molecular characterisation was performed in Saccharomyces cerevisiae, 
consequently it is an established model for autophagy and the major steps 
involved in the yeast process will be outlined. 
3.1.3 Induction of autophagy 
CMA can only degrade specific soluble proteins, but micro and macroautophagy 
have the ability to engulf large structures through both selective and non-
selective mechanisms.  To prevent uncontrolled degradation that would damage 
cells, tight regulatory mechanisms exist to control autophagy.  The most basic 
and fundamental level of control occurs through mediating the activity of 
protein kinase Atg1. 
In yeast autophagy is primarily a response to nutrient starvation.  The abundance 
of nutrients directly controls Tor (target of rapamycin) signalling,  a master 
regulator of cell growth that influences translation initiation and G1 phase 
transition (Barbet et al. 1996).  Coupled to its nutrient sensing capabilities Tor 
also acts as negative regulator of the autophagic response.  Addition of 
rapamycin, a Tor specific inhibitor, to cells in nutrient rich media produced the 
same autophagic response as starvation (Noda et al. 1998).  Deciphering the 
molecular mechanism revealed that Tor controlled the activity of Atg1.  During 
times of high nutrient availability Tor hyperphosphorylates Atg13 which reduces 
its affinity for Atg1.  However, following Tor inactivation by starvation or 
rapamycin, Atg13 is rapidly dephosphorylated promoting interaction with Atg1 
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and stimulating kinase activity and promoting autophagosome formation 
(Kamada et al. 2000).     
3.1.4 Autophagosome formation 
Genetic screens have determined 16 ATG factors that are directly involved in the 
formation of the autophagosome, suggesting it requires the input of more 
autophagy proteins than any other stage.  The biogenesis of autophagosomes 
occurs at a distinct foci called the pre-autophagosomal structure (PAS), which 
serves as a platform to enable the recruitment and accumulation of the core 
autophagy proteins (Suzuki et al. 2001).  Following induction (e.g. starvation) a 
bowl shaped membrane, called the isolation membrane, emerges from the PAS 
to engulf and eventually surround the cargo in a mature autophagosome 
(Mizushima et al. 2001).  Organisation of proteins at the PAS occurs in an 
ordered and hierarchical manner with the absence of initial early PAS proteins 
reducing recruitment of subsequent PAS components (Suzuki et al. 2007).  Atg17 
is the most basic protein required for PAS organisation and serves as a scaffold 
for the recruitment of all others.  The initial tier of PAS recruitment (dependent 
on Atg17) includes Atg1 and Atg13, along with Atg9 and the phosphatidylinositol 
(PtdIns) 3-kinase complex I.  These in turn help to recruit the Atg2-Atg18 
complex, as well as those proteins involved in two conjugation systems that are 
required for membrane expansion and completion (Atg8-PE and Atg12-Atg5, 
discussed in detail in sections 3.1.5 and 3.1.6 respectively).   
Atg9 is an integral membrane protein that localises to the PAS, small puncta in 
the cytoplasm and to the surface of mitochondria.  The exact function of Atg9 
remains unknown but it was postulated that it could serve as a membrane 
carrier, transporting lipids from the mitochondria to the PAS to help generate 
new autophagosomes (Reggiori et al. 2005b).   
The activity of phosphatidylinositol (PtdIns) 3-kinases is essential for autophagy 
(Kihara et al. 2001; Petiot et al. 2000).  They catalyse the phosphorylation of  
PtdIns to produce phosphatidylinositol 3-phosphate (PtdIns3P) and have been 
shown to have diverse regulatory functions including a role in membrane 
trafficking.  In yeast there is only one PtdIns 3-kinase, Vps34 that is known to 
interact with two complexes; complex I is involved in autophagy and complex II 
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has a role in vacuolar protein sorting (Kihara et al.  2001; Petiot et al.  2000).  
Atg14 associates only with complex I and has been shown to coordinate the 
localisation of the complex to the PAS (Obara et al. 2006).  It is speculated that 
the PtdIns3P produced by complex I could function as a site to aid further 
recruitment of proteins to the PAS.  Indeed the Atg2-Atg18 complex, known to 
be essential for autophagosome formation has been shown to interact with 
autophagic membranes in a PtdIns3P dependent manner (Obara et al. 2008).        
The exact mechanism detailing how the PAS develops into the isolation 
membrane and complete autophagosome has yet to be fully determined, 
however it is known that two novel ubiquitin-like protein conjugation systems 
are critical to the process (Ohsumi et al. 2004).  The two ubiquitin-like proteins 
are Atg12 and Atg8.  Atg12-conjugation is essential for formation of the 
preautophagosome, whereas Atg8 is essential for autophagosome formation 
(Tanida et al. 2004b). 
Furthermore, for many years the source of the autophagosome membrane has 
proved both illusive and contentious (Juhasz et al. 2006).  In mammalian systems 
it appears that different sources provide membrane material.  By starving rat 
kidney cells of nutrients it was recently found that, the outer membrane of the 
mitochondria served as site for autophagosome biogenesis and provided lipids for 
the autophagosome membrane (Hailey et al. 2010).  However an additonal site 
has been identified on the endoplasmic reticulum, called the omegasome, that is 
enriched in PtdIns3P (a key component of autophagosomes) which could serve as 
a scaffold for recruitment of further autophagosomal proteins (Axe et al. 2008).  
Furthermore, the plasma membrane can also serve as site for autophagosome 
biogenesis and directly provides membrane for autophagosomes (Ravikumar et 
al. 2010).  Despite the variety of membrane sources used to form the 
autophagosome it has yet to be determined whether this contrives to influence 
its function. 
3.1.5 Atg12-Atg5 conjugation 
In yeast, Atg12 conjugation occurs constitutively and is not dependent upon 
nutrient conditions, such as starvation.  Atg12 is a small ubiquitin-like protein 
(UBL) that covalently links to Atg5, shortly after translation.  The C-terminal 
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glycine of Atg12 conjugates to a specific lysine residue on Atg5 (position 149) by 
an isopeptide bond (Mizushima et al. 1998).  Although Atg12 has very limited 
amino acid sequence identity with ubiquitin, the mode of conjugation with Atg5 
does bear similarities to the process of ubiquitination (Mizushima et al.  1998; 
Ohsumi et al.  2004).  Atg12 is activated by Atg7 (acting as the E1 enzyme), and 
then forms a conjugate with Atg7 via a thioester bond between the C-terminal 
glycine of Atg12 and a cysteine (amino acid position 572) in Atg7 (Tanida et al. 
2001).  Atg12 is then transferred to Atg10 (E2 enzyme) and forms a thioester 
bond between the C-terminal glycine of Atg12 and cysteine (amino acid position 
133) of Atg10 (Shintani et al. 1999).  Atg12 can then bind to the target molecule 
Atg5.  Once conjugation has occurred Atg16, a coiled-coil protein, associates 
with Atg5.  The coiled coil region of Atg16 allows it to form multimers (with 
itself), which can then crosslink to conjugated Atg5 (Figure 3-2) (Mizushima et 
al. 1999).  Whilst Atg16 is not required for the conjugation reaction, association 
with the Atg12-Atg5 complex is required for autophagy in vivo.  Interestingly, 
there appears to be no peptidase activity enabling deconjugation, suggesting 
this is an irreversible reaction.  The Atg12-Atg5 conjugate leaves the membrane 
just prior to or just after autophagosome formation (Ohsumi et al.  2004).     
3.1.6 Atg8 conjugation 
Ubiquitin and other UBL proteins (e.g. Atg12) interact with other proteins, 
however uniquely the UBL Atg8 is conjugated to an abundant membrane 
phospholipid called phosphatidylethanolamine (PE) (Ichimura et al. 2000).  In 
the initial step the cysteine peptidase Atg4 removes the C-terminal arginine 
(position 117) from newly synthesised Atg8.  This exposes a glycine residue 
(position 116), which allows activation of the Atg8-Glycine-116 intermediate by 
Atg7 (E1 enzyme), which in turn transfers it to Atg3 (E2 enzyme).  Finally, Atg8-
Glycine-116 conjugates to PE (forming Atg8-PE) via an amide bond between the 
C-terminal glycine carbonyl group and the amino group of PE (Figure 3-2).  The 
lipid modification of Atg8 changes the protein from a soluble form to a tightly 
associated membrane protein.  Once the mature autophagosome is formed 
externally located Atg8-PE is released by the deconjugating action of Atg4, 
however a portion remains trapped inside (Ohsumi et al.  2004).  The Atg8 system 
confers a particular benefit to researchers as it offers the chance to monitor 
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autophagosome formation through green fluorescent protein (GFP) tagging of 
Atg8-PE.  GFP-Atg8-PE has been shown to function as Atg8-PE and due to its 
association with the preautophagosome and autophagosome it has been used as 
a useful autophagy marker in numerous organisms including transgenic mice, 
yeast and Leishmania (Besteiro et al. 2006; Klionsky et al. 2007; Mizushima et 
al. 2004; Williams et al. 2006). 
As the membrane expands the ATG factors start to concentrate in specific 
locations.  Atg12-Atg5 and Atg16 congregate on the outside of the curve, 
whereas ATG8-PE seems to favour the internal surface.  The curvature is 
exaggerated and continued by Atg12-Atg5 and Atg16 forming polymers at the 
phagophore tips.  This could act as a protein framework, which allows the 
incorporation of the ATG8-PE membrane lipid, effectively plugging the gap 
(Reggiori et al.  2005a).  Additionally, the cargo selected could help to form the 
three-dimensional shape of the membrane.  This could explain how selective 
autophagy, dictates the contents of the autophagosome.  And the cargo-directed 
expansion could provide an explanation for the accommodation of cargos of 
varying size (Reggiori et al.  2005a). 
Mammals have eight orthologues of the yeast Atg8 protein, that are divided into 
LC3 and GABARAP/GATE-16 subfamilies, with LC3B being the best studied (He et 
al. 2003; Kabeya et al. 2004).  However despite the common autophagosomal 
association of proteins from both subfamilies, they play distinct roles in 
autophagosome biogenesis.  LC3 proteins appear to function in the early stages 
of phagophore formation and elongation, where as the GABARAP/GATE-16 
subfamily are involved in later stages and possibly mediate the sealing of the 
autophagosome (Weidberg et al. 2010).    
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Figure 3-2 Atg12 and Atg8 conjugation pathways in S. cerevisiae. 
Adapted from (Geng et al. 2008) A) Atg12 is conjugated to Atg5 by the action of Atg7 (E1 enzyme) 
and Atg10 (E2 enzyme).  Atg16 associates with the conjugate and helps for multimers. B) Atg8 is 
cleaved by Atg4 before Atg7 (E1 enzyme) and Atg3 (E2 enzyme) coordinate the conjugation to the 
membrane lipid phosphatidylethanolamine PE.  Atg12-Atg5 complex also facilitates Atg8 
conjugation.  Ubl, ubiquitin-like proteins.  For details of both pathways see section 1-5 and 1-6.      
 
3.1.7 Autophagosome fusion with the lysosome  
The external membrane of the autophagosome fuses with the yeast vacuole and 
releases cargo still bound by the inner membrane into the vacuolar cavity where 
it can be degraded.  To release and reuse the constituent units of the cargo it 
must be degraded, which requires a low pH, a vacuolar serine peptidase Prb1 
and a vacuolar aspartic peptidase PEP4.  In yeast degradation of the 
autophagosome is facilitated by Atg15, a membrane bound lipase (Teter et al. 
2001).  Another important autophagy protein operating in the vacuole is Atg22, a 
vacuolar membrane protein that functions as an efflux pump to help return 
regenerated amino acids to the cytosol (Yang et al. 2006).   
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3.1.8 Physiological functions of autophagy 
In lower eukaryotic organisms, such as yeast, the primary function of autophagy 
appears to be ensuring survival during times of starvation.  However autophagy 
also plays a key role in responding to other external stresses like high population 
densities and temperatures (Levine et al. 2004).  Unicellular organisms 
commonly respond to environmental stress by differentiating into alternative life 
forms that are better adapted for survival.  Several studies have highlighted the 
importance of autophagy in mediating these cellular differentiation and 
remodelling events.  In S. cerevisiae starvation induces the differentiation of 
diploid budding yeast into resistant spore structures (sporulation).  Disrupting 
autophagy by making mutant cell lines blocked sporulation (Talloczy et al. 
2002).  Unicellular Dictyostelium discoideum respond to starvation by assembling 
multicellular fruiting bodies to facilitate the dispersal of spores.  Two separate 
autophagy mutant cell lines were unable to differentiate into productive fruiting 
bodies (Otto et al. 2003).                   
Perhaps surprisingly mammals also rely on autophagy as a response to nutrient 
limitation.  The upregulation of autophagy in various tissues was seen following 
the starvation of mice (Mizushima et al.  2004) and also in the early neonatal 
period when the nutrient supply was stopped (Kuma et al. 2004).  Furthermore, 
autophagy is increasingly linked to a variety of physiological processes in higher 
eukaryotes.  Critically the deregulation of autophagy has been implicated in a 
wide spectra of disease pathologies including, cancer, muscular diseases and 
neurodegenerative disorders (Levine et al. 2008; Mizushima et al.  2008). 
3.1.9 Autophagy in Trypanosomatidae Protozoa 
The advantages that autophagy can bring to single celled organisms suggests it is 
likely to be beneficial to many lower eukaryotes.  Bioinformatic analyses only 
detected half of the S. cerevisiae autophagy-associated machinery in 
Trypanosomatidae genomes (Herman et al.  2006; Rigden et al.  2009; Williams et 
al.  2006).  However, many of the missing autophagy proteins were also absent in 
a wider range of organisms, suggesting that certain proteins are specific to fungi 
(Rigden et al.  2009).  The successful bioinformatics screens combined with 
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accumulating experimental evidence confirm that autophagy is conserved in a 
wide variety of unicellular eukaryotes (Duszenko et al. 2010 in press).  Of all the 
protists that are currently amenable to genetic and experimental investigation 
much of the research has focused on human and animal pathogens and the 
current understanding of autophagy in select Trypanosomatidae parasites will be 
discussed.     
3.1.9.1 Leishmania 
In silico analysis of candidate ATG genes in L. major, using S. cerevisiae 
autophagy genes as the queries identified candidates for half of the yeast genes 
(Williams et al.  2006).  While strong evidence of an ATG8-PE conjugation system 
was found, the presence ATG12-ATG5 conjugation pathway was initially disputed 
(Herman et al.  2006; Rigden et al.  2009) because weak orthologues were only 
detected following exhaustive searches using autophagy genes from alternative 
species.  However, extensive alignments revealed the presence of most key 
residues in the L. major orthologues even if their overall sequence similarity was 
low (Williams et al.  2006).  Interestingly the genome mining also provided 
evidence for a unusually large expanded family of ATG8 genes, (discussed in 
more detail below). 
Based on the strong evidence for the presence of an ATG8-PE conjugation 
system, it was possible to evaluate the use of green fluorescent protein-labelled 
ATG8 (GFP-ATG8) as an autophagosome marker in L. mexicana (Williams et al.  
2006).  Fluorescent microscopy revealed the redistribution of GFP-ATG8 from 
cytosolic forms to lipid-anchored punctate structures following starvation-
induced stress and during differentiation events occurring in the L. mexicana 
lifecycle.  The structures were confirmed as autophagosomes by using autophagy 
inhibitors and ultrastructural analysis (Williams et al.  2006).  This effective 
autophagosome marker revealed that autophagy was activated during the 
differentiation of procyclic promastigotes to the infective metacyclic form and 
to a higher extent during differentiation of metacyclic promastigotes to 
amastigotes (Williams et al.  2006).  Interestingly, Leishmania do not have 
orthologues of the yeast vacuolar peptidases PEP4 and PBR1, but do have an 
unusually large repertoire of Clan CA, Family C1 cysteine peptidases found in the 
lysosome.  The two major lysosomal peptidase CPA and CPB were shown to be 
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necessary for effective autophagy in L. mexicana.  CPA and CPB null mutants 
showed reduced viability during starvation, impaired differentiation to 
metacyclic promastigotes and amastigotes forms and an accumulation of GFP-
ATG8 autophagosomes in the lysosome (Williams et al.  2006).  Degradation of 
the autophagosome by cysteine peptidases instead of aspartic and serine 
peptidase, represents an interesting difference between Leishmania and yeast 
autophagy.         
Additionally, L. major dominant negative mutants for VPS4, an ATPase known to 
be involved in endosomal sorting, were unable to differentiate into metacyclic 
promastigotes and had defects in the autophagy pathway (Besteiro et al.  2006).  
Increased GFP-ATG8 autophagosome numbers were found in the mutant lines, 
indicating a possible block of autophagosome with the lysosome.  It was also 
found that mutants lacking the cysteine peptidase ATG4.2, were unable to 
differentiate into infective metacyclics, supporting the involvement of 
autophagy in L. major differentiation and ultimately virulence (Besteiro et al.  
2006).   
Investigations into the expanded family of L. major ATG8s revealed that proteins 
from the different families were likely to have distinct roles (Williams et al. 
2009).  The 25 ATG8 genes were sub-classified into one ATG8, three ATG8A, 
eight ATG8B and 13 ATG8C genes.  GFP-tagging of representative members of 
each family revealed different localisations; only GFP-ATG8 formed 
autophagosomes during both starvation and differentiation indicating it was a 
‘true’ ATG8 (Williams et al.  2009).  Puncta were also formed by GFP-ATG8A 
expressing cells, that were strongly induced by starvation but interestingly 
remained unaffected by differentiation (Williams et al.  2009).  The proteins 
selected from the ATG8B and ATG8C families, were found to form punctate 
structures close to the flagellar pocket in a small number of cells, but appeared 
unchanged following starvation or differentiation (Williams et al.  2009).  Despite 
the differences in vivo, all of the proteins were able to fully complement a yeast 
Atg8 null mutant strain.  Additionally, the different L. major ATG8 proteins were 
found to be selectively cleaved by the two ATG4 cysteine peptidases, possibly 
further indicating regulatory differences.  LmATG4.1 was able to cleave ATG8, 
ATG8B and ATG8C, but LmATG4.2 would only cleave ATG8A (Williams et al.  
2009).   
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As referred to earlier the components of the ATG5-ATG12 pathway were 
tentatively identified and have latterly been characterised and validated.  
LmATG5, LmATG10, LmATG12 and LmATG16 were shown to complement the 
respective null mutant S. cerevisiae cell lines (Williams et al.  2009).  Further 
detailed characterisation showed that GFP-ATG12 and mCherry-ATG5 were 
always found localised to the same puncta, whereas mCherry-ATG5 only 
associated with a portion of GFP-ATG8 puncta (Williams et al., 2010 personal 
communication).  This suggests typical ATG5-ATG12-type labelling of the 
isolation membrane and  early autophagosomes but disassociation with the 
mature autophagosome.  Final confirmation of the correct identification of the 
ATG5-ATG12 pathway proteins was provided by successful in vitro reconstitution 
of the conjugation of ATG5 to ATG12.  To achieve this conjugation purified 
LmATG7, LmATG10 were required along with ATP and a pre-exposed scissile 
glycine on LmATG5 (Williams et al., 2010 personal communication).                
3.1.9.2 Trypanosoma cruzi 
Ultrastructural changes characteristic of autophagy have been presented in T. 
cruzi following treatment with various compounds.  Perhaps the most convincing 
data was generated when testing the trypanocidal activity of three 
napthoimidazoles (Menna-Barreto et al. 2009).  Electron microscopy revealed an 
increase in double-membrane bound vesicles following treatment, which 
corroborated well with an increase in monodansylcadaverine (MDC) staining 
(Menna-Barreto et al.  2009).  MDC is commonly used to label autophagosomes, 
however caution must always be taken when interpreting the results as a direct 
comparative analysis revealed MDC staining only partially colocalised with GFP-
ATG8 labelled autophagosomes (Mizushima 2004).  However, increased mRNA 
levels corresponding to genes involved in the ATG8 conjugation pathway 
provided additional evidence in support of autophagy upregulation in this 
particular study (Menna-Barreto et al.  2009).  Furthermore, pre-treatment of T. 
cruzi with wortmannin and 3-methyladenine (3-MA) inhibited the trypanocidal 
effects of the three napthoimidazoles, suggesting that a form of cell death 
accompanied by autophagy was occurring (Menna-Barreto et al.  2009).   
Detailed characterisation of part of the T. cruzi autophagy pathway revealed 
potential roles in both the starvation response and differentiation events 
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occurring during the lifecycle (Alvarez et al. 2008).  Bioinformatics revealed that 
T. cruzi possesses two orthologues for the S. cerevisiae ATG4 and ATG8 genes.  
TcATG4.1, TcATG4.2 and TcATG8.1 were able to restore autophagy in their 
corresponding yeast null mutant strains whereas TcATG8.2 was unable to 
complement ScATG8 (Alvarez et al.  2008).  Interestingly, only TcATG4.1 was 
able to process the T. cruzi ATG8s, implicating an alternative role for TcATG4.2.  
Epitope tagging of TcATG8.1 and TcATG8.2 provided insights into the in vivo 
function of these two proteins.  Immunofluorescent analysis showed that 
TcATG8.1 formed punctate structures following starvation.  This process could 
be blocked by mutation of the conserved scissile glycine residue of TcATG8.1, 
indicating a requirement for PE conjugation in puncta formation (Alvarez et al.  
2008).  The cytoplasmic location of TcATG8.2 was not changed by starvation.  
Finally, the differentiation of epimastigotes to metacyclic trypomastigotes was 
also accompanied by an increase in puncta formation.          
3.1.9.3 Trypanosoma brucei 
Bioinformatic screening of the T. brucei genome identified half of the yeast 
autophagy related genes (Herman et al.  2006; Williams et al.  2006).  Orthologues 
for many of the ‘core’ autophagy genes were identified (Table 4), including 
components of both the ATG8 and ATG12 conjugation pathways.  In common 
with the other parasites discussed T. brucei has multiple ATG8 genes, which in 
the past have been referred to differently.  For the purposes of this report the 
T. brucei ATG8 genes will be referred to as ATG8.1, ATG8.2 and ATG8.3 
corresponding to the following TritrypDB accession numbers Tb927.7.5900, 
Tb927.7.5910 and Tb927.7.3320 respectively.   
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Table 4 Core Autophagy Machinery and corresponding putative T. brucei orthologues. 
Genes essential to all types of autophagy were identified and designated ‘core autophagy’ genes 
(Xie et al.  2007).  TritrypDB identifiers of T. brucei orthologues as identified in Herman et al., 2006 
and Williams et al., 2006.  Genes grouped by function: autophagy induction (yellow), phagophore 
initiation (grey), autophagosome completion Atg8 conjugation pathway (blue), autophagosome 
completion Atg12-Atg5 conjugation pathway (green).  Tb972.7.3320 has been designated both as 
an ATG8 orthologue (Herman et al.  2006) and an ATG12 orthologue (Williams et al.  2006), and is 
discussed further in section 3.3.4. 
 
Protein alignment of the three T. brucei ATG8s with S. cerevisiae shows that 
there is moderate sequence identity including many of the residues required for 
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protein interaction (Figure 3-3, Table 5).  Indeed the crystal structure of 
TbATG8.2 has been solved and shows that the overall structure contains a 
classical ubiquitin fold consisting of central β-sheets (β1 to β4) surrounding two 
α-helices (α3 and α4) and displays significant structural homology with ATG8s 
from higher eukaryotes (Koopmann et al. 2009).  Detailed mutational studies of 
the yeast ATG8 identified two sites essential for function; Phe77 and Phe79 form 
part of the Atg4 recognition site, and Tyr49 and Leu50 that are important for 
lipidation (S. cerevisiae numbering) (Amar et al. 2006).  The sequence alignment 
(Figure 3-3) show a high degree of conservation for these key residues.  
Predictive modelling of TbATG8.2 superimposed over the known structure of rat 
LC3 in complex with human ATG4, revealed the required orientation of the 
conserved Phe80 and Tyr82 (T. brucei ATG8.2 numbering) to mediate ATG4 
interaction (Koopmann et al.  2009).   
The proteins TbATG8.1 and TbATG8.2 share 82% amino acid identity (Table 5), 
with only slight divergence in their N-terminal regions.  Structurally, therefore, 
they are likely to be very similar, although interestingly TbATG8.1 terminates in 
a glycine residue (Figure 3-3).  This could mean TbATG8.1 is translated in a 
mature form that does not require proteolytic activation, hinting at an 
alternative physiological role.  Interestingly TbATG8.3 contains an insertion that 
is predicted to extend the ubiquitin fold, which modelling suggested would 
prohibit interaction with TbATG4 (Koopmann et al.  2009).  However, TbATG8.3 
also terminates in a glycine allowing conjugation to PE without the action of 
ATG4.  Furthermore the insertion found in TbATG8.3 is somewhat characteristic 
of those found in other ATG12 proteins.  Indeed, it is predicted to be the 
orthologue of the LmjF22.1300, which has recently been confirmed to function 
as an ATG12 protein (Williams et al., 2010 personal communication).  Further 
characterisation of the TbATG8 proteins is required to divulge their true 
physiological functions and possible roles in the autophagy pathway.   
 71 
  
 
Figure 3-3 Alignments and features of the three TbATG8s. 
Vector NTI protein sequence alignment for T. brucei ATG8.1, ATG8.2 and ATG8.3 and the S. 
cerevisiae ATG8.  Sequences aligned using Clustal W algorithm of the Align X program.  Identical 
and conserved amino acids are highlighted yellow and blue respectively.  Blocks of similar 
sequences are highlighted in green and green coloured text indicates weak conservation.  
Numbers in brackets indicate the position of the first amino acid in the linear polypeptide in the 
section of each protein analysed.  The tritrypDB identifiers and accession numbers are: TbATG8.1 
(Tb927.7.5900), TbATG8.2 (Tb927.7.5910), TbATG8.3 (Tb927.7.3320) and ScATG8 (YBL078C).  
Site of ATG4 cleavage after conserved scissile glycine residue is indicated by black arrowhead.  
Conserved alpha helices (α red boxes) and beta folds (β grey arrows) of ubiquitin-like fold, 
identified from crystal structure (Koopmann et al.  2009).  Key residues required for ATG4 
interaction and lipidation marked with star (∗) (Amar et al.  2006). 
 
 
 
Table 5 Percentage identity of S. cerevisiae and T. brucei ATG8 proteins. 
Percentage of identical amino acids displayed for TbATG8.1 (Tb927.7.5900), TbATG8.2 
(Tb927.7.5910), TbATG8.3 (Tb927.7.3320) and ScATG8 (YBL078C) as aligned in Figure 3-3. The 
tritrypDB identifiers and accession numbers are stated in brackets.    
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The majority of information on autophagy in T. brucei is based on the 
interpretation of ultrastructural studies depicting characteristic morphological 
changes attributed to a variety of compounds.  One such compound, 
dihydroxyacetone (DHA) a common substrate for energy in many cells, was found 
to inhibit BSF T. brucei growth (EC50 at 1 mM) by blocking cell cycle progression.  
Concurrent with this effect DHA treatment was also found to stimulate the 
formation of autophagic-like bodies (Uzcategui et al. 2007).  Another class of 
chemicals reported to induce autophagy in T. brucei are neuropeptides.  A range 
of neuropeptides were found to be effective in curing mice of trypanosome 
infections without any detectable toxicity side effects (Delgado et al. 2008).  
The antimicrobial effect of neuropeptides arises from their ability to punch 
holes in or destabilise the membrane but unusually T. brucei endocytosed the 
neuropeptides which caused lysosome disruption and cytosolic accumulation of 
glycolytic enzymes (Delgado et al.  2008).  This destabilised parasite metabolism 
and caused cell death.  Electron microscopy revealed this was accompanied by 
the accumulation of autophagic-like vacuoles,  which was further verified by 
immunofluorescence using human anti-LC3, which is a homologue of the yeast 
ATG8 protein (Delgado et al.  2008).  Both of these reports show an increased 
autophagic response accompanying cell death.  Whether this is an active process 
or just an artefact related to aberrant cells in general remains to be 
determined.   
The significance of autophagy to processes such as cellular development and 
remodelling has been discussed above in the context of numerous different 
organisms.  The lifecycle of T. brucei requires significant morphological and 
metabolic changes (see section 1.4).  In BSF T. brucei energy is primarily 
supplied by a simplified cohort of metabolic enzymes sequestered in an 
organelle called the glycosome (Michels et al.  2006).  In contrast, PCF parasites 
have a more complex metabolism including a functional mitochondrion and an 
elaborated repertoire of glycosomal enzmes.  Consequently during the cell cycle 
there is an obvious requirement for efficient turnover of glycosomes.  In yeast, 
the peroxisome is degraded by an autophagic process called pexophagy (Dunn et 
al. 2005).  Indeed in T. brucei there was a small tendency for the glycosomes to 
associate with the lysosome during long slender bloodstream to short stumpy 
bloodstream differentiation (Herman et al.  2008).  However this association was 
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much more pronounced in cells differentiating from short stumpy BSF to PCF and 
was accompanied by an enlarged lysosome found to contain glycolytic enzymes.  
No glycosomes were detected within an autophagic membrane suggesting that a 
process analogous to micropexophagy was occurring (Herman et al.  2008).    
3.2 Project aims 
Evidence is accumulating showing the presence of autophagy in T. brucei, 
however conclusive molecular characterisation of the machinery and process has 
yet to be carried out.  In this project we attempt to provide definitive evidence 
for autophagy in T. brucei by focusing on:  
1) Autophagy pathway characterisation – using fluorescent reporter 
systems to investigate and monitor autophagosome formation. 
2) Investigation of the three predicted T. brucei ATG8 genes to 
determine whether they are all functional Atg8 orthologues. 
3) Revealing the essentiality of the autophagy pathway to T. brucei 
parasites by using RNAi to downregulate orthologues of key autophagy 
proteins. 
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3.3 Results 
3.3.1 Tagging of ATG8.1 in its native locus 
In mammalian and yeast models the ATG8 gene encodes a conjugating protein 
that is incorporated into the membrane of autophagosomes.  Labelling of ATG8 
with fluorescent reporter proteins has been shown to be an effective method for 
the study of autophagy in Leishmania and was instrumental in confirming the 
presence of a functional autophagy pathway in these parasites (Besteiro et al.  
2006; Williams et al.  2006).  Consequently, the use of specific protein markers 
was selected to investigate the roles of the three putative ATG8s of T. brucei 
and their involvement in the autophagy pathway. 
The initial strategy was based on a PCR-generated epitope tagging system of T. 
brucei genes (Shen et al. 2001).  It was anticipated that the fusion of a GFP:HA 
tag to the N-terminus of the ATG8.1 ORF at the native locus would allow for the 
visualisation of the transgene under the control of the natural processing signals 
thus minimising possible artefacts associated with over expression (Benzel et al. 
2000).  To create the native expression construct a reporter cassette containing 
a GFP:HA tag and drug resistance marker was amplified by PCR with long primers 
containing flanking sequences specific to ATG8.1.  One primer added 80 
nucleotides homologous to the 5’ UTR immediately upstream of ATG8.1, and the 
second primer added the first 80 nucleotides of the target ORF (Figure 3-4A).  
The PCR product was cloned and sequenced before transfection into both BSF 
and PCF 427 cells.  Clones were generated for both lifecycle stages and 
successful integration and expression was confirmed by western blot using an 
antibody specific to the HA epitope (Figure 3-4B).  Proteins corresponding to the 
expected size of the GFP:HA ATG8.1 fusion (~43 kDa) were detected in both BSF 
and PCF, although overnight incubation with the primary antibody was required 
with only a weak signal detected.  This suggested that the expression level of 
the native protein was very low in the cell lines and conditions tested.  The 
scarcity of GFP-ATG8.1 in both BSF and PCF presented significant problems for 
microscopic analysis of the cells.  High exposure times were needed, which 
produced substantial background auto-fluorescence and only weak fluorescent 
signals could be detected.  
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The analytical challenges of the cells tagged at the native ATG8.1 locus 
prompted a new approach to enable a more practicable and detailed analysis of 
autophagy in T. brucei.  Expression of GFP-ATG8 from an ectopic locus has been 
shown to be an effective method for monitoring autophagy in Leishmania 
(Besteiro et al.  2006; Williams et al.  2006).  Accordingly, a system for the 
ectopic expression of YFP tagged ATG8s in T. brucei was developed (see section 
3.3.3). 
 
Figure 3-4 GFP tagging of native TbATG8.1 locus.   
A) Creating the native expression construct.  Reporter cassette was amplified, as indicated, with 
long primers which added flanking regions containing 80 nucleotides of ATG8.1 5’ UTR and 80 
nucleotides of 5’ end of ATG8.1 ORF.  Resulting PCR product was cloned and sequenced.  
Cloning vector derived EcoRI restriction sites used to digest and prepare linear DNA prior to 
transfection.  B) Western blot analysis of GFP:HA ATG8.1 native tagged PCF and BSF cell lines, 
using anti-HA.  Protein corresponding to expected size of transgene (41.2 kDa) was detected in 
PCF and BSF.  Unknown protein (~70 kDa) detected in PCF cells. 
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3.3.2 ATG8 expressed by BSF and PCF T. brucei 
Tagging of the ATG8.1 native locus with GFP suggested that the expression level 
was low in both lifecycle stages during normal growth.  This finding was 
consistent with those of a subsequent published study on glycosome turnover 
during T. brucei differentiation, in which the expression profile of ATG8 in T. 
brucei was also analysed by western blotting with an antibody raised against 
TbATG8.2 (Herman et al.  2008).  To confirm this and to facilitate later studies a 
polyclonal antibody specific to T. brucei ATG8.1 was made.  The ORF for ATG8.1 
was cloned into protein expression vector pET28a and expressed in BL21 Rosetta 
E. coli overnight at 15oC induced with 0.1mM IPTG.  ATG8.1 was purified via the 
N-terminal HIS tag using immobilised metal ion affinity chromatography (IMAC) 
(Figure 3-5A).  One rabbit was immunised with purified recombinant ATG8.1 and 
the anti-serum was affinity purified against immobilised ATG8.1 producing anti-
ATG8.  Due to the high degree of sequence similarity (82%) between ATG8.1 and 
ATG8.2 proteins it was predicted both proteins would be recognised by anti-
ATG8.     
Western blotting of whole cell lysate was used to investigate ATG8 expression in 
wild type BSF and PCF T. brucei at different phases of growth in culture.  Cells 
were grown in media and the growth phase determined by haemocytometer 
counts.  Aliquots of cells were removed and prepared for western blot analysis 
when the culture was classed to be in early, mid and late logarithmic growth 
phase.  It was found that ATG8 expression was maintained at a constant level 
during logarithmic BSF growth.  However, in PCF the protein level increased with 
culture density (Figure 3-5B).   A cross reacting protein detected in the PCF 
western blot served as an internal control to demonstrate equal loading (Figure 
3-5B).  The weak bands detected by western blot were attributed to low cellular 
protein levels and not a low affinity antibody, as the anti-ATG8 antibody has 
been shown to work effectively with cell lines over expressing ATG8 proteins 
(Figure 3-7).  Additionally, anti-ATG8 recognised both over-expressed ATG8.1 
and ATG8.2 (Figure 3-7), which means the exact identity of the protein detected 
in the wild type cells cannot be discerned and the similarity in predicted protein 
size (ATG8.1 13.25 kDa, ATG8.2 13.75 kDa) prevented potential separation of 
the two ATG8s by SDS-PAGE.   
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Figure 3-5 Monitoring ATG8 expression in BSF and PCF T. brucei.  
A) Coomassie stained 15% SDS-PAGE of purified ATG8.1.  The ORF of ATG8.1 was cloned into 
pET28a adding an N-terminal HIS tag.  ATG8.1 was expressed in BL21 E. coli cells at 15oC 
induced with 0.1mM IPTG and purified by IMAC on a nickel NTA agarose column.  Eluted material 
was pooled, desalted and analysed for purity by SDS-PAGE before being used to immunise a 
rabbit.  B)  Western blot of wild type BSF and PCF cell lines using affinity purified anti-ATG8.  The 
density of cultured BSF and PCF was assessed and 3.5 x106 cell equivalents were removed and 
prepared for SDS-PAGE analysis when the cultures were determined to be in early (1), mid (2) and 
late (3) log growth phases. BSF cell densities: early 2 x105 ml-1, mid 6 x 105 ml-1, late 2 x106 ml-1.  
PCF cell densities: early 1 x 106 ml-1, mid 5 x 106 ml-1, late 2 x 107 ml-1. Asterisk indicates cross 
reacting band and demonstrates equal PCF loading.  
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3.3.3 Localisation of YFP-ATG8.1 and YFP-ATG8.2 
3.3.3.1 Improved cell lines for the investigation of autophagy 
To overcome the difficulties associated with visualising ATG8.1 tagged at the 
native locus over expression constructs were created for the three ATG8s of T. 
brucei (Figure 3-6).  The constructs were based on a plasmid backbone 
designated p2625 (Kelly et al. 2007) also known as pGL1731.  It was selected to 
specifically add an N-terminal YFP tag to the target ATG8 protein to ensure the 
C-terminal region was free to undergo the processing required for ATG8 
modification.  The constructs were designed to integrate into a non transcribed 
spacer region between ribosomal RNA genes with expression of the transgene 
directed by the EPI procyclin promoter under the control of a tetracycline 
operator system (Kelly et al.  2007).  The bleomycin drug resistance marker used 
for the selection of transfected parasites was expressed by modified T7 RNA 
polymerase.  Consequently cell lines BSF 427 90-13 and PCF 29-13 were used for 
transfection, as they were engineered to express both T7 RNA polymerase and 
the tetracycline repressor (Wirtz et al.  1999).  
 
 
Figure 3-6 Constructs for ectopically expressed YFP-ATG8s.  
N-terminal YFP tagging was achieved by cloning the individual ATG8 ORFs using HindIII and 
BamHI restriction sites into pGL1731 backbone.  Main features of the tetracycline inducible 
expression vectors are displayed.  
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Stable cell lines were established for all three ATG8s in both BSF and PCF cells 
(ATG8.3 is discussed separately in section 3.3.4).  Expression of YFP-ATG8.1 and 
YFP-ATG8.2 transgenes had no negative effects on cell growth (data not shown) 
and were efficiently induced by the addition of 1 µg ml-1 tetracycline in both 
lifecycle stages.  Visualising the regulated transgene expression by western blot 
was easily achieved using anti-ATG8, although the concentration of antibody 
(1/1000) and incubation time (1 hour), do not enable detection of endogenous 
ATG8 (Figure 3-7).  Subsequent analysis of the fluorescence produced by induced 
parasites also showed a much stronger signal than the natively tagged proteins 
and allowed for accurate microscopic analysis and investigation of autophagy in 
T. brucei. 
 
Figure 3-7 Tetracycline induced YFP-ATG8.1 and YFP-ATG8.2 expression.  
PCF 29-13 cells transfected with YFP-ATG8.1 and YFP-ATG8.2 expression constructs were grown 
for 24 hours in SDM79 media supplemented with 1 µg ml-1 tetracycline (Tet +) or left as uninduced 
control (Tet -).  1 x 106 cell equivalents were loaded per lane and probed with affinity purified anti-
ATG8.  YFP-ATG8.1 (40.2 kDA) and YFP-ATG8.2 (40.75 kDa) were only detected in the presence 
of tetracycline.  To demonstrate equal loading the membrane was stripped and reprobed with anti-
EF1α.    
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3.3.3.2 YFP-ATG8.1 and YFP-ATG8.2 are predominantly located in the 
cytosol during normal growth 
Having established cell lines able to express YFP-ATG8.1 and YFP-ATG8.2, 
fluorescent microscopy was used to investigate the localisation of the tagged 
proteins to determine whether any characteristics typical of ATG8 proteins could 
be detected.  For each condition analysed 200 cells were counted for a series of 
3 replicate experiments, carried out on three individual clones, with all data 
presented as means (unless indicated as otherwise).   
Early log phase cells were induced with 1 µg ml-1 tetracycline and maintained in 
nutrient rich media for 24 hours before fixation in paraformaldehyde and 
microscopic analysis.  For both the BSF and PCF parasites the majority of YFP-
ATG8.1 and YFP-ATG8.2 was distributed throughout the cytoplasm, with 
punctate structures only detected in some cells (BSF Figure 3-8, PCF Figure 3-9).  
More detailed analysis revealed that the BSF parasites expressing YFP-ATG8.1 
had visible punctate structures in 31% of cells, whereas 44% of cells expressing 
YFP-ATG8.2 contained labelled puncta (Figure 3-8).  During normal growth PCF 
T.brucei had fewer cells containing puncta than the BSF cells; only 16% of YFP-
ATG8.1 and 11% of YFP-ATG8.2 PCF cells had visible puncta in early log cultures 
(Figure 3-9).  Interestingly under normal cultured growth conditions there was a 
bias for increased YFP-ATG8.1 puncta formation in PCF cells and YFP-ATG8.2 
puncta formation in BSF cells.   
To confirm the YFP labelled puncta were autophagosomes, several different 
methods were used to investigate whether induction or inhibition of puncta 
occurred in a manner characteristic of autophagy.  
3.3.3.3 Nutrient starvation induces puncta formation 
Nutrient deprivation is well known to stimulate autophagy, triggering increased 
autophagosome formation to promote the supply of material to the lysosome.  
The two lifecycle stages of T. brucei are well adapted for survival in vastly 
different host environments.  BSF parasites reside in nutrient rich mammalian 
blood and rely exclusively on glucose metabolism to produce ATP.  The tsetse fly 
gut inhabited by PCFs is less stable and nutrient availability can fluctuate, 
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dependent upon potentially infrequent bloodmeals.  This is reflected in the PCF 
metabolism that is adapted to cope with diminishing glucose levels and ensure 
continued survival during periods of nutrient limitation or starvation.  Having 
established a baseline level of puncta formation during normal growth it was 
possible to investigate the changes in YFP-ATG8.1 and YFP-ATG8.2 puncta 
formation caused by nutrient depletion and starvation.  Only PCF cell lines were 
analysed to give an accurate reflection of natural circumstances.   
To investigate nutrient depletion a comparison of puncta formation was made by 
microscopic analysis of cells taken from induced early log cells (nutrient rich) 
and late log cultures (nutrient depleted).  It was found there was a significant 
increase in the percentage of late log cells with YFP-ATG8.1 puncta compared to 
early, 21% to 16% respectively (Figure 3-9).  However, whilst the percentage of 
YFP-ATG8.2 puncta containing cells rose from 11% to 16% in late log cultures, 
this change was not statistically significant (Figure 3-9).  
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Figure 3-8 Analysis of YFP-ATG8.1 and YFP-ATG8.2 localisation in BSF T. brucei. 
BSF cells expressing YFP-ATG8.1, YFP-ATG8.2 were induced with 1 µg ml-1 tetracycline and 
maintained in nutrient rich HMI9 media for 24 hours (normal growth).  Washed cells were fixed in 
1% paraformaldehyde before settling onto poly-l-lysine coated slides and analysis on an Applied 
Precision DeltaVision microscope.  Representative images of cells with and without puncta are 
shown.  Left hand images DIC filter, right hand images FITC filter set.  Scale bar 5 µm.   
The percentage of cells containing punctate structures was determined by counting >200 cells for 
each condition, with data displayed as a mean of a series of three replicate experiments for 3 
clones,  error bars represent standard deviation.  
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Figure 3-9 Analysis of YFP-ATG8.1 and YFP-ATG8.2 localisation in PCF T. brucei . 
PCF cells expressing YFP-ATG8.1, YFP-ATG8.2 were induced with 1 µg ml-1 tetracycline and 
maintained in nutrient rich SDM79 media for 24 hours (normal growth) or extensively washed and 
starved of nutrients by incubation in PBS supplemented with 1 µg ml-1 tetracycline for 2.5 hours 
(nutrient starvation).  Washed cells were fixed in 1% paraformaldehyde and viewed on an Applied 
Precision DeltaVision microscope.  Left hand images DIC filter, right hand images FITC filter set.  
Scale bar 5 µm. 
Fluorescent microscopy was used to monitor autophagosome formation in PCF cells expressing 
YFP-ATG8.1 (light grey bars) and YFP-ATG8.2 (dark grey bars) during different stages of cell 
growth in nutrient rich SDM79 media and following 2.5 hours in nutrient free PBS media 
(starvation).  The effect of 10 µM wortmannin on autophagosome formation was also investigated.  
The percentage of cells containing punctate structures was determined by counting >200 cells for 
each condition, with data displayed as a mean of three replicate experiments from three 
independent clones.  Error bars represent standard deviation.  Asterisk(s) indicate where data from 
late log cultures differed significantly from early log cultures * p<0.05, ** p<0.01, ***p<0.001.
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Cells from early and late log cultures were investigated to determine if there 
were any growth phase related factors able to influence puncta formation.  
However, to evaluate the response to complete nutrient starvation, induced PCF 
cells were washed and incubated in PBS supplemented with tetracycline and 
analysed for puncta formation by microscopy.  Nutrient starvation was found to 
be a strong inducer of puncta formation for both YFP-ATG8.1 and YFP-ATG8.2 
with clear punctate structures detected by microscopy (Figure 3-9).  Starved 
parasites from late-log cultures were more likely to contain puncta, suggesting 
they were conditioned to respond more rapidly to starvation.  After 2.5 hours in 
nutrient free PBS 60% of starved early log cells contained YFP-ATG8.1 puncta 
compared to 82% of starved late log cells (Figure 3-9).  More detailed analysis 
revealed an increase in the average number of puncta per positive cell, which 
rose from 1.4 in non starved to 2.2 and 2.6 in starved early and late respectively 
(Figure 3-10).  For YFP-ATG8.2 the percentage of starved cells with puncta was 
52% for early log cultures and 58% of late log cells (Figure 3-10).  Again the 
average number of puncta per positive cell also increased, from 1.2 in non 
starved to 1.7 and 1.8 in starved early and late respectively (Figure 3-10).    
Having successfully established starvation as robust method of inducing puncta 
formation, we sought to see if this process could be blocked by wortmannin, a 
classical inhibitor of autophagy.  Wortmannin blocks autophagy by inhibition of 
PI3 kinases and has been shown to be effective in mammalian cells at 
concentrations of 10 nM (Blommaart et al. 1997; Petiot et al.  2000).  However, 
the inhibition of autophagosome formation in Leishmania required the use of 
wortmannin at 10 µM (Besteiro et al.  2006; Williams et al.  2006), which although 
much higher than for mammalian cells was selected as the starting 
concentration for the T. brucei experiments.  It was found that the addition of 
10 µM wortmannin to the PBS starvation media completely abolished the 
formation of YFP-ATG8.2 puncta and reduced YFP-ATG8.2 puncta containing 
cells to only 7% (Figure 3-9).  Together the starvation and inhibition data 
strongly support the hypothesis that TbATG8.1 and TbATG8.2 are true ATG8 
proteins and that the punctate structures observed are true autophagosomes.  
 85 
 
Figure 3-10 Detailed analysis of autophagosome formation in PCF T. brucei.   
Fixed PCF cells expressing YFP-ATG8.1 (light grey bars) and YFP-ATG8.2 (dark grey bars) were 
analysed by fluorescent microscopy during different stages of cell growth in nutrient rich SDM79 
media and following 2.5 hours in nutrient free PBS media (starvation).  A and B show the number 
of autophagosomes per cell.  Determined for >200 cells and the frequency expressed as a 
percentage of the total number of cells counted.  C) The average number of autophagosomes per 
positive cell was calculated. 
All data displayed as means of three replicate experiments from three independent clones.  Error 
bars show standard deviation. 
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3.3.3.4 Vasoactive Intestinal Peptide rapidly stimulates autophagosome 
formation in BSF cells. 
In an effort to explore novel trypanocidal compounds a selection of endogenous 
human neuropeptides were found to effectively kill trypanosomes during in vitro 
culture and in in vivo mouse models (Delgado et al., 2008).  Further detailed 
characterisation revealed that following neuropeptide uptake an increase in 
double membrane bound organelles was detected by electron microscopy 
(Delgado et al.  2008).  The appearance of autophagosome-like structures in 
dying cells prompted the suggestion that the cells were dying by autophagic cell 
death.  To investigate the effect of neuropeptides on autophagosome formation, 
the BSF ATG8 reporter cell lines were treated with a representative 
neuropeptide, vasoactive intestinal peptide (VIP).  Induced cells were incubated 
with a sub-lethal dose of VIP for 4 and 16 hours and then fixed in 
paraformaldehyde and analysed by microscopy.  Treatment with VIP was found 
to stimulate redistribution of cytosolic YFP-ATG8.1 and YFP-ATG8.2 into 
autophagosome-like puncta, which appeared throughout the cell (Figure 3-11).  
The overall percentage of cells containing both YFP-ATG8.1 and YFP-ATG8.2 
labelled autophagosomes increased significantly after the addition of VIP (Figure 
3-11), however the increase in the average number of autophagosomes per 
positive cell was more slight (Figure 3-12).  The average number of YFP-ATG8.1 
autophagosomes per positive cell increased from 1.6 in the untreated control to 
1.9 following 4 hours incubation with VIP.  Similarly, the average number of YFP-
ATG8.2 autophagosomes per positive cell increased from 1.3 in the untreated 
control to 1.7 following 4 hours incubation with VIP (Figure 3-12).  Induction of 
autophagosome formation was rapid, however extension of the VIP incubation 
period to 16 hours did not significantly increase autophagosome formation in 
comparison to 4 hours treatment. 
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Figure 3-11 Localisation of YFP-ATG8.1 and YFP-ATG8.2 in BSF T. brucei following 
vasoactive intestinal peptide treatment.   
BSF cells expressing YFP-ATG8.1, YFP-ATG8.2 were induced with 1 µg ml-1 tetracycline and 
maintained in nutrient rich HMI9 media for 24 hours (mid-log) supplemented with 3.75 µM 
vasoactive intestinal peptide for 4 and 16 hours.  Washed cells were fixed in 1% paraformaldehyde 
before settling onto poly-l-lysine coated slides and viewed on an Applied Precision DeltaVision 
microscope.  Left hand images DIC filter, right hand images FITC filter set.  Scale bar 5 µm.  
The percentage of cells containing autophagosomes was determined by counting >200 cells for 
each condition, with data displayed as a mean of three replicate experiments from one clones.  
Error bars represent standard deviation.  Asterisk(s) indicate where data from VIP treated cultures 
differed significantly from mid log control cultures  ** p<0.01, ***p<0.001. 
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Figure 3-12 VIP rapidly stimulates autophagosome formation in BSF T. brucei.   
A) The number of autophagosomes per cell was determined by fluorescent microscopy of BSF 
cells expressing YFP-ATG8.1 and YFP-ATG8.2.  Mid log cultures grown in nutrient rich HMI9 
media (control) and those supplemented with 3.75 µM VIP for 4 and 16 hours were analysed.  The 
number of autophagosomes per cell was determined for >200 cells and expressed as a percentage 
of the total number of cells counted.  Data displayed represents means of three replicate 
experiments for one clone.  Error bars show standard deviation.  
B) The percentage of cells containing autophagosomes was determined by counting >200 cells for 
each condition, with data displayed as a mean of three replicate experiments from one clones.  
Error bars represent standard deviation.  Asterisk(s) indicate where data from VIP treated cultures 
differed significantly from mid log control cultures: * p<0.05, ** p<0.01, ***p<0.001.  
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3.3.3.5 Rapamycin does not induce autophagy in T. brucei 
In yeast rapamycin stimulates autophagy through the inhibition of TOR, which is 
a protein kinase that controls cell growth in response to levels of ATP and amino 
acids.  TOR operates in two separate complexes to exert control upon two 
distinct aspects of cellular growth.  TOR complex 1 (TORC1) regulates temporal 
cell growth, whereas TOR complex 2 (TORC2) controls spatial cell growth 
(Wullschleger et al. 2006).  Rapamycin selectively inhibits TORC1 (Zheng et al. 
1995), which suggests it is the TOR complex responsible for autophagy regulation 
(Kamada et al.  2000).  T. brucei possesses two TOR orthologues TbTOR1 and 
TbTOR2, which through interactions with their respective TOR complexes were 
shown to regulate temporal aspects of cell growth and cell polarization, 
respectively (Barquilla et al. 2008).  Detailed characterisation of the T. brucei 
TOR complexes revealed that only TbTOR2 was specifically inhibited by 
rapamycin.  Unlike TOR kinases in other eukaryotes, TbTOR1 remained 
insensitive, which suggested rapamycin is unlikely to induce T. brucei autophagy 
in a TOR dependent manner (Barquilla et al. 2009).   
However, previous to the work of Barquilla and colleagues, rapamycin had been 
used as a positive control for the induction of autophagy in T. brucei, with 
electron micrographs presented depicting the potential resulting 
autophagosomes (Uzcategui et al.  2007).  To resolve the disparity and 
investigate potential TOR independent autophagy stimulation, the effect of 
rapamycin on YFP-ATG8.1 and YFP-ATG8.2 labelled autophagosomes was 
investigated.  Rapamycin was added to induced cultured cells and the 
redistribution of YFP-ATG8 into puncta was monitored by microscopy.   
Growth of BSF cells with 1 µM and 5 µM rapamcyin for 24 hours significantly 
increased the percentage of cells containing both YFP-ATG8.1 and YFP-ATG8.2 
autophagosomes.  In PCF only 10 µM rapamycin produced a marginal increase in 
the percentage of cells with YFP-ATG8.2 autophagosomes (not statistically 
significant), however no effect on YFP-ATG8.1 was observed (Figure 3-13).  
Despite statistically significant results of YFP-TG8.1 autophagosome formation in 
BSF cells, the effects of rapamycin on autophagy induction were very mild, 
especially when compared to starvation (PCF) and VIP treatment (BSF).  The 
marginally increased autophagosome numbers potentially represented artefacts 
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relating to unhealthy cells arising from the high concentrations used, as opposed 
to direct autophagy induction.  The small and inconsistent increases in 
autophagosome formation, in relation to the high concentrations of rapamycin 
used, suggest the effects observed were unlikely to stem from a direct induction 
of autophagy but were possibly related to an increase in aberrant cells.  Thus it 
appears rapamycin is unsuitable for use as an inducer of autophagy and does not 
appear to dramatically stimulate autophagosome formation in a TOR 
independent manner.   
 
Figure 3-13 Rapamycin does not stimulate autophagosome formation in T. brucei.   
YFP-ATG8.1 and YFP-ATG8.2 expressing cells were grown in the presence of rapamycin for 24 
hours before fluorescent microscopy analysis.  The percentage of cells containing punctate 
structures was determined by counting >200 cells for each condition, with data displayed as a 
mean of three replicate experiments from an individual clone.  Error bars represent standard 
deviation.  Asterisk(s) indicate where data from rapamycin treated cultures differed significantly 
control cultures: * p<0.05, ***p<0.001. 
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3.3.4 Investigating TbATG8.3  
Multiple copies of ATG8 can be found in mammals and plants; the significance of 
these expanded ATG8 gene families is not yet fully understood.  Yeast has only 
one ATG8 gene, however humans have eight ATG8 orthologues that are divided 
into two subfamilies, MAP1LC3 and GABARAP/GATE-16 (He et al.  2003).  Analysis 
of the autophagy network identified 67 proteins that interacted with the cohort 
of human ATG8s, of which only approximately one-third were found to interact 
with both subfamilies (Behrends et al. 2010).  This could reflect the distinct 
roles of the different ATG8 subfamilies (Weidberg et al.  2010) but also 
demonstrates substantial functional overlap of their roles in autophagy.  
Leishmania major has an extended repertoire of 25 ATG8-like genes, grouped 
into ATG8, ATG8A, ATG8B and ATG8C sub-families based on sequence similarity 
(Williams et al.  2006).  Characterisation of ATG8 and representative members 
from each subfamiliy revealed distinct differences.  All of the LmATG8s could 
complement yeast ATG8 null mutants suggesting a shared ability to function as 
true ‘ATG8 proteins’.  Additionally, GFP-labelled puncta were formed by 
proteins from all four subfamilies, however their distribution and response to 
starvation and differentiation was markedly different (Williams et al.  2009).   
In this work the labelling of TbATG8.1 and TbATG8.2 with YFP was used to 
establish that these proteins were incorporated into autophagosomes and 
behaved like other yeast and mammal ATG8s.  However, as discussed in section 
3.1.9.3, bioinformatic searches revealed that a third ATG8 homologue existed in 
T. brucei, ATG8.3 (Tb927.7.3320).  The TbATG8.3 protein shares a high degree 
of sequence similarity to ATG8.1 and ATG8.2, and contains many of the key 
conserved residues identified in yeast (Figure 3-3).  However ATG8.3, contains a 
large insertion, characteristic of many ATG12 type proteins (Figure 3-14) 
including LmjF22.1300, an ATG8-like protein that has been shown to function as 
an ATG12 protein in L. major and is able to form punctate structures (Williams et 
al.  2009).  In yeast cells the ATG12-ATG5 complex has been shown to be 
predominantly located in the cytoplasm with only small amounts associated to 
the isolation membranes and is entirely absent from autophagosomes (Mizushima 
et al.  2001). 
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                   1                                                                             80 
   LmjATG12    (1) -----------------------------MHAPPQPPPPPRTHYQYMHSFEHRCLLSKKMLRLYGASTVPVIVEPTESHL 
    ScATG12    (1) MSRILESENETESDESSIISTNNGTAMERSRNNQELRSSPHTVQNRLELFSRRLSQLGLASDISVDQQVEDSSSGTYEQE 
   TbATG8.3    (1) -------------------------------------MPSHYRYQYTRSFAERAKETE-SARLRYPKHIPILCEPTSAAS 
   TbATG8.1    (1) ---------------------------------------MKYNFKDSHSLVKRLNEST-KVRKSHPNHFPVICEKVYNSD 
   TbATG8.2    (1) ------------------------------------MSKKDSKYKMSHTFESRQSDAA-KVRERHPDRLPIICEKVYNSD 
     ScATG8    (1) ---------------------------------------MKSTFKSEYPFEKRKAESE-RIADRFKNRIPVICEKAEKSD 
  
 
 
                   81                                                                           160 
   LmjATG12   (52) RLSPSPPSLHGESKSSAGSAGGFGGYARHGQLSSSGRAGAGVTASSLASAFTSPSAKSTLKCILLRSKSVAEVILTLRGR 
    ScATG12   (81) ETIKTNAQTSKQKS--------------------HKDEKNIQKIQIKFQPIGSIGQLKPSVCKISMSQSFAMVILFLKRR 
   TbATG8.3   (43) ASTPRDVRLFSTRQQ-------------------------------------VQRELDCNKFLLPETATVMEFMMALRQR 
   TbATG8.1   (41) IG-----------------------------------------------------ELDRCKFLVPSDLTVGQFVSVLRKR 
   TbATG8.2   (44) IG-----------------------------------------------------ELDRCKFLVPSDLTVGQFVSVLRKR 
     ScATG8   (41) IP-----------------------------------------------------EIDKRKYLVPADLTVGQFVYVIRKR 
 
 
 
                   161                                                                   233 
   LmjATG12  (132) LALDSCQSLFLSVGENDVLVPGNSLLGDLYERYRNADGFLYLGYLLENTFGGDVRSAAGEAASHTVRRPVQR- 
    ScATG12  (141) LKMDH---VYCYIN-NSFAPSPQQNIGELWMQFKTND-ELIVSYCASVAFG---------------------- 
   TbATG8.3   (86) LLLEEGQAVFVFI--GNELPPNSACLGDIYARAKDPDGFLYVSYGVENTFG---------------------- 
   TbATG8.1   (68) VQLEAESALFVYT--NDTVLPSSAQMADIYSKYKDEDGFLYMKYSGEAAFG---------------------- 
   TbATG8.2   (71) VQLEAESALFVYT--NDTVLPSSAQMADIYSKYKDEDGFLYMKYSGEATFGC--------------------- 
     ScATG8   (68) IMLPPEKAIFIFV--NDTLPPTAALMSAIYQEHKDKDGFLYVTYSGENTFGR--------------------- 
 
Figure 3-14 TbATG8.3 contains an insertion typical of ATG12 proteins. 
Vector NTI protein sequence alignment for Leishmania major ATG12, S. cerevisiae Atg12,  T. brucei ATG8.1, ATG8.2 and ATG8.3 and S. cerevisiae ATG8.  
Sequences aligned using Clustal W algorithm of the Align X program.  Identical and conserved amino acids are highlighted yellow and blue respectively.  Blocks of 
similar sequences are highlighted in green and green coloured text indicates weak conservation.  Numbers in brackets indicate the position of the first amino acid in the 
linear polypeptide in the section of each protein analysed.  The tritrypDB identifiers and accession numbers are: LmjATG12 (LmjF22.1300), ScATG12 (YBR217W), 
TbATG8.1 (Tb927.7.5900), TbATG8.2 (Tb927.7.5910), TbATG8.3 (Tb927.7.3320) and ScATG8 (YBL078C).  Blue dashed line indicates insertion typical of ATG12 
proteins. 
For the in vivo characterisation of TbATG8.3, the ORF was cloned into the same 
N-terminal YFP expression vector as used previously.  Tightly regulated inducible 
expression was clearly detectable by western blot using an antibody specific to 
GFP (recognises the mutant YFP form).  Interestingly expression was not 
detected by the anti-ATG8 antibody (Figure 3-15).  This could suggest 
differences in the protein structure or absent epitopes on ATG8.3.  Analysis of 
the YFP-ATG8.3 cell lines revealed that during normal growth YFP-ATG8.3 was 
almost entirely dispersed in the cytosol (98.6% of cells) with very few punctate 
structures detected.  Upon starvation there was a slight increase in the 
percentage of cells containing puncta (Figure 3-16).  The localisation of YFP-
ATG8.3 conformed to that of an ATG12-like protein, however in the absence of 
definitive data this finding could not be confirmed.   
 
 
Figure 3-15 Tetracycline induced YFP-ATG8.3 expression.  
PCF 29-13 cells transfected with YFP-ATG8.3 expression constructs were grown for 24 hours in 
SDM79 media supplemented with 1 µg ml-1 tetracycline (Tet +) or left as uninduced control (Tet -).  
1 x 106 cell equivalents were loaded per lane and probed with anti-GFP and affinity purified anti-
ATG8.  YFP-ATG8.3 (42.2 kDA) were only detected in the presence of tetracycline.  To 
demonstrate equal loading the membrane was stripped and reprobed with anti-EF1α (bottom 
boxes).  
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Figure 3-16 YFP-ATG8.3 puncta formation in PCF cells.  
Fluorescent microscopy was used to monitor autophagosome formation in PCF cells expressing 
YFP-ATG8.3 during cell growth in nutrient rich SDM79 media (normal) and following 2.5 hours in 
nutrient free PBS media (starvation).  Scale bar 5 µm.  The percentage of cells containing punctate 
structures was determined by counting >200 cells for each condition, with data displayed as a 
mean of three replicate experiments from three independent clones.  Error bars represent standard 
deviation.   
 
3.3.5 Selective ATG8 lipid conjugation 
The formation of autophagosomes requires two ubiquitin-like protein 
conjugation systems, centred on Atg12 and Atg8.  In yeast, Atg8 is conjugated to 
an abundant membrane phospholipid called phosphatidylethanolamine (PE).  The 
conjugation reaction requires Atg4 (cysteine peptidase) mediated removal of the 
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C-terminal arginine (amino acid position 117) from newly synthesised Atg8.  This 
exposes a glycine residue (amino acid position 116), which allows activation of 
the Atg8-Glycine-116 intermediate by Atg7 (E1 enzyme), which in turn transfers 
it to Atg3 (E2 enzyme).  Finally, Atg8-Glycine-116 is conjugated to PE (forming 
Atg8-PE) via an amide bond between the C-terminal glycine carbonyl group and 
the amino group of PE.  Atg8-conjugation allows incorporation into the 
autophagosome membrane and is essential for autophagosome formation 
(Ohsumi et al.  2004; Tanida et al. 2004a).  The possibility that TbATG8.1 and 
TbATG8.2 undergo posttranslational lipid conjugation reactions was investigated 
by monitoring their mobility on SDS-PAGE supplemented with urea, combined 
with analysing their sensitivity to phospholipase D. 
Whole cell lysates were made from induced PCF cultures which had either been 
grown under normal conditions or subject to two hours starvation.  The lysates 
were separated by SDS page in the presence of 6M urea.  Under these conditions 
ATG8 conjugated to a phospholipid will migrate faster and consequently appear 
as lower molecular weight band on the gel.  Western blots using anti-ATG8 
revealed that during normal growth there is a low level of lipidated YFP-ATG8.1, 
however starving the cells increased the amount of lipidated YFP-ATG8.1, which 
correlated with the increased number of cells containing fluorescent puncta 
(Figure 3-16).  To further verify YFP-ATG8.1 lipidation, starved cell lysates were 
incubated with phospholipase D, which releases phosphatidic acid from the 
conjugate corresponding to a decrease in the faster running band.  A reduction 
in the intensity of the lipidated YFP-ATG8.1 was observed, but full delipidation 
did not occur.  Interestingly, lipidated forms of YFP-ATG8.2 were not detected 
during normal growth or following starvation (Figure 3-16).  In other organisms 
the conjugated phospholipid is PE and it is therefore likely that PE is the 
phospholipid in this case.  
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Figure 3-17 YFP-ATG8.1 conjugates to a phospholipid. 
6M urea gels were used to separate 30 µg of PCF cell lysate from YFP-ATG8 overexpressing cell 
lines and western blotted using affinity purified anti-ATG8.1.  Induction was carried out with 1 µg ml-
1
 of tetracycline for 24 hours.  Starved cells were washed twice before resuspension in PBS for 2 
hours.  Phospholipase D (PLD) was added to cell lysates and incubated at 37oC for 1 hour.  Lane 
1, non-induced PCF, lane 2, induced normal growth PCF, lane 3, induced starved PCF, lane 4 
induced starved PCF treated with PLD.  
 
3.3.6 Essentiality of autophagy pathway in PCF T. brucei 
After the discovery of autophagy in yeast it was possible to screen mutants 
defective in the production of autophagosomes, which originally lead to the 
identification of 14 autophagy genes (Tsukada et al. 1993).  This showed that 
disruption to autophagy was not lethal to yeast maintained in normal culture 
conditions.  For example, analysis of mutant yeast strains lacking either ATG3 or 
ATG7, not only helped divulged the role of these proteins, but also 
demonstrated that the absence of a functional autophagy system increased 
sensitivity to starvation (Kim et al. 1999; Schlumpberger et al. 1997).       
To validate the importance of the autophagy pathway to PCF T. brucei a gene 
fundamental to autophagy was selected for RNAi downregulation.  TbATG3 
(Tb927.2.1890) was identified as suitable RNAi target due to the detection of 
only one homologue in the T. brucei genome (Herman et al.  2006), reducing the 
possibility of functional complementation from other gene copies.  A target 
region of 500 base pairs was cloned into the 2T7ti RNAi vector pGL571 (LaCount 
et al. 2000) and transfected into the PCF 29-13 cell line (Wirtz et al.  1999).  
Three independent clones were analysed. 
 97 
RNAi was induced in each clone by the addition of 1µg ml-1  tetracycline to the 
culture media and the growth rate of induced (Tet +) was compared to non 
induced control (Tet -) over a 9 day period to evaluate whether the down 
regulation of target gene was detrimental to cell growth.  Every three days the 
cells were reseeded in fresh media (supplemented with tetracycline) to maintain 
cells in exponential growth.  All three clones for ATG3 followed the same 
pattern following induction of RNAi; a strong reduction in the growth rate visible 
from 4 days post induction continuing for the remainder of the time course 
(Figure 3-18).  No visible defects were detected in appearance of the cells until 
day 7 when the appearance of elongated cells became more common.  To 
confirm that RNAi induction was targeting and reducing ATG3 mRNA, 
quantitative RT-PCR was used and revealed an average ATG3 transcript 
depletion of 78% (average of 3 clones) from 5 days post induction (Figure 3-18). 
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Figure 3-18 RNAi downregulation of ATG3 reduces PCF growth rate. 
Top panel, cumulative growth curve for representative PCF ATG3 RNAi clone in the presence (Tet 
+) and absence (Tet -) of 1µg ml-1  tetracycline.  Bottom panel, relative quantification of ATG3 
mRNA in induced and noninduced RNAi cell as determined by real time PCR at day 5.  Data mean 
of average down regulation in three independent clones, error bar shows standard error. 
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3.4 Discussion 
Autophagy has been well characterised in yeast with over 30 individual proteins 
known to participate in the pathway.  The yeast protein sequences were used 
for bioinformatic screens and identified T. brucei orthologues for half of the 
yeast autophagy machinery (Herman et al.  2006; Williams et al.  2006).   
The presence of many key autophagy genes implied that a functional system was 
likely to exist.  However the absence of certain orthologues raised interesting 
questions about the conservation of the overall pathway in T. brucei.  The 
reduced repertoire of genes could reflect a streamlined version of the autophagy 
machinery that is fully functional without orthologues specific only to yeast.  
Alternatively, proteins with limited or no homology to their yeast counterparts 
could be functioning in the same pathways but remain undetected by BLAST 
searches.  One important finding was the detection of all components of the 
yeast Atg8 conjugation pathway including three candidate ATG8 genes (Herman 
et al.  2006; Williams et al.  2006), one of which (ATG8.3) could encode for an 
ATG12 (Williams et al.  2006).  The crystal structure for T. brucei ATG8.2 has 
been solved and shows the presence of many key functional residues in the 
correct spatial orientation as well as a high degree of structural homology with 
other ATG8 proteins (Koopmann et al.  2009). 
To confirm the presence of a functional autophagy system in T. brucei the three 
candidate ATG8 orthologues were N-terminally tagged with YFP and ectopically 
expressed in both BSF and PCF.  Thorough characterisation of YFP-ATG8.1 and 
YFP-ATG8.2 localisation following a variety of external stimuli revealed that 
they behaved with hallmarks of other characterised ATG8 proteins.  Crucially 
following nutrient starvation of PCF cells, fluorescent microscopy revealed a 
dramatic redistribution of cytosolic YFP-ATG8.1 and YFP-ATG8.2 into distinct 
punctate structures, a process that was blocked by the classical autophagy 
inhibitor wortmannin.  Furthermore, urea gel separation and western blot 
analysis revealed increased YFP-ATG8.1 lipidation following starvation, although 
YFP-ATG8.2 appeared not to be conjugated to a lipid.  Taken together these key 
findings suggested that TbATG8.1 and TbATG8.2 are true ‘ATG8’ proteins that 
participate in a functional autophagy system in T. brucei. 
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Interestingly the cell densities of PCF cultures influenced the percentage of cells 
containing YFP-tagged autophagosomes.  For both YFP-AG8.1 and YFP-ATG8.2 
small but significant increases in the number cells containing autophagosomes 
were seen in starved cultures taken from late log densities in comparison to 
early log cultures.  Higher culture density also increased the percentage of cells 
with autophagosomes during growth in normal media, potentially in response to 
stresses related to high population densities.  The increased basal rate of 
autophagy in late log cells could ensure more of the required molecular 
components were already present allowing for more rapid adaptation to 
starvation leading to the observed increase in autophagosome numbers. 
BSF parasites were also shown to produce YFP-ATG8.1 and YFP-ATG8.2 labelled 
autophagosomes during normal growth.  However, BSF parasites cannot be 
maintained at high densities or deprived of nutrients, so alternative methods for 
the induction of autophagosome formation were investigated.  Initially it was 
hoped that rapamycin would be a suitable candidate but it failed to stimulate 
high levels of YFP-labelled autophagosome formation, most likely due to the 
insensitivity of TbTOR1 to rapamycin (Barquilla et al.  2008).  However, treating 
BSF cells with the neuropeptide VIP proved to be an effective method of 
stimulating autophagosome formation; significantly increasing the number of 
YFP-ATG8.1 and YFP-ATG8.2 autophagosomes per cell.  Delgado et al., reported 
that VIP caused BSF cell death accompanied by autophagy, with increased 
autophagosome formation revealed by ultrastructural studies using transmission 
electron microscopy and immunofluorescence analysis using human anti-LC3 
(Delgado et al.  2008).  The demonstration of VIP induced autophagy using 
confirmed markers for T. brucei autophagy (YFP-ATG8.1 and YFP-ATG8.2) 
provided strong support for the findings reported by Delgado et al. 
Bioinformatics analysis revealed a third T. brucei ATG8, designated TbATG8.3.  
YFP-tagging of TbATG8.3 revealed a predominant cytosolic distribution with 
limited puncta formation occurring at much lower frequencies than TbATG8.1 
and TbATG8.2.  Nutrient starvation induced the formation of puncta, although 
overall the percentage of cells with puncta remained very low.  The different 
localisation pattern of the T. brucei ATG8.3 could be due to a number of factors:   
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I) ATG8.3 could localise to autophagosomes but is not induced by starvation.  
Process specific involvement of ATG8-like proteins was found in the expanded L. 
major family of proteins, LmATG8A labelled autophagosomes were only induced 
by starvation not differentiation (Williams et al.  2009).  
II) ATG8.3 functions as an ATG12 protein.  Despite moderate sequence identity 
to other ATG8 proteins it contains a 16 amino acid insertion which is 
characteristic of ATG12 proteins and is predicted to interfere with its ability to 
interact with ATG4 (Koopmann et al.  2009).  In L. major the gene LmjF22.1300 
encodes a protein that has been experimentally verified to function as an ATG12 
(Williams et al.  2009).  However, sequence analysis suggests the protein has a 
closer resemblance to yeast Atg8 rather than Atg12 (Rigden et al.  2009).  It is 
possible that in L. major a protein divergent from the yeast Atg12 has evolved to 
fulfil similar functions within the autophagy pathway.  Furthermore interrogation 
of the T. brucei genome using the L. major ATG12 protein sequence in a BLAST 
searches, identified T. brucei ATG8.3 as a potential orthologue (Williams et al.  
2006).  Thus it is possible T. brucei ATG8.3 plays an equivalent role in the 
autophagic pathway; resembling an ATG8-like protein while functioning like an 
ATG12 protein.    
The low number of YFP-ATG8.3 puncta observed further supports a possible role 
as an ATG12 protein.  In yeast and mammals the Atg12-Atg5 complex is largely 
distributed in the cytosol and only localises to the isolation membrane and 
developing phagophore not to the mature autophagosomes (Mizushima et al. 
2003; Suzuki et al.  2001).  The reduced number of YFP-ATG8.3 structures could 
be attributed to the selective labelling of the developing autophagosomes only, 
whereas ATG8.1 and ATG8.2 are also present on mature autophagosomes.  
Indeed the number of PAS structures per cell varies according to species, yeast 
have only one whereas mammals have multiple sites of autophagosome 
biogenesis (Mizushima et al.  2003).   
III) ATG8.3 is not involved in autophagy but functions in another distinct cellular 
process.  ATG8-like proteins have a diverse range of functions, for example in L. 
major, two proteins from the ATG8B and ATG8C families appeared to be 
involved in autophagy-independent processes (Williams et al.  2009).   
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The affinity purified polyclonal antibody raised against ATG8.1 was able to 
recognise both ATG8.1 and ATG8.2 proteins, demonstrated by western blots of 
the individual over expression cell lines.  Interestingly the antibody failed to 
recognise ATG8.3 indicating significant differences between the proteins caused 
by low amino acid sequence identity.  
Endogenous TbATG8 protein was detected in both BSF and PCF monomorphic 
parasites, although a high antibody concentration and extended overnight 
incubation period were required which suggested low expression levels.  The 
similarity in the predicted size of ATG8.1 and ATG8.2 proteins means it is 
impossible to discern which isoform is detected by western blot.  Analysis of 
transcript abundance by microarray confirmed that both genes are expressed, 
although ATG8.1 is more abundant than ATG8.2 in all the lifecycle stages 
investigated (Jensen et al. 2009).   
This investigation revealed in BSF parasites the expression level of ATG8 was 
constant, whereas in PCFs higher culture densities stimulated an increase in 
ATG8 expression.  These findings correlate well with the microarray analysis of 
transcript abundance in logarithmically dividing and stationary phase PCF 
cultures.  The general pattern (all genes) revealed a tendency for reduced mRNA 
levels in stationary cultures compared to the actively replicating log PCF cells 
(Jensen et al.  2009).  However, interestingly the abundance of many core 
autophagy genes was found to peak in PCF stationary phase cultures (ATG6, 
Vps15, ATG8.2, ATG8.3, ATG3, ATG4.1, ATG10).  Indeed, ATG8.1 and ATG8.2 
transcript levels were 2.16 and 2.71 times higher respectively in stationary 
cultures compared to log dividing PCF cultures (Jensen et al.  2009).  The authors 
add a note of caution as higher transcript levels may not necessarily indicate 
active expression but could reflect reduced decay rate.  However, it is tempting 
to speculate that the high transcript abundance for autophagy associated genes 
in stationary culture conditions helps mitigate against the more stressful 
conditions.  If the higher transcript abundance corresponds to protein level (as it 
appears to be for ATG8) it could be a contributing factor for the increased 
puncta formation found in the late log cells.   
The increased ATG8 protein expression in stationary phase cultures provides a 
compelling reason to revisit the natively tagged ATG8.1 cell lines.  Initial 
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investigations were focused on mid log PCF cultures, however increased GFP-
ATG8.1 expression in stationary phase PCF cells might yield stronger fluorescent 
signals.  Furthermore a recent report showed that in situ YFP-tagging of 
TbATG8.2 only produced visible punctate structures following prolonged stress to 
the endoplasmic reticulum not during normal growth conditions (Goldshmidt et 
al. 2010).  My work has identified suitable stresses (e.g. starvation, VIP) that 
could be used to induce autophagosome formation in the natively tagged cell 
lines to facilitate further investigations. 
As discussed ATG8.1 and ATG8.2 are both functional components of the T. brucei 
autophagic pathway.  However, one interesting difference between these two 
proteins is the availability of the conserved glycine residue required for PE 
conjugation.  Unusually ATG8.1 terminates at the site of the conserved glycine 
(commonly proteolytic cleavage by ATG4 is required for exposure and 
subsequent conjugation) whereas ATG8.2 has one more cysteine residue.  It has 
been postulated that ATG8.1 is produced as mature protein and is involved in 
basal autophagic processes.  The requirement for ATG8.2 processing (presumably 
by ATG4.1 or ATG4.2) suggests a regulated function allowing for specific 
activation during certain conditions such as starvation or differentiation 
(Koopmann et al.  2009).    
The selective lipidation of T. brucei ATG8.1 and ATG8.2 was an unexpected and 
interesting finding.  In S. cerevisiae Atg8 lipidation is a multi step reaction that 
culminates in the conjugation of Atg8 to PE allowing incorporation into the 
autophagosome membrane.  Western blot analysis was only able to detect T. 
brucei YFP-ATG8.1 phospholipid conjugation.  However, further investigation is 
required as fluorescent microscopy of cells expressing YFP-ATG8.2 revealed that 
autophagosomes were actively formed.  
The high degree of conservation between the two proteins means even subtle 
differences in sequence and structure could contribute to the regulatory 
mechanisms that influence ATG8.1 and ATG8.2 interactions.  The ubiquitin-cores 
of T. brucei ATG8.1 and ATG8.2 differ by only one amino acid and the proteins 
only diverge towards the N-terminal region, which corresponds to the α1 and α2 
helices.  As both ATG8s contain the conserved glycine residue required for PE 
conjugation it is tempting to speculate that the N-termini are critical in 
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mediating T. brucei ATG8 targeting and interactions.  Indeed the N-terminal 
region of the human Atg8 homologues have been suggested to influence their 
interactions with other molecules.  Structural analysis of LC3, GATE-16 and 
GABARAP revealed a high degree of conservation in the residues required for 
attachment of the α1 and α2 helices to the ubiquitin core (Sugawara et al. 
2004).  However despite this critical conservation, the α1 and α2 moeties of the 
human Atg8 homologues exhibited different electrostatic potentials which was 
thought to coordinate their interactions with different target proteins (Sugawara 
et al.  2004).   
To investigate the essentiality of autophagy in T. brucei a gene essential to the 
pathway was downregulated by RNAi.  The ATG3 orthologue was selected as a 
suitable target due to its fundamental role in autophagy pathway where it 
functions as the E2-like enzyme in the ATG8 conjugation pathway.  Induction of 
RNAi produced a strong down regulation of ATG3 transcript and a reduction in 
the growth rate visible from four days post induction.  At the end of the 9 day 
RNAi induction period the cells were still viable but appeared ‘unhealthy’ and 
were replicating at much lower level that the control cells.  The consistent 
results from all clones analysed confirms that ATG3 is important and required for 
normal PCF cell growth.  However, from the analysis carried out so far it cannot 
be discerned whether depletion of ATG3 successfully inhibited autophagy leading 
to the reduced growth rate or if ATG3 plays other roles in cellular proliferation.     
The diversity of the physiological roles of autophagy in T. brucei remains 
unknown.  The initial characterisation carried out in this study revealed a robust 
autophagic response in cultured PCF parasites following nutrient deprivation but 
whether this translates into the natural environment awaits confirmation.  
However, as discussed below there is a strong rationale to suggest autophagy is 
likely to be involved in many aspects of biology of wild T. brucei parasites. 
The short stumpy BSFs that are ingested during the tsetse fly bloodmeal must 
undergo a complex differentiation cycle within the fly.  A crucial aspect of PCF 
development is their migration to the tsetse fly salivary glands where they 
differentiate into mature metacyclics, which are perfectly adapted to ensure 
survival in a new mammalian host.  It can take up to 24 days to establish a 
mature metacyclic salivary gland infection and many parasites fail to leave the 
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fly midgut (Van den Abbeele et al.  1999).  Indeed in nature the tsetse fly 
infection rate is very low, with approximately only 10% of flies from disease 
endemic areas carrying trypanosomes (Aksoy et al. 2003).   
The potential for lengthy PCF maturation means the parasites must be able to 
successfully persist for extended periods in the turbulent environment of the fly 
host.  Unlike the relatively stable mammalian blood, tsetse flies are at the 
mercy of their environment and dramatic changes in temperature and rainfall 
that frequently occur during the cycle of wet and dry seasons can have profound 
impacts.  For example the fluctuating external environment has been shown to 
alter fly size as well the fat content of Glossina moristans moristans, with higher 
fat levels detected during the cool season and lower levels during hot periods 
before the rainy season (Van den Bossche et al. 1999).  Ultimately however all 
nutrients are obtained from bloodmeals and the feeding frequency of tsetse flies 
can be variable and subject to external influences such as prey availability.  
Accurate determination of natural feeding frequencies is difficult although it is 
generally accepted to occur approximately every 42 hours (Aksoy et al.  2003; 
Van den Bossche et al.  1999).  Difficulties in securing a blood meal present 
potential nutrient limitation for both host and parasite.  
The tsetse flies fat body functions as an energy reserve and provides proline for 
the flight muscles (Aksoy et al.  2003).  The consequent abundance of proline in 
tsetse flies combined with unreliable and diminishing glucose availability, means 
proline is used by PCF parasites as an energy source.  Therefore any factors 
resulting in variations to proline abundance, whether seasonal artefacts or 
bloodmeal frequency could result in host parasite competition for proline.  Little 
is known about the possible compartmentalisation of proline within the tsetse fly 
and whether access is restricted for PCF parasites (Attardo et al. 2006).  
However complete depletion of tsetse fly proline would create an obvious cost 
to parasite fitness by blocking transmission.  Accordingly autophagy could help 
to ensure the viability of PCF T. brucei in the tsetse fly by recycling internal 
nutrients during times of stress and proline limitation.  Interestingly laboratory 
experiments have revealed that extended periods of starvation appear to 
increase the ability of T. brucei to establish mature salivary gland infections, 
possibly due to an impaired immune response in malnourished tsetse flies (Akoda 
et al. 2009; Kubi et al. 2006).  This raises the interesting possibility that 
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autophagy allows PCFs to successfully endure periods of starvation and 
ultimately facilitates parasite transmission.   
Autophagy is known to be essential for cellular remodelling in S. cerevisiae and 
D. discoideum as well as species more closely related to T. brucei such as  L. 
major and L. mexicana (Besteiro et al.  2006; Otto et al.  2003; Talloczy et al.  
2002; Williams et al.  2006).  The developmental cycle of PCF parasites is very 
complex and involves multiple developmental steps consisting of morphologically 
distinct lifecycle stages (see section 1.4.2) and is presumed to require the 
considerable turnover of redundant proteins and organelles.  Indeed variations in 
metabolism and enzymatic contents of glycosomes are known to exist in 
parasites from different lifecycle stages.  In differentiating T. brucei cells 
microautophagy has been implicated in the efficient and rapid degradation of 
unwanted glycosomes containing enzymes suited to a previous lifecycle stage 
(Herman et al.  2008).  This represents one example of autophagy facilitating T. 
brucei cellular remodelling, however given the complexity and importance of 
efficient transition between lifecycle stages we speculate that autophagy may 
have further critical roles to play. 
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4 Metacaspases 
4.1 Introduction 
4.1.1 General introduction to peptidases 
Peptidases (also known as proteases or proteinases and peptide hydrolases) are 
proteins capable of cleaving peptide bonds.  They have a well established role as 
mediators of non-specific degradation, yet it is becoming apparent that 
peptidases participate in a wide variety of roles and are emerging as key 
regulators of many biological processes (Lopez-Otin et al. 2010).  Controlled 
proteolytic cleavage is a wide spread post-translational modification known to 
have far reaching effects on target proteins.  Significantly, abnormal peptidase 
activity is emerging as a major contributor to human disease (Lopez-Otin et al. 
2008; Lopez-Otin et al.  2010).  
4.1.2 Cysteine peptidase mechanism 
Peptidases that cleave within a peptide chain are called endopeptidases, 
whereas those cleaving at the end of a polypeptide chain are referred to as 
exopeptidases.  A broad requirement for catalytic activity and a key property of 
all peptidases is their ability to force the formation of a tetrahedral 
intermediate at a specific site in the substrate peptide chain.  This is achieved 
through specific interaction with the substrate in the highly ordered active site 
of the enzyme.  For successful hydrolysis the substrate must fit in the active site 
in such a fashion that the scissile bond (amino acid bond cleaved by the 
peptidase) is positioned in close proximity to the catalytic residues.  In cysteine 
peptidases the catalytic residues are histidine and cysteine but other residues 
can also participate.  The cysteine and histidine work in partnership to cleave 
the peptide bond;  the sulphur atom of the cysteine functions as the 
nucleophile, capable of attacking the carbonyl carbon of the scissile bond and 
the histidine is involved in proton shuttling (Stennicke et al. 1999).   
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Figure 4-1 Cysteine peptidase catalytic mechanism. 
Schematic depicting general mechanism for cysteine peptidase substrate hydrolysis.  Enzyme 
active site depicted in blue, catalytic residues are indicated including nucleophilic sulphur atom of 
cysteine and imidazole group of histidine.  Detailed mechanism outlined in text section 4.1.2.  
   
 
The basic side chain of the histidine residue (imidazole group) mediates the 
deprotonation of the thiol belonging to the active site cysteine, promoting 
nucleophile formation.  In some cysteine peptidases (e.g. caspases) nucleophilic 
attack is facilitated by hydrogen bond donation from the active site cysteine and 
another residue proximal to the carbonyl oxygen, which serves to polarise the 
carbon oxygen bond (Fuentes-Prior et al. 2004).  The electrophilic carbon is 
attacked by the nucleophilic thiol group of the active site cysteine, creating a 
tetrahedral intermediate (Figure 4-1A).  At this stage the imidazole group of 
histidine protonates the α amino group of the cleaved peptide chain, ensuring 
the peptide bond is not reformed (Figure 4-1A/B) (Fuentes-Prior et al.  2004).  
The enzyme-substrate complex is broken by the deprotonated histidine 
extracting a proton from water, which creates a nucleophile capable of 
attacking the thioester bond and forming a second tetrahedral intermediate, 
with a hydroxyl group now attached to the carbonyl carbon (Figure 4-1B/C).  The 
process is ended by rupturing the sulphur-carbon bond, which frees the cleaved 
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substrate from the enzyme (Figure 4-1D)(Fuentes-Prior et al.  2004).  In serine 
peptidases the reactive hydroxyl group of the serine residue functions as the 
nucleophile. 
4.1.3 Peptidase classification 
The vast number of identified peptidases and their diverse structures and 
mechanisms prompted the formation of a central database (called MEROPS), that 
currently contains sequences for over 140,000 peptidases (Rawlings et al. 2010).  
To facilitate the interpretation and investigation of this data set, the peptidases 
are ordered according to a classification system which is based on primary and 
tertiary structural similarities.  Peptidases with statistically significant 
similarities in amino acid sequence are assigned into ‘families’ and structurally 
homologous families and grouped together in a ‘clan’ 
(http://merops.sanger.ac.uk).    
Peptidases are first subdivided by catalytic type.  This distinguishes the broad 
mechanism used for peptide bond hydrolysis, of which the cysteine peptidases 
represent one of eight classes (aspartic, cysteine, glutamic, metallo, mixed, 
serine, threonine and unknown).  The cysteine peptidases are then further 
subdivided into 9 clans: CA, CD CE, CF, CH, CL, CM, CN and CO.    
Clan CA peptidases are the largest and most thoroughly researched clan of 
cysteine peptidases.  Indeed members of clan CA  peptidases represent 84% of 
the known cysteine peptidases found in parasitic helminths and protozoa, with 
peptidases from 12 out the 24 families identified (Atkinson et al. 2009).  
4.1.4 Clan CD  
Clan CD peptidases have several characteristics that separate them from the 
familiar clan CA peptidases.  For example they are all endopeptidases and have 
well defined and strict substrate specificity, directed towards the P1 residue 
(Mottram et al. 2003).  Accordingly, E-64, a potent inhibitor of clan CA activity 
fails to inhibit clan CD peptidases because it lacks a corresponding P1 residue 
and thus does not bind to the active site (Mottram et al.  2003).   
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4.1.5 Family C14A: Caspases 
Since the initial identification of the ced-3 gene of Caenorhabditis elegans as a 
key requirement for developmental cell death (Yuan et al. 1993), vast amounts 
of work have contributed to the molecular characterisation of a form of 
programmed cell death (PCD) called apoptosis.  At the cellular level apoptosis is 
characterised by various morphological and biochemical events, including DNA 
degradation, chromatin condensation, membrane blebbing and cell volume 
contraction (Danial et al. 2004).  It has been the focus of intense research 
because deregulation of apoptosis leads to a variety of human pathologies 
including cancer, autoimmune diseases and neurodegenerative disorders (Elmore 
2007).  After the initinial discovery in C. elegans, it was soon found that 
apoptosis was conserved in metazoan organisms, where it was regulated by a 
group of clan CD, family C14A peptidases, called caspases (CED-3-like proteins).  
Consequently caspases represent an extremely well studied family of enzymes 
and much is known about their activation and regulation. 
The human caspase family is comprised of 15 members 
(http://merops.sanger.ac.uk) which are known to play distinct roles in apoptosis 
or inflammation (Pop et al. 2009).  Recent studies however, have extended the 
boundaries of caspase function, revealing involvement in cell proliferation, 
differentiation, adhesion and motility  (Frisch 2008; Kuranaga et al. 2007). 
The caspases are not directly associated with non-specific degradation events 
but instead function in specific signalling pathways.  This in part is due to the 
highly specific nature of caspase proteolysis which is directed to a specific amino 
acid in the P1 position of the substrate, creating highly defined cleavage events 
(Fuentes-Prior et al.  2004).  The name ‘caspase’ derives from their ability to 
cleave peptide chains only after an aspartic acid residue (cysteinyl aspartate-
specific proteinases).  This well defined substrate specificity ensures their 
proteolytic activities can be exploited to transmit signals through limited 
cleavage of a variety of molecules.   
Caspases play pivotal roles in many cellular processes and to stop uncontrolled 
activity they are subject to tight regulation.  As a principle level of regulation 
caspases are produced as inactive zymogens, which are comprised of a variable 
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length prodomain followed by two subunits, a large P20 (~20 kDa) and a small 
P10 (~10 kDa) (Stennicke et al.  1999).  Activation of the zymogen occurs either 
by an intramolecular reaction (autoprocessing) or following proteolytic cleavage 
performed by upstream peptidases (Pop et al.  2009).   
Based on their role in the cell death pathway the apoptotic caspases are divided 
into initiator and effector peptidases.  Following cell death signals initiator 
caspases (caspase-8, -9 and -10) are recruited to specific activation platforms 
via signalling motifs present in their long N-terminal prodomains; caspase-9 to 
the apoptosome (Jiang et al. 2004) and caspse-8 and -10 to the death-inducing 
signalling complex (DISC) (Yu et al. 2008).  The resulting localised increase in 
caspase concentration facilitates dimerization which induces activation 
(Boatright et al. 2003).  Executioner caspases (caspase-3, -6 and -7) have short 
prodomains and consequently lack protein-protein interaction motifs.  However, 
shortly after synthesis they form inactive homodimers which require proteolytic 
activation from upstream initiator caspases.  Specific cleavage events occurring 
in the linker regions between the P10 and P20 subunit stimulate the 
reorganisation of the active site and generate activity (Pop et al.  2009). 
4.1.6 Family C14B: Metacaspases 
In the year 2000 two new caspase-related families were identified in plants, 
fungi and protozoa (Uren et al. 2000).  They were identified by Uren et al 
following iterative database searches using previously identified Dictyostelium 
discoideum and human protein sequences that showed distant yet significant 
similarities to caspases (Aravind et al. 1999).  The two families were named 
paracaspases and metacaspases and separated based on sequence similarity and 
domain structure.  Paracaspases are found in metazoan organisms and slime 
moulds (Dictyostelium species) whereas metacaspases are found in plants, fungi 
and protozoa (Uren et al.  2000).  The absence of metacaspases from mammals 
suggests they could be promising targets for the development of novel 
therapeutics against protozoa parasites such as T. brucei. 
The MCAs have been further classified into two categories based on structure 
and sequence similarity (Uren et al.  2000).  Type I MCAs have prodomains 
containing proline rich repeats (plants and fungi) and zinc finger domains (plants 
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only).  The Type II MCAs from plants have no N-terminal prodomain and contain 
large C-terminal insertions.   
The classification of protozoan MCAs is less straight forward.  Phylogenetic 
analysis of select MCAs revealed that the kinetoplastid MCAs clustered together 
in a separate group, distinct from the fungi and plant type I and type II clusters 
(Kosec et al. 2006).  Furthermore the domain architecture of kinetoplast MCAs 
reveals they do not fully conform to either Type I or Type II classification (Figure 
4-2).  Several contain extended C-terminal domains rich in proline repeats 
similar to type II MCAs (T. brucei MCA5, T. cruzi MAC5, Leishmania donovani MC1 
and MC2, Leishmania major MCA, Leishmania braziliensis MCA and Leishmania 
infantum MCA); and T. brucei MCA2, MAC3 and MCA5 contain N-terminal proline 
rich repeats somewhat reminiscent of type I MCAs.   
The canonical caspase active site histidine and cysteine catalytic dyad is well 
conserved, however several MCAs contain substitutions that could effect activity 
(Figure 4-2) (Mottram et al.  2003).  For example Plasmodium MCA2 and MCA3 
and T. brucei MCA1 do not contain either a histidine or cysteine in the conserved 
active site positions, making it unlikely they possess catalytic activity.                        
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Figure 4-2 Domain structure of metacaspases and caspases. 
Adapted from González 2009.  Schematic representation of human caspase-1 and MCAs from 
Arabidopsis thaliana (Atmc1 type I, Atmc7 type II), Plasmodium falciparum, P.  vivax, Trypanosoma 
brucei, T. cruzi, Leishmania donovani, L. major, L. braziliensis and  L. infantum.  The major 
domains of each protein are depicted.  Where the conserved catalytic dyad differs from the 
canonical histidine and cysteine, the amino acids are marked in white.  Gene identifiers and length 
of peptide chain displayed in brackets.  All proteins are represented as full length zymogens.     
 
4.1.7 Substrate specificity of MCAs 
MCAs posses the conserved histidine-cysteine catalytic dyad and the general 
mechanism of catalysis is likely to be similar to other cysteine peptidases with 
substrate limitations directed by strict P1 specificity, typical of Clan CD 
peptidases (Mottram et al.  2003).  In caspases this selectivity is dictated by 
conserved residues in the mature enzyme (arginine-179, arginine-341 and 
glutamine-283, caspase-1 numbering) that form a deep and highly basic S1 
pocket.  The basic nature of the caspase S1 pocket is perfectly adapted to 
accommodate the acidic side chain of aspartic acid in the P1 position of 
substrates (Fuentes-Prior et al.  2004).  While MCAs contain a caspase-like fold, 
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alignment with mammalian caspases revealed that glutamine-283 is replaced by 
an aspartic acid and arginine-341 is replaced by aspartic acid or glutamic acid 
(Vercammen et al. 2007).  These highly conserved MCA-specific substitutions are 
predicted to create an acidic S1 pocket, which is more suited to accepting the 
basic amino acid side chains of arginine and lysine in the P1 position 
(Vercammen et al.  2007).  Indeed experimental evidence from numerous MCAs 
confirms the arginine/lysine specificity, which reveals a fundamental difference 
in MCA and caspase activity.   
Evidence for MCA arginine and lysine P1 specificity was first demonstrated for 
the type II Arabidopsis thaliana MCAs, Atmc4 and Atmc9 (Vercammen et al. 
2004).  Expression in E. coli revealed caspase-like autoprocessing (abolished for 
active site cysteine mutant) and using N-terminal Edman degradation the Atmc9 
processing site was mapped to an arginine residue.  Further characterisation of 
purified recombinant Atmc4 and Atmc9, revealed arginine and lysine dependent 
activity that was resistant to classical caspase inhibitors and E-64 (Vercammen et 
al.  2004).  Similar substrate specificities were also reported for the yeast MCA 
(Yca1) and two further A thaliana MCAs (Atmc2 type I and Atmc5 type II) 
following overproduction in E. coli and analysis of cell lysate (Watanabe et al. 
2005).         
Analysis of kinetoplastid MCAs further confirmed the Clan CD family C14B 
peptidase requirement for processing substrates after a basic P1 residue.  The L. 
major MCA overexpressed in yeast cells missing Yca1 (∆yca1) was found to 
preferentially cleave substrates with arginine in the P1 position (Gonzalez et al. 
2007).  Furthermore detailed biochemical characterisation of purified T. brucei 
recombinant MCA2 revealed it was an active peptidase capable of cleaving after 
arginine and lysine residues in both short peptides and whole proteins (Moss et 
al. 2007).  Interestingly the activity of TbMCA2 was dependent on calcium, 
which was also found for the plant type II MCAs (Moss et al.  2007; Vercammen et 
al.  2004; Watanabe et al.  2005).  
Shortly after the discovery of the MCAs a report was published detailing the 
caspase-like processing activity of Yca1 (Madeo et al. 2002).  Cell lysates from 
yeast cells overexpressing Yca1, were more active against substrates with 
aspartic acid in the P1 position (designed for caspases) than control lysates 
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(Madeo et al.  2002).  The later studies into MCA specificity, combined with a 
lack of firm evidence directly showing Yca1 protein specifically produced the 
caspase-like activity, suggested downstream peptidases could be responsible 
(Vercammen et al.  2007).   
4.1.8 Autolytic processing of MCAs 
Autolytic processing is a key step in the activation of several caspases (detailed 
in section 4.1.5).  Indeed, the MCAs from yeast and L. major undergo 
autoprocessing in a caspase-typical manner when expressed in yeast (Yca1) 
(Madeo et al.  2002) or heterologously in bacteria (LmjMCA) (Gonzalez et al.  
2007), producing processing products analogous to the small and large caspase 
subunits.   
In plants only the type II MCAs are known to autoprocess.  Recombinant Atmc4 
and Atmc9 zymogens autoprocessed producing two major proteins 
(approximately 25 kDa and 15 kDa) that were proposed to heterodimerize like 
caspases to form the active peptidase (Vercammen et al.  2004).  Atmc9 
autoprocessing was essential for activity of the recombinant protein 
(Vercammen et al.  2004).  Further investigation into AtMCA9 revealed the 
presence of a second catalytic cysteine residue (position-29, Atmc9 numbering) 
that is widely conserved in all metacaspases (Belenghi et al. 2007).  Specific 
Atmc9 mutants were created in which the canonical active site cysteine-147 
(Atmc9C147A) and cysteine-29 (Atmc9C29A) were replaced with alanine.  
Interestingly mutation of the canonical active site cysteine-147 blocked both 
autoprocessing and activity.  However, Atmc9C29A was able to partially 
autoprocess, but only displayed 10% of the wild type activity, implicating a key 
role for cysteine-29 in catalysis (Belenghi et al.  2007).  To exclude an inhibitory 
role of an uncleaved N-terminal peptide present in the Atmc9C29A protein, full 
processing was ensured by adding a minimal amount of Atmc9.  Indeed activity 
of Atmc9C29A increased dramatically when fully processed (as per wild type) an 
effect not observed in a double cysteine mutant (Belenghi et al.  2007).   
A proposed explanation for the two Atmc9 catalytic cysteines was developed by 
analysing a predicted three dimensional structure of Atmc9 modelled on the 
structure of human procaspase-7.  The Atmc9 zymogen model predicted 
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cysteine-29 would lie in the active site, but too far away from the catalytic 
histidine, thus inhibiting deprotonation of thiol group from cysteine-29 (Belenghi 
et al.  2007).  The processing event (mediated by cysteine-147) would favour a 
reorganisation and a reduction in the distance between the second cysteine-29 
and the histidine, thus allowing two cysteines to participate in catalysis  
(Belenghi et al.  2007).       
Interestingly recombinant T. brucei MCA2 autoprocesses into three fragments (30 
kDa, 6 kDa and 4 kDa) in a calcium dependent manner (Moss et al.  2007).  
Mutation of the TbMCA2 autoprocessing sites generated a recombinant protein 
resistant to calcium induced autolysis, which still retained full activity towards 
small peptide substrates (Moss et al.  2007).  This was somewhat unusual given 
the autoprocessing dependent activity of caspases and Atmc9.  Furthermore no 
evidence for in vivo autoprocessing of TbMCA2 has been detected in BSF T. 
brucei (Helms et al.  2006).  Although it is possible that autoprocessing only 
occurs following specific induction conditions such as stress.    
4.1.9 Yeast MCAs 
Apoptosis, a common form of PCD, is an evolutionary conserved cell suicide 
mechanism commonly used by metazoan organisms to selectively eliminate 
dangerous, superfluous or damaged cells.  Thus in multicellular organisms the 
raison d’etre for apoptosis appears obvious; sacrificing one cell for the overall 
benefit of the whole organism.  However apoptosis in unicellular organisms is a 
controversial proposition, due to questionable benefits to the individual and 
concerns over the potential evolutionary advantage provided by cell suicide.  To 
counter this argument it has been proposed that forms of PCD could confer 
benefits in an altruistic manner to a population rather than individual cells 
(Buttner et al. 2006).  Indeed in Saccharomyces cerevisiae, cell death 
accompanied by hallmark characteristics of apoptosis has been detected (Madeo 
et al. 1997) and given the absence of orthologs of classical metazoan apoptotic 
regulators it was speculated that the single yeast MCA (Yca1) could mediate the 
apoptotic pathway in yeast (Madeo et al.  2002).  
Disruption of the yca1 gene (∆yca1) increased yeast survival following incubation 
with two known inducers of apoptosis, hydrogen peroxide (H2O2) and acetic acid, 
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with a concurrent reduction in the physical hallmarks of apoptosis such as DNA 
fragmentation and chromatin condensation.  Additionally ∆yca1 cells were less 
prone to age related clearance linked to apoptosis (Madeo et al.  2002).  
Furthermore overexpression of Yca1 increased apoptotic markers in cells 
challenged by H2O2 and acetic acid (Madeo et al.  2002).  Similar studies using 
∆yca1 yeast implicated a role for the protein in apoptosis following a variety of 
stresses including: hyperosmotic stress caused by high concentrations of glucose 
or sorbitol (Silva et al. 2005); viral toxin challenge (Ivanovska et al. 2005) and 
increased mRNA stability caused by disruption to RNA splicing and decapping 
(Mazzoni et al. 2005).    
These studies highlight Yca1 involvement in numerous PCD pathways, however 
non cell death roles for Yca1 have also been described.  Detailed 
characterisation of the DNA content of ∆yca1 and wild type cells revealed no 
differences during normal growth conditions.  However upon growth in 
fermentative conditions (more representative of natural environment) the ∆yca1 
cells exhibited a significant decrease in the proportion of cells in the G1 phase 
of the cell cycle and a concurrent increase in G2/M phase cells (Lee et al. 2008).  
Additionally Yca1 enzyme activity was shown to be required for correct 
progression through the cell cycle, with yeast expressing inactive Yca1 showing 
decreased doubling times and abnormal G1 and S phase progression (Lee et al.  
2008).  Furthermore under fermentative conditions ∆yca1 cells failed to arrest at 
G2/M checkpoint following addition of nocodazole, a compound known to block 
the cell cycle.  Thus it seems that the accumulation of wild type cells at the 
G2/M checkpoint depends of Yca1 activity (Lee et al.  2008).  These studies 
provide an interesting insight to a multifunctional role for the single yeast MCA.      
4.1.10 Plant MCAs 
PCD has a well defined and critical role to play in many developmental processes 
in plants, including embryogenesis, leaf and petal scenescence, development of 
vascular tissues (xlogenesis), sex determination of unisexual plants, seed 
development and germination (Watanabe et al. 2004).  Additionally, cell death 
observed in response to a variety of abiotic stresses, such as heat shock, low 
temperature, UV irradiation, ozone exposure, as well as pathogen invasion has 
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also been attributed to apoptosis (Watanabe et al.  2004).  Indeed MCA activity 
has since been directly linked to apoptosis required for embryogenesis in Norway 
spruce (Picea abies) (Bozhkov et al. 2005) and PCD induced by H2O2 and 
ultraviolet (UV) light exposure (He et al. 2008). 
A.thaliana contains 9 MCAs (Atmc1-3 type I and Atmc4-9 type II) and given the 
variation in pH optima and substrate specificity of the Atmcs characterised so 
far it has been hypothesised that they could play different roles or operate in 
different cellular compartments (He et al.  2008).  Indeed analysis of Atmc1-9 
expression revealed that only the transcript for Atmc8 is up-regulated in 
response to oxidative stress (He et al.  2008).  Furthermore Atmc8 could 
complement PCD phenotypes of ∆yca1 yeast cells and overexpression in 
A.thalina protoplasts increased apoptosis when stimulated by UV light and H2O2 
(He et al.  2008).  Supporting experimental evidence was provided by knocking 
out Atmc8 from A.thalina protoplasts, which resulted in decreased cell death 
following exposure to UV light and H2O2 stress (He et al.  2008).  Additionally a 
tentative link to apoptosis was provided for two different Atmcs (Atmc2 and 
Atmc5) that were able to successfully complement apoptotic phenotypes of 
∆yca1 yeast cells and induce apoptosis in wild type yeast when overexpressed 
(Watanabe et al.  2005) 
Using synthetic caspase substrates, caspase-like activity has been detected in 
plant tissues undergoing PCD (Bonneau et al. 2008).  For example, during in vitro 
P. abies embryogenesis cells committed to PCD showed increased activity 
towards a synthetic caspase substrate (Suarez et al. 2004).  Additionally 
incubation with the corresponding caspase specific inhibitor blocked 
differentiation and prevented apoptotic cell death events associated with 
normal embryogenesis.  Furthermore a similar phenotype was observed following 
genetic disruption of the mcII-Pa gene.  Therefore it was proposed that mcII-Pa 
was the peptidase responsible for the caspase-like activity detected (Suarez et 
al.  2004).  However, recombinant mcII-Pa was later shown to have canonical 
MCA substrate specificity, cleaving only after arginine residues (Bozhkov et al.  
2005).  Therefore although mcII-Pa is not directly responsible for the caspase-
like activity accompanying embryogenesis, it seems its proteolytic activity is 
required for some aspect of the PCD linked to development.  In support of this 
hypothesis immunofluorescent microscopy depicted mcII-Pa translocation from 
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the cytoplasm into the nuclei of cells selected to be eliminated by apoptosis 
(Bozhkov et al.  2005).  Furthermore extracellular assays were used to show that 
mcII-pa enzyme activity caused nuclear envelope disassembly and DNA 
fragmentation, both classic features of apoptosis (Bozhkov et al.  2005). 
A significant advance towards understanding MCA function has been provided by 
the identification of the first known in vivo substrate for a MCA (Sundstrom et 
al. 2009).  McII-Pa was found to cleave the P. abies tudor staphylococcal 
nuclease protein (TSN) at four different sites following either arginine or lysine 
residues.  Expression of inactive mutant mcII-Pa or addition of an inhibitor 
blocked this cleavage process (Sundstrom et al.  2009).  PaTSN cleavage was 
concurrent with PCD events during embryogenesis and following H2O2 stress and 
correlated well with the activity profile of the mcII-Pa in cell lysate.  Indeed 
silencing of mcII-Pa by RNAi reduced both mcII-Pa activity and the cleavage of 
PaTSN (Sundstrom et al.  2009).  The cleavage of PaTSN caused an impairment in 
its ribonuclease activity, a function shown to be essential for both plant viability 
and reproduction (Sundstrom et al.  2009).   
These findings were of particular interest as the authors also demonstrated that 
human caspase-3 was responsible for both in vitro and in vivo cleavage of human 
TSN, although occurring after an aspartate residue (Sundstrom et al.  2009).  
Caspase-3 proteolytic control of the intracellular abundance of functional HsTSN 
was demonstrated using a mutant non-cleavable form of HsTSN.  Expression of 
non-cleavable HsTSN increased cell proliferation and resistance to apoptosis, 
whereas RNAi depletion of HsTSN directly induced apoptosis (Sundstrom et al.  
2009).  Functional analysis of HsTSN revealed caspase-3 cleavage inhibited 
ribonuclease activity and reduced its ability to stimulate pre-mRNA splicing.  
Thus despite the different substrate requirements of mcII-Pa and caspase-3 
cleavage (P1 residues must be arginine/lysine or aspartic acid respectively) they 
appear to inactivate a conserved nuclease that functions in a PCD pathway of 
human and plants (Sundstrom et al.  2009). 
4.1.11 Leishmania MCAs 
Metacaspases have been detected in a variety of protozaon parasites and most 
work has so far been restricted to disease causing organisms.  In parallel to the 
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MCAs of other organisms links to PCD have been investigated, however in 
protozoa they were not always established. 
L. major contains one MCA (LmjMCA), which is a syntenic orthologue of TbMCA5 
and has a predicted N-terminal signal sequence and a proline, glutamine and 
tyrosine rich C-terminal extension (Figure 4-2).  Expression of LmjMCA was 
detected in both procyclic promastigote and amastigote stages of the parasite 
lifecycle (Ambit et al. 2007).  Expression of LmjMCA in ∆yca1 yeast 
demonstrated it was able to functionally complement the role of Yca1 in the 
PCD death pathway (Gonzalez et al.  2007).  Furthermore the proteolytic activity 
of LmjMCA was implicated in the yeast PCD response, as expression of 
catalytically inactive LmjMCA restored H2O2 induced cell death rates to the 
parental ∆yca1 levels (Gonzalez et al.  2007).  However no functional evidence 
has been presented to support a role for LmjMCA in L. major PCD processes. 
In fact the only detailed investigation to date revealed that LmjMCA played an 
essential role in the progression of the L. major cell cycle (Ambit et al.  2007).  
Immunofluorescent analysis of L. major promastigote cells using an antibody 
specific to the TbMCA2 and TbMCA3 active site (generated similar LmjMCA 
protein recognition to the anti-LmjMCA antibody but with reduced background) 
revealed an association with different organelles at different stages of the cell 
cycle (Ambit et al.  2007).  During interphase LmjMCA appeared as punctate 
structures dispersed throughout the cytoplasm.  However, in cells undergoing 
mitosis LmjMCA was found to be tightly associated with the nucleus and mitotic 
spindle.  Additionally LmjMCA was also localised to the kinetoplast during 
division of this organelle.  Overexpression of LmjMCA lead to aneuploid cells 
which grew poorly due to abnormal cell cycle progression (Ambit et al.  2007).  
The LmjMCA locus initially proved refractory to genetic deletion and both alleles 
could only be removed with simultaneous ectopic expression of LmjMCA at 
physiological levels; implying an important role for LmjMCA in controlling 
regulating nuclear and kinetoplast division (Ambit et al.  2007).  However 
recently adopting a more sensitive transfection procedure it has been possible to 
knockout LmjMCA, showing it is not essential for the parasite.  The phenotypic 
characterisation of ∆LmjMCA parasites is ongoing (E. Castanys-Muñoz personal 
communication 2010).       
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Interestingly L. donovani contains two highly similar MCA proteins (LdMC1 and 
LdMC2), which both show considerable sequence homology to LmjMCA and 
TbMCA5 proteins (Lee et al. 2007a).  LdMC1 and LdMC2 were detected in 
procyclic promastigote and amastigote lifecycle stages and immune precipitated 
protein (combined LdMC1 and LdMC2) was shown to have proteolytic activity 
(Lee et al.  2007a).  LdMCs were linked to PCD following the finding that protein 
precipitated from cells pretreated with H2O2 displayed increase in activity (Lee 
et al.  2007a).  However the link to PCD based on activity must be treated with 
caution especially as the proteolytic activity of precipitated LdMC1 did not 
appear to require the conserved active site histidine and cysteine residues (Lee 
et al.  2007a).  Thus whether the activity detected genuinely represented LdMC 
activity is questionable because proteolysis relying on residues not in the 
conserved active site seems unlikely. 
4.1.12 Trypanosoma cruzi MCAs 
In the draft T. cruzi genome one group of MCAs homologous to TbMCA3 and a 
single MCA homologous to TbMCA5 were identified.  The haploid genome of T. 
cruzi was predicted to contain approximately 16 copies of TcMCA3, arranged in 
two tandem repeat clusters in stark comparison to the single copy of the TcMCA5 
gene (Kosec et al.  2006).   
TcMCA3 genes were expressed throughout all four of the major developmental 
life cycle stages (epimastigote, amastigotes, trypomastigotes and metacyclic 
trypomastigotes).  However, TcMCA5 was only expressed in epimastigotes, a 
form limited to the insect host stage (Kosec et al.  2006).  Additionally there was 
a strong antigenic reaction in response to sera from patients with Chaga’s 
disease to TcMCA3 but not TcMCA5 (Kosec et al.  2006).  Indirect evidence of 
TcMCA involvement in PCD was provided by immunofluorescence analysis of 
TcMCA3 cellular localisation following PCD induction using human serum.  
TcMCA3 translocated from cytoplasm to the nucleus following serum treatment 
where it possibly contributed to nuclear degradation (Kosec et al.  2006).  
Furthermore overexpression of TcMCA5 in epimastigote cells caused increased 
sensitivity to human serum induced PCD (Kosec et al.  2006).  Whilst no firm 
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conclusions can be drawn from these results, they do hint at an involvement of 
TcMCAs in a PCD process.  
4.1.13 Trypanosoma brucei MCAs 
Five distinct MCA genes (TbMCA1-TbMCA5) were identified in the T. brucei 
genome (Mottram et al.  2003; Szallies et al. 2002).  Alignments of T. brucei 
MCAs with human caspase-3 identified conservation of the Clan-CD histidine and 
cysteine catalytic dyad in TbMCA2,TbMCA3 and TbMCA5 (Mottram et al.  2003; 
Szallies et al.  2002).  However, in TbMCA1 the predicted conserved histidine and 
cysteine catalytic dyad was replaced with tyrosine and serine respectively.  The 
predicted TbMCA4 active site contains the canonical histidine residue but has a 
serine in place of the cysteine nucleophile (Figure 4-2 and Figure 4-3).  Due to 
the irregular active site residues it has been speculated that TbMCA1 and 
TbMCA4 might not be catalytically active enzymes (Mottram et al.  2003).  This 
appears most likely for TbMCA1, which is missing both the histidine required for 
proton shuttling and an active site nucleophile.  TbMCA4 however does have the 
active site histidine and contains a serine residue which is capable of utilising a 
reactive hydroxyl group as a nucleophile, thus might retain activity and function 
as mixed type peptidase.  Additionally all kinetoplastid MCAs have a second 
cysteine immediately adjacent to (C-terminal side) the canonical cysteine 
residue and it has been proposed this residue could function as an alternative 
catalytic residue (Figure 4-3) (Szallies et al.  2002).   
Analysis of the T. brucei MCA proteins reveals that TbMCA2 and TbMCA3 show 
89% sequence identity with divergence at the N-terminus only (Mottram et al.  
2003).  The N-terminal region of TbMCA3 contains a potential transmembrane 
import domain that is absent of TbMCA2 (Figure 4-2).  This could confer 
different cellular localisation upon these two similar peptidases (Mottram et al.  
2003).  Additionally TbMCA1 and TbMCA5 also have predicted N-terminal signal 
peptides (Figure 4-2).  Interestingly the three MCAs with the conserved catalytic 
dyad (TbMCA2, TbMCA3 and TbMCA5) have N-terminal proline rich domains and 
TbMCA5 contains an extended C-terminal proline rich domain that contains 
repeating sequences of proline, glutamine, alanine and tyrosine (Figure 4-2).   
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Figure 4-3 Alignments of select domains of metacaspase proteins. 
Selected regions of Vector NTI protein sequence alignment of MCA proteins, tritrypDB and 
accession numbers in brackets: LmMCA (LmjF35.1580), TbMCA5 (Tb09.211.4760), Atmc1 
(AAP44514.1), Yca1 (NP_014840.2), Atmc9 (NP_196040.1), TbMCA2 (Tb927.6.940), 
TbMCA3.(Tb927.6.930), TbMCA1 (Tb11.02.0730) and TbMCA4 (Tb927.10.2440).  Sequences 
aligned using Clustal W algorithm of the Align X program.  Identical and conserved amino acids are 
highlighted yellow and blue respectively.  Blocks of similar sequences are highlighted in green and 
green coloured text indicates weak conservation.  Numbers in brackets indicate the position of the 
first amino acid in the linear polypeptide in the section of each protein analysed.  The red and grey 
arrows indicate the position of the canonical metacaspase active site histidine and cysteine 
residues, respectively.  The back arrows indicate additional cysteine with potential catalytic activity.  
The blue arrowheads label the aspartic acid residues predicted to comprise the enzyme S1 pocket.  
Whole alignment shown in (Figure 4-21).       
 
Separate antibodies raised against TbMCA2/TbMCA3 and TbMCA5 revealed a 
regulated pattern of expression in specific parasite lifecycle stages.  TbMCA5 
was expressed in both BSF and PCF parasites, where as TbMCA2 and TbMCA3 
proteins were only detected in BSF parasites (Helms et al.  2006).  A combination 
of reverse genetic techniques (RNAi and gene knockouts) was used to provide 
functional insights into the physiological role of these three MCAs.  Individual 
RNAi of TbMCA2/TbMCA3 and TbMCA5 failed to generate detectable phenotypic 
changes.  However, simultaneous triple RNAi demonstrated their collective 
essentiality to BSF parasites, with multi-nuclei and multi-kinetoplast containing 
cells rapidly accumulating post induction, indicating a pre-cytokinesis block 
(Helms et al.  2006).  Despite this severe phenotype it was possible to generate 
triple null mutant parasites (∆mca2/3∆mca5) by sequential replacement of both 
MCA2/3 alleles followed by the MCA5 alleles with drug resistance cassettes.  The 
∆mca2/3∆mca5 parasites exhibited no growth defects in vitro in culture or in 
vivo in mice (Helms et al.  2006).  These data combined suggested that TbMCA2, 
TbMCA3 and TbMCA5 were essential for BSF parasites but displayed overlapping 
functions that could be compensated for following gradual elimination 
(generation of triple knockout lines) (Helms et al.  2006).   
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It was reported that prostaglandin D2 induced PCD in T. brucei that was 
accompanied by many hallmark features associated with apoptosis (Figarella et 
al. 2005).  As prostaglandin D2 is produced by T. brucei it was proposed that this 
could serve as mechanism to limit parasitemia and prolong infection (Figarella et 
al.  2005).  The mediators of this cell death phenotype remain unknown 
(Figarella et al.  2005) and analysis of ∆mca2/3∆mca5 parasites revealed they 
responded as wild type cells following prostaglandin D2 induced PCD, suggesting 
they are not the effectors in this cell death pathway (Helms et al.  2006). 
Immunofluorescence microscopy revealed that TbMCA2, TbMCA3 and TbMCA5 
were predominantly associated in the same subcellular compartment located 
between the nucleus and kinetoplast and significant colocalisation with RAB11 
positive endosomes was observed (Helms et al.  2006).  Interestingly the 
∆mca2/3∆mca5 showed no defects in the known functions of RAB11 positive 
endosomes (VSG recycling and degradation of internalised anti-VSG), suggesting 
an alternative unknown role for MCA containing RAB11 positive endosomes.   
Direct evidence of TbMCA2 and TbMCA3 proteolytic activity was provided by 
detailed characterisation of the recombinant enzymes purified from bacteria, 
discussed in sections 4.1.7 and 4.1.8 (Moss et al.  2007).  Having confirmed the 
essentiality of MCAs to T. brucei and developed robust activity assays using 
recombinant protein the development of specific MCA inhibitors was undertaken.  
An initial investigation used the substrate specificity of TbMCA2 to inform the 
design of a range of substrate based inhibitors with arginine or lysine in the P1 
position (Berg et al. 2010).  The most potent inhibitor had IC50 values of 0.6 µM 
against recombinant TbMCA2, and 32.9 µM against cultured T. brucei parasites.  
Encouragingly this inhibitor also showed low cytotoxicity towards human 
fibroblast cells (Berg et al.  2010).         
TbMCA1 and TbMCA4 were excluded from initial investigations due to their 
unusual active site configurations (Helms et al.  2006).  However an insight into 
the role of TbMCA4 was provided by the individual heterologous expression of all 
T. brucei MCAs in S. cerevisiae.  It was demonstrated that only TbMCA4 
produced a detectable phenotype when overexpressed in yeast, causing  growth 
inhibition, reduced clonogenicity, loss of respiratory competence and 
mitochondrial function (Szallies et al.  2002).    
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Interestingly alignments of multiple metacaspases from different species 
revealed the presence of a well conserved cysteine residue (position-98 TbMCA4 
numbering).  Furthermore predictive modelling of MCA using the known crystal 
structures of two clan CD enzymes (gingipain and caspase-1) as templates 
revealed cysteine-98 was located within the active site (Szallies et al.  2002).  
Heterologous expression of mutant forms of TbMCA4, in which the active site 
residues (cysteine-98 and -99, histidine-164 and cysteine-218) were replaced 
with alanines was not detrimental to the yeast cells.  Thus it seems that the 
proteolytic activity of TbMCA4 is required to stimulate mitochondrial dysfunction 
in yeast  (Szallies et al.  2002).  Any conclusions regarding TbMCA4 function are 
clearly limited as these experiments involved the expression of non-native 
protein in yeast.  However, the findings do suggest that TbMCA4 has proteolytic 
activity.  The significance of a ‘second’ MCA active site cysteine (cysteine-98 
TbMCA4 numbering) was also investigated in A. thaliana, where the equivalent 
residue in Atmc9 (cysteine-29, Atmc9 numbering) was demonstrated to be 
required for full proteolytic activity of the recombinant protein, with the 
Atmc9C29A mutant displaying a 90 % reduction in activity (see section 4.1.8 for 
details) (Belenghi et al.  2007).      
4.1.14 What is in a name? Are metacaspases caspases? 
The identification of MCAs in plants fungi and protozoa (Uren et al.  2000), 
prompted much speculation and interest that these peptidases could be 
responsible for initiating and executing apoptosis like their mammalian 
namesakes the caspases.  Indeed several early studies directly connected MCAs 
to caspase-like activity in yeast and plant cells undergoing apoptosis.  However, 
it subsequently became evident that the strict P1 substrate specificity of MCAs 
was entirely different to caspases and would prevent caspase-like proteolytic 
activity.  The MCAs only cleave after basic arginine and lysine residues whereas 
caspases require acidic aspartate residues in the P1 position.  
Nevertheless many investigations have revealed a link between MCAs and PCD;  
with one report even showing mcII-PA and caspase-3 cleave and inactivate an 
evolutionary conserved component of a human and plant apoptosis pathway 
(Sundstrom et al.  2009).  Clearly some evidence exists to show that MCAs and 
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caspases function in similar cellular pathways which prompted Carmona-
Gutierrez et al., to state that MCAs are unequivocally caspases (Carmona-
Gutierrez et al. 2010).   
However, as outlined MCAs do not meet the strict biochemical classification for 
caspases, so in that sense alone they cannot be classified as caspases (Enoksson 
et al. 2010; Vercammen et al.  2007).  Furthermore it is now evident that 
caspases do not only play fundamental roles in apoptosis, but also function in a 
wide range of other cellular processes including motility, proliferation, adhesion 
and differentiation (Frisch 2008; Kuranaga et al.  2007) .  Equally other 
peptidases are known to play a role cell death processes yet these are not 
caspases (Enoksson et al.  2010).  This therefore highlights the dangers and 
possible pitfalls of classifying peptidases solely by function.   
4.2 Project Aims 
The five MCAs of T. brucei are an interesting family of cysteine peptidases.  
Significant effort has been put in to investigating their function and activity, 
however there are clearly many remaining questions to be answered.  
Discovering the exact physiological function of these peptidases is a priority and 
will require a thorough knowledge of all members of the T. brucei MCA family.  
Consequently this project aims to characterise T. brucei MCA4, by focusing on 
the following topics:      
1) MCA4 peptidase activity – does the non-canonical active site serine 
prohibit peptidase activity? 
2) MCA4 function – inferred from investigations into expression, localisation, 
interactions and loss of function phenotypes. 
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4.3 Results 
4.3.1 Metacaspase expression profile. 
The expression of MCA2 and MCA3 is tightly regulated with the proteins only 
detected in BSF and not PCF parasites (Helms et al.  2006)(illustrated in Figure 
4-4A and Figure 4-4C).  Interestingly MCA5 is expressed at approximately the 
same level in both lifecycle stages (Figure 4-4C) (Helms et al.  2006).  To see if 
MCA4 was subject to similar regulation a chicken polyclonal antibody was raised 
against purified full length MCA4.  The purified total IgY extract was able to 
cleanly detect one protein corresponding to the approximate size of full length 
MCA4 (38.9 kDa) only in BSF cell lysate, no MCA4 protein was detected in PCF 
cell lysate (Figure 4-4B).  The total IgY extract was highly specific for MCA4 and 
western blotting of ∆mca2/3 ∆mca5 cell lysate revealed the presence of the 
same protein which confirmed the antibody did not cross react with either 
MCA2, MCA3 and MCA5 proteins.  It was also evident that MCA4 expression 
remained unchanged in the triple null mutant line, confirming it was not 
upregulated in response to MCA2, MCA3 and MCA5 deletion.  For future 
subsequent procedures the total IgY extract was affinity purified against 
immobilised recombinant MCA4 (described in Materials and Methods 2.7.2).   
  
Figure 4-4 Expression profile of MCAs.  
Total cell lysates were prepared from T. brucei PCF (lane 1) and BSF (lane 2) and BSF ∆mca2/3 
∆mca5 null mutant (lane 2#) and separated by SDS-PAGE and transferred to Hybond-C 
membrane before western blotting.  A) 5 x 106 cell equivalents probed with rabbit anti-MCA2-
MCA3.  B) 1 x 106 cell equivalents probed with chicken anti-MCA4. C) 5 x 106 cell equivalents 
probed with sheep anti-MCA5.  MCA2, MCA3, MCA4 and MCA5 proteins are labelled.  A cross 
reacting protein (labelled ∗) and an antibody specific to EF-1α demonstrate equal loading.  
Immunoblots A and C taken from Helms et al. 2006.   
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4.3.2 MCA4 associates with the flagellar membrane 
4.3.2.1 Membrane localisation 
Having established MCA4 expression was limited to the BSF lifecycle stage the 
cellular localisation of the protein was investigated.  Cellular fractionation 
techniques can be used to separate cellular compartments and organelles from 
homogenous cell lysate.  For the initial characterisation of MCA4 a simple 
cellular fractionation strategy was employed to distinguish between soluble, 
cytoskeletal and membrane associated proteins.  Cultured BSF parasites were 
washed and equally divided into two aliquots and lysed by different methods: a 
hypotonic lysis buffer combined with sonnication and lysis by a buffer containing 
the non ionic detergent triton X-100.  Following centrifugation membrane 
associated proteins remained restricted to the pellet fraction of hypotonically 
lysed cells but were solubilised by the detergent.  This method also distinguished 
cytoskeleton associated proteins which showed resistance to the detergent 
solubilisation and remained in the pellet.  Western blotting of the different T. 
brucei lysate fractions revealed that MCA4 was a membrane associated protein, 
demonstrated by its resistance to hypotonic lysis and sonication but solubility in 
detergent (Figure 4-5A).  To validate the findings and to confirm the quality of 
the cellular fractionation the different lysis fractions were probed with 
antibodies specific to β-tubulin and EF-1α.  The double band seen in the MCA4 
detergent soluble fraction could represent a non-specific degradation product, 
phosphorylated and non phosphorylated MCA4 or a proteolytic cleaved form of 
MCA4 (discussed in sections 4.3.3 and 4.3.4 respectively). 
4.3.2.2 MCA4 is palmitoylated 
Having established MCA4 was a membrane associated protein we sought to 
identify the potential mechanism(s) responsible for mediating this interaction.  
Sequence analysis of MCA4 failed to identify any transmembrane domains, 
however more detailed bioinformatic screening revealed that the N-terminal 
region of MCA4 is potentially subject to specific lipid modifications.  The 
covalent attachment of lipid groups to proteins is a common modification 
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occurring on a wide variety of eukaryotic proteins and is known to regulate many 
processes including membrane interactions (reviewed in Resh 2006).   
   
Figure 4-5 MCA4 is a membrane associated protein.  
A) Cell fraction of BSF T. brucei.  2 x 107 cells lysed in hypotonic buffer followed by sonication 
before centrifugation and separation into pellet (HP) and soluble (HS) fractions.  2 x 107 cells lysed 
in buffer containing 1% triton X-100 detergent before centrifugation and separation into pellet (DP) 
and soluble (DS) fractions.  Loaded 1 x 106 cell equivalents per lane and separated by SDS-PAGE 
before western blotting, with anti-MCA4.  The fractionation was validated by probing fractions with 
antibodies specific to β-tubulin (anti-KMX monoclonal) and EF1α.  B)  Substrate consensus 
sequence recognised by eukaryotic N-myristoyl transferases alignmed with N-terminal of MCA4 
protein.  Predicted acylated residues underlined, N-myristoylation bold line (Mills et al. 2007), 
palmitoylation dashed line (Ren et al. 2008). C)  Acyl-biotin exchange reaction.  Palmitoylated 
proteins from BSF T. brucei were specifically labelled by cleaving palmitate-thioester bonds with 
hydroxylamine.  The free thiol groups created were reacted with biotin-HPDP and purified with 
streptavidin agarose.  Original cell lysate (input), the wash fraction and eluted material from 
hydroxylamine treated and Tris control samples were immunoblotted with anit-MCA4.  MCA4 
protein is indicated and is present in both input fractions but is only purified in the presence of 
hydroxylamine.         
 
The attachment of myristate, a 14-carbon fatty acid (N-myristoylation) is 
catalysed by the enzyme N-myristoyl transferase (NMT), which recognises the 
substrate consensus sequence Met-Gly-X-X-X-Ser/Thr, where X represents any 
amino acid (Resh 1999).  Further substantial work on eukaryotic NMTs has 
identified additional substrate amino acids that influence N-myrisoylation and 
has enabled the development of algorithms that can confidently predict 
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myristoylated proteins.  Comprehensive analysis of L. major, T. brucei and T. 
cruzi genomes revealed a predicted subset of myrsitoylated proteins, which 
included a high confidence prediction for TbMCA4 (Mills et al.  2007).  Figure 4-5B 
shows the N-terminus of MCA4 and its comparison with the short NMT N-terminal 
consensus sequence and highlights the predicted N-myristoylation of glycine-2.   
The attachment of hydrophobic myristoyl moieties confers limited affinity for 
membrane association.  However this interaction is often strengthened by a 
secondary acylation reaction, in which a 16-carbon fatty acid (palmitate) is 
reversibly attached by a thio-ester linkage to cysteine residues in the protein (S-
palmitoylation).  This reaction is catalysed by membrane bound palmitoyl 
acyltransferases (PATs) on proteins already associated with membranes (Greaves 
et al. 2007).  The substrate consensus sequence for PATs is not clearly defined 
which makes predicting palmitoylation sites difficult.  However, one on-line 
algorithm (CSS Palm 2.0, http://csspalm.biocuckoo.org/) has been developed 
based on a data set of published palmitoylation sites in proteins (Ren et al.  
2008), and was used to predict the potential palmitoylation of MCA4 cysteine-4.     
Generally N-myristoylation is a prerequisite for palmitoylation, indeed blocking 
N-myristoylation of Tb44, a dual acylated T. brucei calflagin, inhibited 
palmitoylation and impeded membrane association (Emmer et al.  2009).  To 
experimentally confirm the palmitoylation of MCA4 in vivo, an acyl-biotin 
exchange reaction was performed (Figure 4-5C).  The method was recently used 
to generate the palmitoylproteome of yeast (Roth et al. 2006) and has 
subsequently been adapted for use in T. brucei (Emmer et al.  2009; Liu et al. 
2010).  The acyl-biotin exchange reaction can be broken down into the following 
steps.  Firstly all the existing free thiols on proteins in the cell lysate were 
blocked with NEM  before the addition of hydroxylamine, which selectively 
released all palmitoyl moieties.  The newly exposed thiols were then labelled 
with a thiol-reactive biotinylation reagent, which enabled purification using 
streptavidin agarose.  Non specific labelling and interaction with streptavidin 
were monitored in the control reaction by substituting hydroxylamine with a Tris 
buffer.   
Subsequent western blotting of eluted material from the experimental and 
control reactions, using anti-MCA4, revealed that MCA4 was purified in a 
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hydroxylamine dependent manner from BSF T. brucei cell lysate (Figure 4-5C).  
The confirmation of MCA4 palmitoylation combined with the strong bioinformatic 
prediction for myristoylation suggests that the protein is likely to be dually 
acylated and is the probable mechanism mediating membrane association.  
4.3.2.3 MCA4 localises to the flagellum       
Immunofluorescence microscopy had been used to reveal the cellular location of 
MCA2, MAC3 and MCA5 (Helms et al.  2006).  These three MCAs showed a high 
level of colocalisation and predominantly appeared as punctate structures 
located between the nucleus and kinetoplast.  Further analysis revealed 
significant colocalisation of the MCA labelled structures with RAB11 positive 
endosomes (Helms et al.  2006).  To compare and investigate the cellular 
localisation of MCA4, affinity purified anti-MCA4 was used for 
immunofluorescence microscopy on BSF T. brucei.  Mid log cells were fixed in 3% 
paraformaldehyde and permeabilised with 0.1% triton X-100 before incubation 
with affinity purified anti-MCA4 (1/400) and anti-chicken Alexa fluor 488 
conjugate.  Fluorescent microscopy revealed that MCA4 was found to 
predominantly localise to the flagellum, appearing as a linear array of punctate 
structures and larger confluent foci along the entire flagellum length (Figure 
4-6).  The signal detected was confidently attributed to MCA4 specific labelling 
because no fluorescence was visible following the immuno-staining of ∆mca4 
parasites or after secondary antibody only application to wild type cells.    
The distinct cellular fractionation and immunofluorescence patterns of MCA4 
indicate that it was likely to be associated to the BSF flagellar membrane.  To 
determine whether MCA4 was located on the internal or external surface of the 
flagellar membrane immunofluorescent analysis was performed in the presence 
and absence of the detergent triton X-100 (Figure 4-6).  Strong flagella staining 
was only detected in cells treated with triton X-100, suggesting that cell 
permeabilisation was required to expose the internally facing MCA4 epitopes.  
Although interestingly the cells analysed without triton X-100, consistently 
displayed one or two small punctate structures close to the proximal end of the 
flagellum suggesting a small portion of MCA4 is located on the external surface. 
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To verify MCA4 localisation BSF 427 T. brucei cells were engineered to express 
MCA4 fused with 6 C-terminal HA tags leaving the N-terminus free for acylation 
and membrane interaction.  The MCA4 ORF was cloned into pGL1728 (designated 
p2471 in Kelly et al., 2007) and transfected into the BSF 90-13 cell line (Wirtz et 
al.  1999).  Clonal populations were isolated and effective tetracycline induction 
of transgene expression was verified by western blot (data not shown).  
Immunofluorescent analysis of induced cells using anti-HA, generated flagellar 
localised fluorescent signals, similar to the anti-MCA4 immunoflouresence 
(Figure 4-6).  The anti-HA recognised a tag fused to the C-terminus of MCA4, 
because of the presumed importance of N-terminal acylation for flagellar 
membrane association this suggested full length MCA4 localised to the flagellum.  
However it does not preclude other forms of the enzyme associating with either 
the flagellar membrane or different cellular compartments.    
To provide further details on the nature of the MCA4 localisation affinity purified 
anti-MCA4 was used for immunogold transmission electron microscopy studies 
(Figure 4-7).  The analysis provided further evidence supporting the punctate 
nature of MCA4 along the flagellum.  The enhanced immunogold particles 
clustered at unmarked but distinct foci and consistently appeared to be on the 
internal surface of the flagellum.    The MCA4 signal was clean and very low 
background staining was observed. 
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Figure 4-6 Immunofluorescence analysis of MCA4 in BSF T. brucei.  
Cultured BSF T. brucei were washed before 10 minutes fixation in 3% paraformaldehyde and 
subsequent adherence to poly-l-lysine treated microscope slides.  Cells were permeabilized (+ 
Triton X-100) or left intact (- Triton X-100) and blocked by incubation with 20% foetal calf serum 
(FCS) in PBS.  Wild type BSF and ∆mca4 cells were incubated with affinity purified anti-MCA4 
followed by anti-chicken Alexa Fluor 488 conjugate, visualised using FITC filter set (green).  BSF 
cells expressing C-terminally tagged MCA4 (MCA4:HA) were incubated with monoclonal anti-HA 
followed by anti-mouse Alexa Fluor 594 conjugate, visualised using Rhodamine filter set (red).  
DNA was stained by DAPI (blue) and reference images were taken by differential interference 
contrast (DIC) filter settings.  Analysis performed on Applied Precision DeltaVision microscope with 
fluorescent images displayed as deconvolved projection of 20 individual Z-stacks.  Scale bar 5 µm. 
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Figure 4-7 MCA4 immunogold transmission electron microscopy.  
Fixed wild type BSF T. brucei were cryosectioned and labelled with affinity purified anti-MCA4 and 
1.4 nm gold (rabbit anti-chicken).  Immuno-labelling was enhanced by R-gent (Aurion) and 
visualised with a LEO 912 transmission electron microscope.  Black arrows show enhanced 
immunogold particles clustering along length of BSF flagellum.  The bottom images represent 
digitally magnified sections of the corresponding images above.   
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4.3.3 MCA4 interactions 
Co-immunoprecipitation is a useful technique for the analysis of protein-protein 
interactions and can provide vital functional information.  To investigate 
potential interacting partners and substrates of MCA4, affinity purified anti-
MCA4 was covalently linked to CarboLink resin (Pierce) and used to directly 
pulldown MCA4 and any interacting proteins from BSF parasite lysate (Figure 
4-8).  Carbolink was preferred over traditional two step co-immunoprecipitation 
approaches, which rely on precipitating antibody antigen complexes with protein 
A or G, because anti-MCA4 was raised in chickens and IgY immunoglobulins have 
significantly different properties to mammalian IgGs; crucially they do not bind 
protein A or G (Dias da Silva et al. 2010).   
Approximately 2.25 x 109 BSF cells were purified from rat blood and lysed in an 
buffer containing 0.2% NP40 and 0.5% CHAPS.  A mild lysis buffer was used to 
solubilise MCA4 and release it from the plasma membrane, while simultaneously 
attempting to maintain any protein interactions.  Proteins were precipitated 
from the soluble fraction and separated by 12% SDS-PAGE and analysed by 
western blotting, silver staining and SYPRO staining.  Western blotting confirmed 
that MCA4 was successfully precipitated and the specificity was validated by a 
parallel experiment using pre-immune IgY, which failed to precipitate MCA4 
(Figure 4-8A).  Silver staining of the eluted material revealed the presence of 
multiple proteins (lanes 7 and 8 Figure 4-8B) which were excised and analysed by 
liquid chromatography tandem mass spectroscopy (LC-MS/MS).  Only band 2 
generated a significant protein hit, for which seven peptides were mapped to 
MCA4.  The limited identification rates were possibly caused by formaldehyde 
and/or silver ions present in the stain and destain solutions, which are known to 
interfere with the LC-MS/MS (Richert et al. 2004).  Interestingly for the one 
protein identified evidence was found indicating the phosphorylation of serine 
341, which corroborated the same finding in the phosphoproteome analysis of 
BSF T. brucei (Nett et al. 2009).   
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Figure 4-8 Imuunoprecipitation of MCA4 from BSF T. brucei.  
Wild type BSF T. brucei 427 were purified from rat blood using DE52 anion exchange.  
Approximately 4.5 x 109 cells were lysed in buffer containing 0.2% NP40 and 0.5% CHAPS and 
centrifuged at 100, 000 x g for 45 minutes.  The soluble fraction was precleared with pre-immune 
IgY coupled Carbolink resin and divided into two.  To one aliquot affinity purified anti-MCA4 
Carbolink resin was added and to the other pre-immune IgY Carbolink.  Both samples were 
incubated over night at 4oC.  The resin was washed 5 times and bound material eluted using a low 
pH buffer.  A)  The efficiency of the precipitation (anti-MCA4) and non-specific binding (pre-immune 
IgY) was analysed by western blot using affinity purified anti-MCA4.  Lane 1, total cell lysate; Lane 
2, unbound flow through material; Lane 3, first pre-clear; Lane 4 second pre-clear; Lane 5, first 
wash; Lane 6, last wash; Lane 7, elution 1; Lane 8 elution 2; Lane 9 elution 3; Lane 10 elution 4. B) 
Anti-MCA4 precipitation was separated by SDS-PAGE and silver stained. Lane 1, total cell lysate; 
Lane 2, unbound flow through material; Lane 3, first pre-clear; Lane 4 first wash; Lane 5, last wash; 
Lane 6, elution 1; Lane 7 elution 2; Lane 8 elution 3; Lane 9 elution 4.  The bands indicated were 
excised and analysed by LC-MS/MS.  Band 2 was positively identified as MCA4  C)  The elutions 
for experimental and control precipitations were pooled and separated by SDS-PAGE then stained 
with colloidal blue.  The bands indicated were excised and analysed by LC-MS/MS. Band labelled ∗ 
was identified as MCA4.  Band # generated two protein hits, MCA4 and glycerol-3-phosphate 
dehydrogenase (Tb927.8.3530).      
 
To improve the sensitivity of the LC-MS/MS the remaining precipitated material 
was separated and stained with colloidal blue protein stain.  This stain was less 
sensitive and only two predominant bands were visible, both of which generated 
significant hits for MCA4 following LC-MS/MS analysis.  However, interestingly 
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the lower molecular weight band (Figure 4-8C marked with #) also produced an 
additional significant hit, with 6 peptides mapped to glycerol-3-phosphate 
dehydrogenase (Tb927.8.3530).  The predicted size of glycerol-3-phosphate is 
~37.81 kDa which corresponds to the approximate size of the protein stained by 
colloidal blue.  To determine if this was a genuine interaction will require repeat 
co-immunoprecipitation experiments and potential verification by yeast two 
hybrid interaction analysis.   
The western blot analysis of immunoprecipitated MCA4 detected two different 
size proteins corresponding to ~40 and ~35 kDa.  It appears unlikely that the two 
MCA4 bands occurred through nonspecific degradation because not only were 
they present in the experimental input fraction but high concentrations of 
protease inhibitors were also used throughout.  It is possible that the two 
proteins represent two cellular states of MCA4; either full length zymogen and 
proteolytic processed forms or phosphorylated and non-phosphorylated MCA4. 
4.3.4  MCA4 activity 
4.3.4.1 Processed MCA4 is an active peptidase 
Detailed biochemical characterisation of recombinant MCA2 revealed it was an 
active peptidase with strict specificity for the basic residues of arginine and 
lysine at the P1 position (Moss et al.  2007).  To investigate MCA4 peptidase 
activity it was cloned into an N-terminal HIS tagging protein expression vector 
and expressed in E. coli.  The recombinant protein was purified by immobilised 
metal ion affinity chromatography using a nickel agarose column, yielding 
approximately 1.4 mg of protein per 100ml of bacterial culture.  MCA4 purity 
was assessed by coomassie stained SDS-PAGE and when necessary further 
purified by ion exchange chromatography.  To facilitate further characterisation 
of MCA4 the active site serine (position 219) was mutated to a cysteine residue 
(MCA4S219C) producing an enzyme with the canonical metacaspase conserved 
histidine-cysteine active site.  Purification of MCA4S219C was performed as before 
but produced reduced yields, typically  250 µg per 100 ml culture.  Where 
indicated MCA2 was produced as previously described (Moss et al.  2007).  
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Recombinant MCA2 was found to undergo autolytic processing in the presence of 
calcium (Moss et al.  2007).  To investigate MCA4 autoprocessing purified MCA4 
and MCA4S219C were incubated in a reaction buffer supplemented with 10 mM 
calcium chloride and 5 mM DTT at 37oC and analysed by SDS-PAGE.  As displayed 
in (Figure 4-9A), MCA4 did not undergo autoprocessing in the presence of 
calcium, however MCA4S219C was capable of autoprocessing, producing three 
lower molecular weight products in a time dependent manner (Figure 4-9B). 
The ability to autoprocess suggested that MCA4S219C was a constitutively active 
peptidase.  Insights into the substrate specificity of this enzyme were revealed 
using N-terminal Edman degradation to sequence the lowest molecular weight 
proteolytic processing product (marked with an asterisk in Figure 4-9B).  Six 
amino acids (GFQPWK) were identified, which showed that MCA4S219C cleaved 
itself after a lysine-64.  This finding was consistent with MCA2 specificity, where 
cleavage occurred only after basic residues (Moss et al.  2007).   
Peptidase activity was further investigated by monitoring the ability of MCA4 and 
MCA4S219C to cleave synthetic fluorogenic peptide substrates.  The peptides 
contained the fluorophore 7-amino-4-methylcoumarin (AMC) which flouresced 
upon cleavage and subsequent release from the peptide and protecting group, 
benzyloxycarbonyl (Z).  Accordingly enzyme activity was determined by 
monitoring the fluorescence produced from any given reaction.  Unless 
otherwise stated all activity assays were run in triplicate and included the 
following components: purified recombinant enzyme, 10 µM Z-RR-AMC substrate 
and reaction buffer containing 10mM calcium chloride and 5 mM DTT.  
Fluorogenic activity assays revealed that full length MCA4 was inactive, whereas 
MCA4S219C was an active peptidase able to cleave after arginine residues (Figure 
4-9C). 
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Figure 4-9 Calcium chloride induces cleavage and activation of MCA4S219C but not MCA4.  
A)  Calcium dependent MCA4 autoprocessing was analysed by SDS-PAGE. 10 µg MCA4 was 
incubated with and without 10 mM calcium chloride for 1 hour.  Full length MCA4 is indicated. B)  
MCA4S219C was incubated with 10mM calcium chloride and a Tris buffer (-CaCl2).  10 µg aliquots 
were removed at time indicated and autoprocessing was analysed by SDS-PAGE.  Full length 
protein and products of autolytic processing are indicated.  The N-terminal of the major processed 
product (marked with asterisk) was sequenced by Edman degradation and six amino acids were 
identified (underlined) which revealed cleavage after lysine-64, highlighted in blue, MCA4 amino 
acid numbering in brackets. C) Cleavage of Z-RR-AMC by 2 µg MCA4S219C and 2 µg MCA4 was 
measured in a buffer containing 10 mM calcium chloride.  Enzyme activity displayed is 
representative of three replicate experiments. 
140 
This finding suggested that MCA4S219C had similar substrate preferences to MCA2.  
To confirm this, MCA4S219C activity was screened against a library of 19 
fluorogenic substrates comprised of a mixture of 7-residue peptide chains, 
where one amino acid was fixed and the remaining positions were occupied 
randomly by any of the 19 amino acids (cysteine omitted to exclude 
dimerization).  The maintenance of one specific amino acid ensures this type is 
over-represented in each of the 19 sub-libraries and fluorescence generated 
represents cleavage after this residue.  Indeed MCA4S219C was most active against 
peptides containing arginine and lysine in the fixed position further supporting a 
preference for basic amino acids in the P1 position (Figure 4-10).  However low 
overall enzyme activity meant the separation from background fluorescence was 
limited.  Additionally MCA4 was screened against the whole peptide library and 
no proteolytic activity was detected, which further supported the finding that 
full length MCA4 was inactive.   
 
Figure 4-10 MCA4S219C activity against fixed position peptide library.  
Purified MCA4S219C (10 µg) was incubated with 10 mM calcium chloride and 10 µM Abz-XXZXXQ-
EDDnp substrate, where Abz stands for o-aminobenzoic and EDDnp for ethylenediamine 2,4-
dinitrophenyl.  X represents any amino acid and Z indicates fixed amino acid (excluding cysteine).  
Enzyme activity expressed as a relative value and given as means of two replicates.  
 
Many peptidases require proteolytic processing to activate the enzyme,   
accordingly this was investigated for MCA4.  Limited proteolysis reactions 
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containing 10 µg MCA4 and low ng quantities of MCA2 were incubated with 
calcium chloride at 37oC.  Analysis by SDS-PAGE revealed that MCA2 reproducibly 
processed MCA4 generating processing products similar to the MCA4S219C 
autoprocessing pattern (Figure 4-11A).  Sequencing of the prominent processing 
product by N-terminal Edman degradation revealed the same six amino acid 
sequence (GFQPWK) as previously identified for MCA4S219C.  MCA2 cleavage of 
MCA4 lysine-64, further supports the overlap of substrate specificity for MCA2 
and MCA4S219C.    
Full length MCA4 showed no activity against a Z-RR-AMC substrate (Figure 4-9A), 
however MCA4 processed by MCA2 was active (Figure 4-11B).  Controls were 
established to distinguish MCA4 activity from residual MCA2 activity, which was 
also capable of cleaving Z-RR-AMC (Moss et al.  2007).  Accordingly the activity of 
processed MCA4 was found to be higher than control assays containing the 
equivalent amount of MCA2 used for the limited proteolysis reactions (Figure 
4-11A and Figure 4-12A).  Furthermore, potential stabilising or enhancing effects 
of an additional protein in the reaction were shown to be negligible by 
substituting MCA4 with BSA, with no effect on MCA2 activity (Figure 4-12A).   
Additional evidence linking processed MCA4 to the detected activity was 
provided by altering the progression of the processing reaction.  Extension of the 
limited proteolysis reaction time reduced the abundance of full length MCA4 and 
created more processing products (Figure 4-12B).  Proteolytic activity of these 
samples was found to be relative to the amount of processed MCA4 present; 
more processed MCA4 corresponded to an increased cleavage rate of Z-RR-AMC.  
However, increasing the reaction time did not alter the activity of MCA2, 
suggesting the change in activity is dependent on MCA4. 
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Figure 4-11 Processed MCA4 is an active peptidase.  
A) MCA4 processing by MCA2 was analysed by SDS-PAGE.  10 µg MCA4 was incubated with 10 
mM calcium chloride and MCA2 as indicated.  Full length and processed forms of MCA4 are 
labelled. The N-terminal of the major processed product (marked with asterisk) was sequenced by 
Edman degradation and six amino acids were identified (underlined) which revealed cleavage after 
lysine-64, highlighted in blue, MCA4 amino acid numbering in brackets. B) Cleavage of Z-RR-AMC 
by: 2 µg MCA4 processed by 0.02 µg MCA2; 0.02 µg MCA2; and buffer only control was measured 
in a buffer containing 10 mM calcium chloride.  Enzyme activity displayed is representative of three 
replicate experiments.  
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Figure 4-12 Distinguishing processed MCA4 activity from residual MCA2 activity.  
A) Cleavage of Z-RR-AMC by MCA4, processed MCA4, and MCA2 controls was measured in 
buffer containing 10 mM calcium chloride.  Recombinant enzymes present in each assay are 
indicated in the table.  Enzyme activity is expressed as a relative value and given as means of 
three replicates, error bars show standard deviation.  B)  Processing reactions containing MCA4 
and MCA2 (ratio 100:1) were incubated at 37oC for 0, 30 and 60 minutes in buffer containing 10 
mM calcium chloride.  Aliquots containing 20 µg MCA4 and 0.2 µg MCA2 were removed and 
assayed for activity (Z-RR-AMC cleavage).  Enzyme activity mean of three replicates and error 
bars show standard deviation.  Aliquots containing 5 µg MCA4 and 0.5 µg MCA2 were analysed for 
processing by SDS-PAGE.   
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Concerted efforts were made to purify an inactive MCA4 mutant to provide 
unequivocal verification that the activity detected stems from MCA4.  Site 
directed mutagenesis was used to mutate potential catalytic residues: histidine-
164 to alanine, cysteine-218 to glycine, serine-219 to glycine and a double 
mutant simultaneously changing cysteine-218 and serine-219 to glycines.  To 
obtain soluble protein, expression was attempted at a range of temperatures 
(15oC, 25oC and 37oC) induced with different IPTG concentrations (0.01 mM and 
0.1 mM) and using autoinduction media incubated at two temperatures (25oC 
and 37oC).  However only MCA4S219G could be purified, mutation of hisitidine-164 
or cysteine-218 consistently resulted in insoluble protein (under all conditions 
tested), which was refractory to standard purification attempts.       
Preliminary experiments showed that MCA4S219G was active when processed by 
MCA2 (Figure 4-13A).  Although more thorough analysis is required (specifically 
SDS-PAGE analysis), the data generated so far suggest cysteine-218 is 
catalytically active in MCA4.  Interestingly the cysteine is conserved in all 
kinetoplast MCAs and mutation of the equivalent cysteine residue to glycine in 
MCA2C212G decreased enzyme activity by approximately 70% (Moss et al.  2007). 
MCA4 activity was further investigated by adding specific peptidase inhibitors to 
the activity assay (Figure 4-13B).  Supplementing processed MCA4 with the broad 
profile cysteine and serine peptidase inhibitors leupeptin (100 µM) and antipain 
(100 µM) completely abolished activity.  Addition of E64, a specific inhibitor of 
clan CA cysteine peptidases had limited effect on activity at 10 µM,  inhibiting 
activity by 5%.  These results were consistent with the inhibition profile of 
MCA2, however given the presence of a serine residue in the proposed MCA4 
active site (position 219) the effects of specific serine peptidase inhibitors were 
investigated.  PMSF did not inhibit activity at 0.5 mM and Pefabloc only reduced 
activity by 20% at 2.5 mM.  The absence of inhibition of on processed MCA4 
activity by two serine peptidase inhibitors does not specifically rule out a 
catalytic serine residue.  It is possible that structural features specific to clan CD 
cysteine peptidases could restrict the access of these two serine peptidase 
inhibitors to the MCA4 active site and thus prevent inhibition. 
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Figure 4-13 Investigating MCA4 active site using mutagenesis and peptidase inhibitors.  
A) Cleavage of Z-RR-AMC by 2 µg MCA4S219G processed by 1 ng MCA2 and MCA2 control (1ng), 
was measured in buffer containing 10 mM calcium chloride.  Enzyme activity displayed is 
representative of three replicate experiments. B) The effect of peptidase inhibitors on the activity of 
2 µg processed MCA4 was assed by cleavage of Z-RR-AMC.  Standard assays conditions were 
supplemented with 100 µM leupeptin, 100 µM antipain, 10 µM E64, 0.5 mM PMSF, 2.5 mM 
Pefabloc.  Enzyme activity is representative of three replicate experiments and expressed as 
percentage of full activity, error bars show standard deviation. 
    
146 
The active site mutant MCA4S219C was also able to cleave Z-RR-AMC without being 
processed by MCA2 (Figure 4-9C).  As previously demonstrated MCA4S219C 
autoprocesses which could be a requirement of MCA4 activity.  The creation of a 
mutant MCA4S219C that is unable to autoprocess was attempted by mutating the 
processing site, lysine-64 (the residue identified as the processing site by N-
terminal Edman degradation), to a neutral glycine residue.  Interestingly 
MCA4S219C,K64G retained activity and separation by SDS-PAGE revealed evidence of 
autoprocessing, presumably occurring at an additional available lysine or 
arginine residue (Figure 4-14).   
The data generated so far show that recombinant MCA4 was active only after 
proteolytic processing.  This is consistent with many mammalian caspases, which 
require cleavage to generate an active enzyme from the inactive zymogen 
(Fuentes-Prior et al.  2004).  Evidence has also been presented for similar 
processing events occurring in the MCA of L. major (Ambit et al.  2007; Gonzalez 
et al.  2007), Yca1 of yeast (Madeo et al.  2002) and several of the A. thaliana 
MCAs (Vercammen et al.  2004).  Interestingly while recombinant MCA2 was found 
to autoprocess, it was not required for enzyme activity (Moss et al.  2007).  
Investigation into the MCA4 active site points to cysteine 218 as a catalytic 
residue although further work is required to provide  complete characterisation 
of MCA4 activity. 
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Figure 4-14 MCA4S219C activity and autoprocessing is not inhibited by mutation of lysine-64.  
A) Cleavage of Z-RR-AMC by 2 µg MCA4K64G,S219C was measured in a buffer containing 10 mM 
calcium chloride.  Enzyme activity displayed is representative of three replicate experiments.  B) 
MCA4K64G,S219C was produced by site directed mutagenesis and was incubated with 10mM calcium 
chloride and in Tris storage buffer.  Aliquots were removed at the times indicated and analysed by 
SDS-PAGE.  Full length protein and products of autolytic processing are indicated.   
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4.3.5 MCA4 function in BSF analysed by RNAi 
In previous studies the function of T. brucei MCA2, MCA3 and MCA5 were 
investigated by RNAi (Helms et al.  2006).  Individual downregulation produced no 
discernable phenotypic defects, however simultaneous triple RNAi caused rapid 
growth arrest with cells accumulating pre-cytokinesis (Helms et al.  2006).  
Further detailed characterisation of this phenotype provided insights into their 
physiological roles.  To investigate MCA4 function a 500 base pair gene fragment 
was cloned into the 2T7ti RNAi vector pGL571 (LaCount et al.  2000) and 
transfected into the BSF 90-13 cell line (Wirtz et al.  1999).  Following RNAi 
induction a consistent phenotype was observed in three independent clones, 
hence only data from one representative is presented.   
RNAi was induced by the addition of 1 µg ml-1 tetracycline to the culture media 
and the growth rate of induced (Tet +) cultures was compared to non induced 
controls (Tet -).  Following RNAi induction rapid growth arrest occurred.  A 
reduced growth rate was initially detected at 8 hours and cell numbers remained 
consistently low throughout the RNAi time course (Figure 4-15A).  The efficiency 
and timing of MCA4 downregulation following induction was analysed by western 
blot.  Whole cell extracts were prepared from induced and non-induced cultures 
at different time points throughout the first 24 hours of induction.  Probing the 
western blot with anti-MCA4 revealed that MCA4 expression remained constant 
in uninduced control cells.  However following MCA4 RNAi induction, depletion 
of the protein was evident by 16 hours and at 24 hours post induction the MCA4 
protein level was severely reduced in comparison to the non-induced control 
cells (Figure 4-15B).   
To analyse the progression of RNAi induced parasites through the cell cycle the 
configuration of nuclei and kinetoplasts was determined by fluorescent 
microscopy of DAPI stained cells (Figure 4-16A).  Following induction of RNAi the 
proportion of cells with 1N1K decreased steadily from an initial figure of 76% in 
non-induced to 31% at 24 hours post induction.  This was accompanied by a 
minor reduction in 1N2K cells and a rapid persistent increase of 2N2K cells; rising 
from 6% (0 hours) to approximately 18% at 8, 16 and 24 hours post induction.  
The concomitant decrease of 1N1K cells and increased 2N2K cells and ‘others’ 
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suggested that cells were able to replicate their DNA but failed to correctly 
execute cytokinesis.  Defective cytokinesis was the most credible explanation for 
the dramatic accumulation of aberrant cells containing misconfigured DNA 
(predominantly cells with increased DNA content and zoids, all classified as 
‘others’), which were the most abundant cell types at 24 hours post induction 
(Figure 4-16C).  The flow cytometry profiles of the induced cells confirmed the 
DAPI analysis; showing a reduced 2C peak (1N1K) and increased 4C peak (2N2K) 
combined with the appearance of abnormal 8C cells (>2N2K) and those with less 
than 2C at later time points (Figure 4-16B).  These data suggest that MCA4 is 
essential for the multiplication of BSF T. brucei and that MCA4 is involved in 
mediating interactions linked to post-mitotic or cytokinetic events. 
 
Figure 4-15 RNAi of MCA4 in BSF T. brucei.   
A) MCA4 RNAi was induced by 1 µg ml-1 tetracycline (TET+) and growth rate determined by 
haemocytometer cell counts and compared to non-induced control (TET-).  Cells induced at 1 x 105 
ml-1 and reseeded to same density after 24 hours.  B) Western blot analysis of MCA4 protein level 
during MCA4 RNAi time course.  Cell lysates taken during first 24 hours from induced (TET+) and 
non induced (TET-) cultures and probed with anti-MCA4.  To demonstrate equal loading the 
membrane was stripped and reprobed with anti-EF-1α. 
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Figure 4-16 Metacaspase 4 RNAi alters BSF T. brucei cell cycle progression.  
A) The effects of MCA4 RNAi on the DNA configuration of BSF T. brucei following induction was 
measured over time, as revealed by DAPI staining and fluorescence microscopy.  Classification 
was based on number of nuclei (N) and kinetoplasts (K) per cell, with >200 cells counted per time 
point.  Cells with abnormal DNA content classified as ‘other’.  B) Flow cytometry profiles of 
propidium-iodide stained cells were determined at time point throughout the course of the RNAi 
induction.  2C peaks represent 1N1K cells, 4C 2N2K cells and 8C cells with abnormal elevated 
DNA content  C) Image of typical induced cell, classified as ‘other’, fixed in methanol and stained 
with DAPI (blue).  Reference image taken using differential interference contrast (DIC) filter 
settings. 
  
4.3.6 MCA4 null mutants show reduced virulence in vivo 
4.3.6.1 Generating MCA4 null mutant lines 
Simultaneous downregulation suggested that MCA2, MCA3 and MCA5 were 
essential genes.  Yet surprisingly it was possible to create null mutant BSF cell 
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lines (∆mca2/3 ∆mca5) by sequential replacement of the MCA2/3 locus and 
latterly the MCA5 locus with drug resistance cassettes (Helms et al.  2006).  The 
∆mca2/3 ∆mca5 parasites initially grew poorly in culture but recovered after 
several weeks and grew at the same rate as wild type.  The disparity between 
the triple RNAi and null mutant phenotypes was attributed to the different 
speeds of MCA removal.  Rapid simultaneous down regulation of MCA2, MCA3 and 
MCA5 by RNAi occurred too quickly for the parasites to activate alternative 
pathways.  However the triple knockout strategy involved sequential removal 
dispersed by long periods of recovery and adjustment.   
To investigate whether a similar phenomenon might occur with MCA4, genetic 
knockout was attempted.  Two unique regions flanking the MCA4 ORF were 
cloned into knockout constructs, which contained a drug resistance marker with 
the appropriate tubulin intergenic sequences to drive mRNA expression.  
Constructs containing two different drug resistance cassettes were developed to 
allow the replacement of both MCA4 alleles.  The constructs were digested out 
of the plasmid backbone and transfected sequentially into wild type BSF cells.  
The unique flanking regions targeted the drug resistance cassette to the MCA4 
locus where it integrated into the T. brucei genome replacing the MCA4 ORF.  
Single allele heterozygote cells (mca4 +/-) were generated by transfection of the 
neomycin (NEO) resistant cassette and null mutants (∆mca4) were created 
following integration of the hygromycin (HYG) cassette. 
When analysing null mutant cell lines it is important that any loss of function 
phenotype can be directly attributed to the absence of the target protein.  Re-
expression of the deleted gene from an alternative site returns the protein to 
the cell, but maintains the previous genetic modifications.  This allows for 
thorough analysis of protein function while controlling against any potential 
negative effects of disruption to the target genetic locus.   
For the ectopic re-expression of MCA4, a YFP-tagging construct (pGL1742 
originally published as p2628 in Kelly et al 2007) was modified for use in the 
∆mca4 cell line.  The resistance marker was switched from HYG to blasticidin 
(BSD) and the MCA4 ORF was cloned into the expression site using XhoI and 
BamHI restriction sites, which removed the YFP tag from the plasmid backbone.  
Following linearization and transfection the construct was designed to integrate 
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into repetitive DNA sequences (the 177 bp repeat) found in minichromosomes 
and intermediate sized chromosomes(Kelly et al.  2007).  Expression of the BSD 
resistance cassette was mediated by the EPI procyclin promoter and transgene 
expression was controlled by a rRNA promoter.  The isolated clones were 
designated ∆mca4:MCA4.    
4.3.7 Confirming null mutant and re-expression cell lines 
Correct integration of the drug resistance cassettes and subsequent deletion of 
MCA4 was confirmed by Southern blotting (Figure 4-17).  Genomic DNA was 
digested with PvuI and AvrII and the Southern blot was probed with the 5’ 
flanking region used to target the knockout constructs and DNA fragments of the 
predicted sizes were obtained (Figure 4-17B).  A 2.3 kb fragment, corresponding 
to the predicted size of the native locus was detected only in wild type and 
heterozygote DNA.  Fragments corresponding to the predicted size of the NEO 
(2.56 kb) and HYG (1.44 kb) replacement loci were only detected in the correct 
heterozygote, null mutant and re-expression cell lines.  For further verification 
the 5’ flank probe was stripped from the membrane and the Southern blot was 
reprobed using the MCA4 ORF.  Positive fragments were only detected in the 
wild type, heterozygote (2.3 kb) and re-expressor (4.22 kb) DNA.  This confirmed 
the correct integration of the knockout constructs and the successful deletion 
and subsequent re-expression of MCA4.           
Using anti-MCA4 it was possible to verify the successful generation of the ∆mca4 
parasites by western blot (Figure 4-17C).  Protein corresponding to MCA4 was 
detected in the parental wild type cell line (lane 1) but was absent in the ∆mca4 
cell line (lane 2).  Furthermore, western blotting revealed that the ∆mca4:MCA4 
cell line was a functional re-expressor, with MCA4 protein detected in the cell 
lysate (lane 3).  
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Figure 4-17 Generating MCA44 null mutants. 
A) Schematic representation of the MCA4 locus in T. brucei 427 before and after integration of the 
targeted hygromycin (HYG) and neomycin (NEO) gene replacement constructs, underlined.  Yellow 
indicates α/β tubulin intergenic regions.  Lower diagram depicts schematic representation of MCA4 
re-expression from ectopic locus.  The predicted sizes DNA fragments of both the native and 
modified MCA4 locus are shown following PvuI and AvrII digest of genomic DNA, with 
corresponding Southern blot probes.  B) Genomic DNA was digested with PvuI and AvrII, 
separated on a 0.8% agarose gel and transferred to a Hybond-N nylon membrane before 
hybridization with a chemiluminescent labelled probe specific to the MCA4 5’ flank.  After detection 
the Southern blot was stripped and reprobed using second labelled probe, specific to the MCA4 
ORF.  C)  Cell lysate from 1 x 106 cells was prepared and analysed by western blot to investigate 
MCA4 expression.  To demonstrate equal loading the blot was stripped and reprobed with anti-EF-
1α.  B and C: Lane 1, wild type T. brucei BSF 427; Lane 2, NEO-resistant heterozygote; Lane 3 
∆mca4; Lane 4 ∆mca4:MCA4.  The NEO-resistant heterozygote is absent in C.            
 
4.3.7.1 In vitro analysis of ∆mca4. 
Generation of ∆mca4 parasites without any significant difficulties was surprising 
given the severity of the RNAi phenotype.  Several independent clones were 
154 
obtained and analysed.  No obvious morphological defects were detected 
however the cultured ∆mca4 cells grew at a reduced rate in comparison to wild 
type cells (Figure 4-18A).   
To see if the reduced growth rate was linked to a defect in the cell cycle, fixed 
mid-log cells were stained with DAPI and analysed by microscopy.  Unlike the 
MCA4 RNAi phenotype which dramatically altered the cell cycle, ∆mca4 parasites 
were only subtly affected with a small yet statistically significant decreased 
percentage of 1N2K cells.  This slight defect to cell cycle progression could be 
responsible for the reduced growth rate witnessed (Figure 4-18B).   
As MCA4 has been shown to associate with the flagellar membrane we postulated 
that null mutant phenotypes could be linked to deficiencies in flagellum 
function.  A prominent role of the T. brucei flagella is motility and flagellum 
motility is known to be essential for BSF trypanosomes (Broadhead et al.  2006).  
Wild type BSF parasites actively swim in the culture media, whereas mutants 
with motility defects sediment more rapidly (Bastin et al. 1999).  To investigate 
∆mca4 motility, cultured cells (1 x 106 ml-1) were divided equally into cuvettes 
and incubated under standard conditions.  Sedimentation rates were determined 
by comparing the optical density (600 nm) of undisturbed cultures with 
resuspended controls.  Both wild type and ∆mca4 cells sedimented at similar 
rates, thus it appears the mechanical motility of the flagellar is not altered by 
the absence of MCA4 (Figure 4-18C).    
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Figure 4-18 In vitro analysis of MCA4 null mutant parasites.  
A) The growth rate of BSF wild type 427 and ∆mca4 parasites was determined by daily 
haemocytometer cell counts.  The cultures were seeded every 24 hours at 2 x105 ml-1 and 
maintained in HMI9. ∆mca4 growth rate mean of four clones, error bars SD B)  The DNA 
configuration of wild type and ∆mca4 parasites (one representative clone) as revealed by DAPI 
staining and fluorescent microscopy.  Classification was based on number of nuclei (N) and 
kinetoplast (K) per cell, with >200 cells counted for both cell lines. Data mean of 3 replicates, error 
bars SD.  Asterisk (∗) indicates where ∆mca4 data differed significantly from wild type cells, 
P<0.05.  C)  The motility of wild type and ∆mca4 parasites was analysed by assessing their ability 
to resist sedimentation in culture.  Cultures were divided into experimental and control cuvettes and 
the optical density (600 nm) recorded over a 6 hour period.  Before each measurement control cells 
were resuspended.  The density of experimental cultures was subtracted from control cells produce 
∆OD600 value, which shows parasite sedimentation. Data mean of 3 replicates, error bars SD 
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4.3.8 In vivo analysis of ∆mca4 parasites 
Given that MCA4 expression was detected only in BSF T. brucei a potential role 
in the mammalian infection process was investigated by comparing wild type and 
∆mca4 infection profiles of ICR mice (Figure 4-19A).  Groups of 4 mice (2 for wild 
type control) were infected by intraperitoneal injection with 5 x 103 parasites, 
provided by a donor mouse.  The parasitemia of individual mice was monitored 
by regular haemocytometer counts of parasites in blood taken from the tail vein.  
To ensure the animal model experiments conformed to regulations and that high 
standards of animal welfare were maintained, those mice displaying severe 
clinical symptoms or with a parasite burden greater than 1 x 108 ml-1 of blood 
were removed from the study.     
Consistent with published data it was found that T. brucei 427 wild type are 
highly virulent in ICR mice (Lanteri et al. 2006) and rapidly established 
parasitemia above the cut off point in 100% of the infected mice by 4 days 
(Figure 4-19A).  Interestingly infection with ∆mca4 parasites drastically altered 
the course of infection and prolonged mouse survival to 15.25 days (mean of 4 
mice).  The reduced in vivo growth rate of MCA4 deficient parasites was partially 
restored to wild type levels by the re-expression of MCA4.  The mean mouse 
survival time for ∆mca4:MCA4 parasites was 7.5 days post infection, with 3 out 
of 4 mice succumbing to infection by day 7. 
The discovery of a quantifiable phenotype complemented by re-expression of 
‘wild type’ MCA4, allowed for the in vivo investigation of MCA4 activity.  Site 
directed mutagenesis was used to alter predicted key catalytic residues of MCA4 
in the re-expression construct.  Initially, histidine-164 was mutated to alanine 
however no clones were isolated following transfection.  Accordingly a double 
mutant was produced, changing the active site serine-219 and the adjacent 
cysteine-218 (predicted MCA4 catalytic residue) to glycines to ensure all 
enzymatic activity was abolished.  Following transfection of this construct 
several independent clones were isolated and successful re-expression of 
MCA4C218G,S219G was confirmed by western blot (Figure 4-19B).  Infection of mice 
with ∆mca4:MCA4C218G,S219G cells produced an infection profile which most closely 
resembled the null mutant with the mean mouse survival time (4 mice) greatly 
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extended to 18.75 days (Figure 4-19A).  This strongly suggested that MCA4 
peptidase activity was required for optimum parasite viability.   
 
Figure 4-19 MCA 4 deficient parasites show reduced virulence in mice.  
A)  Groups of 4 ICR mice were infected with 3 x105 parasites (2 ICR mice for wild type parasites) 
taken directly from a specific donor mouse.  Parasitemia was monitored by tail prick and 
haemocytometer cell count.  Mice were culled when parasitemia reached >1  x 108 cells ml-1 or 
upon presentation of severe symptoms.  Mouse survival was monitored daily and is shown by a 
Kaplan-Meier survival curve.  B) BSF ∆mca4 parasites were engineered to re-express mutant 
MCA4C218G,S219G (lanes 1 and 2) and MCA4S219C (lanes 3 and 4).  Western blotting was used to 
confirm that the mutant MCA4 proteins were being expressed, demonstrated in two independent 
clones for each cell line.   
 
Detailed analysis of the parasitemia patterns of the infected mice revealed 
several interesting trends.  As previously mentioned wild type 427 T. brucei are 
extremely virulent and the parasitemia increased consistently and rapidly.  The 
infection profile of ∆mca4 was drastically different with peaks of parasitemia 
separated by troughs, periods of time where parasitemia was below the 
detection threshold of haemocytometer counting (Figure 4-20)  The ∆mca4 
parasitemia profiles in individual mice broadly followed the same pattern with 
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peaks generally occurring at four days post infection and recrudescence not 
detected until 10 days post transfection.  The parasitemia in 75% of mice 
remained high after the second peak and slowly increased over the remainder of 
the infection, whereas one mouse showed two further troughs in parasitemia.  In 
the ∆mca4:MCA4 re-expression cell line the parasitemia profile was much more 
reminiscent of wild type cells with consistent parasite growth and only one 
mouse briefly able to clear the infection.  Re-expression of inactive mutant 
∆mca4:MCA4C218G,S219G generated variable growth profiles with multiple peaks of 
parasitemia, although interestingly the prolonged trough observed early in the 
∆mca4 infection was not detected.   
Further cell lines re-expressing the constitutively active mutant MCA4S219C were 
generated.  Western blot analysis confirmed successful re-expression and 
interestingly revealed two MCA4 proteins (Figure 4-19).  The lower molecular 
weight MCA4 indicated that autolytic processing of MCA4S219C occurred in similar 
a similar manner both in in vivo and in in vitro settings.   
 
Figure 4-20 T. brucei 427 wild type, ∆mca4 and ∆mca4:MCA4 mouse infection profile.  
Individual ICR mice (labelled mouse 1-4 in each separate study) were infected with 3 x105 
parasites taken directly from a specific donor mouse.  Parasitemia was monitored by tail prick and 
haemocytometer cell count.  Mice were culled when parasitemia reached >1  x 108 cells ml-1 or 
upon presentation of severe symptoms.   
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4.4 Discussion 
The MCAs are one of several families of cysteine peptidases found in protozoan 
parasites (Atkinson et al.  2009; Mottram et al.  2003).  Five MCA genes were 
identified in the T. brucei genome (Szallies et al.  2002), although only MCA2, 
MCA3 and MCA5 contained the conserved histidine-cysteine catalytic dyad 
predicted to be required for activity, raising questions over the catalytic activity 
of MCA1 and MCA4.  Comprehensive analysis of MCA2, 3 and 5 in BSF T. brucei 
revealed a combined essentiality and provided potential insights into their 
physiological functions (discussed in detail 4.1.13) (Helms et al.  2006).  To 
improve our understanding of T. brucei MCAs a comprehensive characterisation 
of MCA4 was undertaken which revealed many unexpected and unique features 
of this enzyme. 
4.4.1 MCA4 expression and localisation    
One prominent observation of the T. brucei MCAs was their regulated expression 
in different lifecycle stages.  Indeed in common with MCA2 and MCA3 the 
expression of MCA4 protein was restricted to the mammalian infective BSF 
parasites.  Whilst expression was not experimentally verified in all lifecycle 
stages, the absence of these MCAs from procyclic parasites strongly suggested 
they were likely to be specific to BSF stage parasites.  However, the function of 
MCA4 appears not to overlap with that of MCA2, MCA3 and MCA5.  Firstly MCA4 
protein level remained unchanged in ∆mca2/3 ∆mca5 parasites, showing that 
MCA4 was not upregulated or proteolytically activated by the parasites to 
compensate for the loss of other MCAs.  Secondly the cellular localisation of 
MCA4 was distinct from the other studied MCA family members in T. brucei.  
Cellular fractionation of BSF cell lysate identified MCA4 as a membrane 
associated protein.  Subsequent immunofluorescence microscopy revealed that 
MCA4 was specifically localised to the flagellar membrane appearing in a linear 
array of punctate structures.  Further detailed investigation using immuno-
electron microscopy identified distinct clusters of MCA4-labelling along the 
length of the flagellum, confirming the punctate nature of MCA4 localisation. 
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Whilst drastically different to the punctate appearance of MCA2, MCA3 and MCA5 
the localisation pattern detected was consistent with several other T. brucei 
flagellar membrane proteins.  One such protein, glycosylphatidylinositol-specific 
phospholipase C (GPI-PLC), an enzyme that cleaves the GPI-anchor of VSG and 
other GPI-anchored proteins was found to be located on the external surface of 
the flagellar membrane (Hanrahan et al. 2009).  To provide functional insights 
into MCA4 functions and possible substrates the position of the protein on the 
flagella membrane was investigated.  Removal of triton-X100 from the MCA4 
immunofluorescence protocol resulted in a stark change in detection.  The 
prominent flagellar localisation was only visible when the cells were 
permeabilised by triton-X100 treatment indicating that MCA4 was located on the 
internal surface of the flagellar membrane.     
The plasma membrane that surrounds T. brucei is one contiguous structure but it 
is separated into three distinct regions: the pellicular (cell) body, the flagellar 
membrane and the flagellar pocket (Fridberg et al. 2007; Gull 2003; Landfear et 
al. 2001).  The classification of these distinct plasma membrane zones is 
reinforced by differences in their protein and lipid composition (Tyler et al. 
2009).  As proteins are not synthesized in the flagellum, a process must exist to 
aid their selective transfer into the flagellum.  To date no single flagellar 
targeting signal has been identified in kinetoplastids (Fridberg et al.  2007), 
however the localisation of several flagellar membrane proteins has been shown 
to depend on dual acylation.  This was originally described for a flagellar 
calcium binding protein (FCaBP) in T. cruzi, where blocking acylation by 
mutagenesis lead to mislocalisation away from the flagellum (Godsel et al. 
1999).  Similarly the dual acylation of the L. major small myristoylated protein 1 
(SMP-1) was identified as one mechanism controlling its flagellar membrane 
localisation (Tull et al. 2004).     
An indepth study has been carried out on the dually acylated T. brucei calflagins 
(Tb17, Tb24 and Tb44), which are a family of proteins predicted to be involved 
in calcium binding (Emmer et al.  2009).  In PCF cells both wild type Tb44 and C-
terminally myc tagged Tb44myc localised to the flagellar membrane, however 
disruption to the acylation status of the N-terminus changed the cellular 
localisation.  Mutation of Tb44myc glycine-2 to an alanine (blocked N-
myristoylation and subsequent palmitoylation of cysteine-3) resulted in a 
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cytoplasmic localisation.  Whereas, mutation of cysteine-3 to alanine (allowed 
N-myristoylation but not palmitoylation) moved Tb44myc to the pellicular 
membrane.  Dual acylation was further implicated in flagellar membrane 
localisation by screening the 12 candidate palmitoyl acyltransferases genes 
(PAT1-12) by RNAi.  The T. brucei PATs were highly specific; only 
downregulation of PAT7 blocked Tb44myc palmitoylation resulting in abnormal 
localisation to the pellicular membrane (Emmer et al.  2009). 
Further evidence implicating dual acylation in flagellar membrane association 
was provided by characterisation of the expanded calpain family of T. brucei.  
Calpains are a large family of calcium dependent cysteine peptidases that are 
implicated in a wide variety of cellular events including signalling and cellular 
remodelling (Croall et al. 2007).  N-terminal acylation was predicted for six of 
the T. brucei calpain-like proteins (Ersfeld et al. 2005).  Subsequent 
characterisation of myc-tagged CALP1.3 revealed it was a palmitoylated 
membrane associated protein.  Immunofluorescence microscopy localised 
CALP1.3myc to the tip of the flagella, which was disrupted by deletion of the 
acylation sites (Liu et al.  2010). 
The combined findings of these studies and the in silico acylation predictions 
prompted further experimental investigation of MCA4.  N-myristoylation was 
confidently predicted for MCA4 (Mills et al.  2007), thus palmitoylation was 
investigated by acyl-biotin exchange.  This technique confirmed that MCA4 was 
palmitoylated, implicating dual acylation as a potential mechanism mediating 
association with the flagellar membrane.  To confirm this prediction, mutant 
MCA4 with blocked predicted acylation sites could be re-expressed and analysed 
in the ∆mca4 cell line.   
Although dual acylation has been shown to mediate the flagellar membrane 
targeting of several different kinetoplastid proteins, details of the precise 
mechanism are only beginning to emerge.  The modification of proteins with two 
lipid moieties allows association with lipid rafts, which are specific 
microdomains found within the plasma membrane.  Lipid rafts differ from the 
surrounding membrane principally in terms their composition; they contain 
enhanced levels of sphingolipids and sterols, which are densely packed and 
highly ordered reducing the membrane fluidity (Tyler et al.  2009).  Recent 
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characterisation of the T. brucei flagellar membrane revealed it was enriched in 
sphingolipids and sterols, suggesting a high concentration of lipid rafts (Tyler et 
al.  2009).  Indeed it was shown that disruption of lipid raft formation caused the 
mislocalisation of the calflagin Tb24 away from the flagellar membrane.  It was 
postulated that dual acylation serves as a mechanism to anchor and/or retain 
specific proteins to the flagellar membrane (Tyler et al.  2009).  
However, acylation only accounts for lipid raft association and does not fully 
explain the flagellar localisation.  A theory for flagellar membrane trafficking 
has recently been proposed by Emmer and co-workers in which they implicated 
targeted delivery as a mechanism to ensure the correct proteins and lipids arrive 
at the flagellum (Emmer et al. 2010a; Maric et al. 2010).  They describe a 
system where membrane-associated proteins synthesised on the rough 
endoplasmic reticulum are subject to N-myristoylation (if required) before 
transfer to the Golgi, where PATs can catalyse their palmitoylation.  Different 
proteins destined for different locations can then be selectively packaged into 
Golgi derived vesicles composed of different lipids; acylated flagellar membrane 
proteins associate with lipid rafts and are packaged into sterol and sphingolipid 
rich vesicles (Emmer et al.  2010a).  These can then be trafficked to the base of 
the flagellum where unknown sorting processes, presumably occurring at the 
flagellar pocket membrane, allow entry of the correct cargo into the flagellum.  
Thus explaining the enrichment of lipid rafts and associated proteins in the 
flagellar and outlining how they are separated from other regions of the plasma 
membrane (Emmer et al.  2010a). 
It should be noted that although blocking dual acylation stops flagellar 
localisation it is not the exclusive factor determining localisation.  It is likely 
additional signals exist because several other dually acylated kinetoplastid 
proteins have been identified that do not localise to the flagellum.  The T. 
brucei calpain-like protein CAP5.5 associates with the subpellicular cytoskeleton 
of the cell body but is absent from the flagellar axonemes (Hertz-Fowler et al. 
2001) and the hydrophilic acylated surface protein B (HASPB) protein of L. major 
is located extracellularly (Denny et al. 2000).  In addition, truncation of the C-
terminus of CALP1.3 caused mislocalisation raising the possibility this region 
contained additional flagellar targeting information (Liu et al.  2010). 
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Furthermore, the exact mechanisms involved in transporting proteins and lipids 
along the length of the flagellum are unknown.  It is unlikely to occur solely by 
passive diffusion due to the potentially restrictive nature of the flagellar pocket 
membrane and the prohibitive length of the mature flagellum (Emmer et al.  
2010a).  However, one active process known to transport proteins along the 
length of the flagellum is intraflagellar transport (IFT).  This is defined as the 
bidirectional movement of protein particles within the flagellar matrix, 
independent of the flagellar beat (Kozminski et al. 1993).  IFT is driven by two 
microtubule associated motor complexes, each responsible for transporting 
particles in a specific direction.  IFT particles assemble at the base of the 
flagellum and travel along the length of the axoneme, unloading their cargo at 
the distal tip before exchanging the motor protein and transporting cargo down 
to the base of the flagellum.  Analysis of the T. brucei genome revealed it 
contained the full repertoire of genes known to be involved in IFT (Absalon et al. 
2008).  An active IFT system was demonstrated in live T. brucei cells using GFP 
tagged IFT52 (component of IFT complex) which demonstrated the rapid (bi-
directional) movement of GFP-IFT52 labelled particles along the flagellum 
(Absalon et al.  2008).  Interestingly, IFT was essential for T. brucei with RNAi 
downregulation of IFT proteins interfering with the production of new flagella 
and causing loss of cell polarity and defective cytokinesis (Absalon et al.  2008).  
Given the punctate distribution of MCA4 along the length of flagellum it is 
possible this represents an association with IFT particles; explaining how MCA4 is 
transported through the flagellum and its punctate appearance.  Confirmation of 
this hypothesis would provide the first example of a novel IFT cargo in T. brucei.   
4.4.2 MCA4 activity 
Enzyme active sites are specifically organised to ensure efficient catalytic 
activity.  This is maintained in different family members by conservation of key 
catalytic residues.  Thus the predicted substitution of the canonical active site 
cysteine to a serine residue within the MCA4 active site (Figure 4-21) prompted 
speculation regarding the catalytic properties of the enzyme (Moss et al.  2007; 
Mottram et al.  2003; Szallies et al.  2002).  In this respect MCA4 is far from 
unique, the accumulation of sequenced genomes has revealed that the 
occurrence of atypical residues in peptidase active sites is surprisingly 
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widespread in both metazoan and protozoan organisms (Atkinson et al.  2009; Pils 
et al. 2004).  Indeed a recent analysis of peptidases from medically important 
parasitic protozoa revealed that 16% of cathepsin-like proteins (clan CA family 
C1) do not contain the classic cysteine-histidine catalytic dyad (Atkinson et al.  
2009).  Given the variety of substitutions found in active sites it is likely this will 
translate into a wide spectra of functional consequences and evidence is now 
emerging to support this assumption.  
The mammalian cFLIPL protein shows significant structural homology to caspase-
8 and caspase-10, containing the same N-terminal signalling domains and the C-
terminal caspase domain (Inohara et al. 1997).  However, crucially key 
substitutions present in the cFLIP active site (histidine and cysteine to arginine 
and tyrosine respectively) preclude peptidase activity (Inohara et al.  1997).  
Interestingly this inactive caspase homologue still plays an important role in the 
regulation of apoptosis.  Overexpression lead to a dominant negative effect and 
inhibited the initiation of apoptosis, a process that requires a proteolytic 
activation cascade initiated by caspase-8 and caspase-10 cleavage (Inohara et al.  
1997).  Interestingly cFLIP can also activate caspase-8 allowing rapid maturation 
into the to fully active form.  Caspase-8 is produced as zymogen and forms 
heterodimers with cFLIP, which further stimulates activation of mature caspase-
8 (Yu et al. 2009).    
Conversely some mutations do not categorically inhibit catalytic activity.  The 
crystal structures of the 3C peptidases from several Picornaviridae virus species 
(including Hepetitis A, rhinovirus, poliovirus) reveal an active site highly 
reminiscent of the classical serine peptidase chymotrypsin.  The catalytic triad is 
located on a two-domain β-barrel structure and is unusually comprised of a 
histidine, cysteine and glutamic acid.  The histidine and glutamic acid appear to 
function as for serine peptidases, however the nucleophile is a cysteine.  Thus 
3C peptidase appear to be hybrids of serine and cysteine peptidases and despite 
this unusual configuration they retain proteolytic activity and are instrumental in 
processing expressed viral proteins.  Additionally it was possible to mutate the 
nucleophile to a serine and maintain proteolytic activity in the 3C peptidases of 
poliovirus and cowpea mosaic virus (Dessens et al. 1991; Sarkany et al. 2003).  
Interestingly substitution of a serine into the poliovirus 3C peptidase active site 
reduced the specific activity by 430-fold (Sarkany et al.  2003), however it 
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demonstrated that for some peptidases cysteine and serine nucleophiles are 
interchangeable.  Although these substitustions may have functional implications 
it crucially shows that they are still viable catalytically. 
Several active site mutations have been identified in parasite peptidases of 
which perhaps the best characterised are the serine repeat antigen (SERA) 
proteins from Plasmodium.  They belong to clan CA family C1 and possess a 
central domain which shows strong homology to the papain cysteine peptidases.  
In a similar fashion to the T. brucei MCA family, Plasmodium falciparum SERA6-8 
maintain the conserved catalytic cysteine whereas SERA1-5 and SERA9 have an 
active site serine (Hodder et al. 2003).  A renatured form of the recombinant 
peptidase domain of SERA5 demonstrated that a cysteine peptidase-like 
structure could function with a serine in the catalytic site.  The renatured SERA5 
domain was able to cleave peptide substrates and also displayed autolytic 
processing that was blocked by serine peptidase inhibitors (Hodder et al.  2003).  
Subsequent structural analysis has revealed several anomalies in the SERA5 
active site (impaired substrate binding capacity and limited access to active site) 
that could potentially limit its proteolytic activity (Hodder et al. 2009).  
Collectively the SERA proteins have been implicated in mediating the egress of 
daughter merozoites from infected red blood cells and potentially the re-
invasion of red blood cells by merozoites (Blackman 2008).  However the weak 
activity detected and the apparent structural limitations of the SERA5 active site 
raise questions over its in vivo activity and the biological significance of these 
unusual features awaits clarification.    
As highlighted the configuration of peptidase active sites is more diverse than 
widely acknowledged.  The broad significance of active site substitutions is not 
yet fully understood, thus characterisation of MCA4 activity would add valuable 
knowledge to the field. 
Purified recombinant MCA4 was recovered close to the approximate size of the 
predicted full length protein and was highly stable but inactive.  Incubation at 
37oC for 1 hour revealed no evidence of calcium dependent autolytic activity 
(Figure 4-9).  Furthermore no proteolytic activity was detected when 
recombinant MCA4 was analysed in fluorometric activity assays with a range of 
substrates, including the fixed position peptide library. 
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Incubation of MCA4 with small amounts of MCA2 resulted in a defined and 
reproducible processing pattern.  Given that many peptidases are produced as 
inactive zymogens and require activation either by themselves or another 
enzyme we postulated that the processed form of MCA4 might be active.  Indeed 
activity assays using fluorogenic synthetic peptide substrates revealed that 
processed MCA4 activity was detected.  However, interpretation of the results 
was complicated by the presence MCA2 in the reaction, a peptidase also capable 
of cleaving the Z-RR-AMC substrate.  The similarity in the active site structure of 
the two enzymes (excluding the cysteine to serine switch in MCA4) meant it was 
unlikely a substrate unique to MCA4 would be identified.  Therefore additional 
assays were used to established residual MCA2 activity and any potential 
enhancement to MCA2 activity related to an exogenous protein in the reaction.  
Although overall activity was weak (approximately 50 times lower than MCA2) it 
was relative to the quantity of processed enzyme in the reaction, further 
suggesting the activity detected was attributed to processed MCA4. 
In the absence of a metacaspase structure the key active site residues have been 
identified based on homology and sequence alignment to known caspase 
enzymes and subsequently experimentally verified by mutagenesis (Moss et al.  
2007; Vercammen et al.  2004).  The active site of MCA4 is particularly 
interesting because it is predicted to have a serine nucleophile set in a cysteine 
peptidase structure (Figure 4-21).  Having established MCA4 activity we sought 
to investigate the active site residues.  Independent mutation of histidine 164 
and cysteine 218 (adjacent to active site serine) produced an insoluble protein 
preventing any further study of these mutants.  However, the active site serine 
was amenable to mutation and it was possible to purify both MCA4S219C and 
MCA4S219G.  Mutating the active site serine to cysteine, produced an active 
peptidase capable of autolytic processing, although the overall activity was still 
much lower than recombinant MCA2.  This could reflect additional differences in 
the MCA4 active site causing reduced activity or suboptimal assay conditions for 
MCA4S219C (substrate preference or missing cofactors).  Interestingly MCA4S219G 
still exhibited activity once processed by MCA2, implying an additional 
nucleophile is responsible for or contributes to catalysis.  The most likely 
candidate is cysteine-218, conserved in all T. brucei metacaspases (Figure 4-21), 
however unfortunately the potentially inactive MCA4C218G mutant could not be 
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purified and used to experimentally verify this hypothesis.  Interestingly 
mutation of the corresponding residue in MCA2 impacted on its peptidase 
activity (~70% reduction) (Moss et al.  2007). 
Proteolytic activity was only detected for processed MCA4 or MCA4S219C (that was 
able to autoprocess) which implicated processing as a requirement for creating  
a mature active peptidase.  SDS-PAGE analysis of MCAS219C autoprocessing and 
MCA2 directed MCA4 processing revealed strikingly similar processing patterns.  
Both proteins were cleaved into three main products of approximately 38, 36 
and 34 kDa.  To identify the MCA4 processing sites the N-terminal amino acids of 
the main 36 kDa fragments were sequenced by Edman degradation and identified 
a common sequence of six amino acids for both proteins.  Mapping the six amino 
acid sequence onto full length MCA4 revealed the fragments were generated 
following cleavage at lysine-64.  The common cleavage site showed a partial 
overlap of MCA2 and MCA4S219C substrate specificity.  Combined with 
fluorometric activity assay data this confirmed the ability of MCA4S219C to cleave 
substrates only with basic residues in the P1 position.   
MCA2 autolytic processing occurred at lysine-55 and lysine-268 (Moss et al.  
2007).  Interestingly sequence alignment of MCA2 and MCA4 proteins revealed 
that the MCA2 lysine-55 is conserved in MCA4 (Figure 4-21).  However to date 
MCA4 processing has only been mapped to a lysine three residues upstream, 
namely lysine-64 (MCA4 numbering) (Figure 4-21).  To investigate the 
significance of autoprocessing on MCA4S219C activity lysine-64 was mutated to a 
neutral glycine residue.  However, the enzyme was still able to autoprocess and 
retained proteolytic activity.  The identification and removal of further 
processing sites will help to define the importance of processing on MCA4 
activity.  One prominent candidate residue for future mutation is MCA4 lysine-
61, which corresponds to the site of MCA2 autoprocessing.  Interestingly 
mutation of the MCA2 active site cysteine to glycine (C213G) completely blocked 
activity and autoprocessing, whereas MCA2C212G could still autoprocess. 
It is tempting to speculate that the MCA4 active site serine restricts 
autoprocessing and places the activation of MCA4 under the control of an 
upstream peptidase(s).  Indeed re-expression of the constitutively active 
MCA4S219C in the ∆mca4 background generated two prominent proteins;  full 
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length MCA4 and a smaller processed protein of about 36 kDA (Figure 4-19B), 
which corroborates well with the autoprocessing pattern of recombinant protein 
(Figure 4-9B).  Western blot analysis of T. brucei whole cell lysate revealed that 
MCA4 is mostly represented by one protein corresponding to the full length.  
Occasionally however evidence of processing was detected (see Figure 4-5A, 
Figure 4-8A, Figure 4-17C Lane 4) although no consistent pattern was detected, 
thus identifying any stimulus was not possible.   
In the recombinant activity assays MCA4 was successfully activated by MCA2, 
however whether this occurs in T. brucei is unknown.  The distinct flagellar 
membrane localisation of MCA4 would seem to place the enzyme out of reach of 
MCA2, which was localised to RAB11 positive vesicles (Helms et al.  2006).  
However, it is possible that localisation of the proteins could change and 
coincide following a specific stimulus such as cell stress.   
Alternatively another activating peptidase localised to the flagellum could 
control MCA4 activity.  An extensive inventory of flagellar proteins has been 
compiled (Ralston et al.  2009) from several proteomic and genomic studies 
(Baron et al. 2007; Broadhead et al.  2006; Hart et al. 2009).  Searching this list 
identified several candidate peptidases for MCA4 activation.  Numerous calpain-
like proteins were identified as flagellar proteins (Liu et al.  2010).  They are 
interesting candidates given their signalling roles in other organisms, however all 
T. brucei calpain-like proteins (except one) are predicted to contain active site 
substitutions and thus may not be proteolytically active (Croall et al.  2007; 
Ersfeld et al.  2005).  Another interesting candidate is a subtilisin-like serine 
peptidase (Tb927.3.4230) that was identified as part of a cohort of 50 proteins 
unique to organisms with motile flagellar or cilia (Baron et al.  2007), although no 
experimental evidence has been presented to confirm its flagellar localisation.  
Interestingly a subtilisin-like peptidase of P. falciparum (PfSUB1) has recently 
been identified as the protein responsible for the proteolytic processing of 
SERA5 (Yeoh et al. 2007).  It must also be considered that the proteomic 
identifications of flagellar proteins were performed on flagellar isolated from 
PCF, so it is possible that if a specific MCA4 activator exists it could also be 
restricted to BSF stage of the lifecycle and therefore absent from these 
proteomic studies.    
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4.4.3 MCA4 reverse genetics 
A two pronged approach was taken to investigate MCA4 loss of function,  firstly 
downregulation by RNAi and secondly genetic knockout.  Unlike the other T. 
brucei MCAs, which showed individual redundancy (Helms et al.  2006), MCA4 was 
essential for BSF cell division and growth.  Targeted RNAi down regulation 
reduced MCA4 protein to almost undetectable levels by 24 hours post induction.  
This was accompanied by the concurrent block of cell cycle progression, which 
manifested in the appearance of abnormal cells with elevated DNA content 
indicating a post mitotic block. 
The MCA4 RNAi phenotype was consistent with the findings of other studies that 
used RNAi to downregulate BSF flagellar proteins (Ralston et al. 2008).  The most 
thorough investigation was carried out by Broadhead et al who selected five 
proteins identified in their flagellar proteome and targeted them individually by 
RNAi (Broadhead et al.  2006).  The selected axoneme associated proteins 
included three newly identified flagellar proteins (TAX-1, PACRGA and DIGIT), a 
homologue of a known Chlamydomonas flagellar protein MBO2 and paraflagellar 
rod protein 2 (PFR2).  Despite the diversity of the selected group, RNAi 
downregulation resulted in a remarkably consistent phenotype.  All five proteins 
were essential for BSF T. brucei and prior to cell death ‘monstrous cells’ 
accumulated containing multiple nuclei and kinetoplasts (Broadhead et al.  
2006).  The cells continued to replicate their organelles but failed to carry out 
cytokinesis; each round of replication produced new organelles but the lack of 
cellular organisation and division rapidly caused detrimental complications for 
the parasites.   
Several other studies on BSF flagellar proteins have reported similar phenotypes 
including: the inducible downregulation of trypanin a component of flagellar 
dynein regulatory complex possibly responsible for axoneme association (Ralston 
et al.  2006a), and the double silencing of two phosphodiesterases TbPDEB1 and 
TbPDEB2 (Oberholzer et al. 2007).       
The severity and physical appearance of the RNAi phenotypes described showed 
compelling similarities to MCA4 downregulation.  There are two possible 
explanations for this.  Firstly, the BSF flagellum is particularly sensitive to 
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functional perturbations and any defect manifests in a terminal block in 
cytokinesis.  This would support the concept of MCA4 playing a key role in 
maintaining correct BSF flagellar function or a more defined role in cytokinesis.  
The other flagellar mutants discussed associate with either the PFR or axoneme; 
thus the MCA4 investigation adds a third flagellar compartment (the membrane) 
to those already associated with maintenance of optimum flagellar function.  
The consistent phenotype observed in a variety of flagellar RNAi mutants adds 
weight to a broad argument supporting complete flagellar function as an 
absolute requirement for BSF viability (Portman et al. 2010).  One interesting 
finding was that RNAi analysis of the flagellar mutants in PCF revealed no 
evidence for cell cycle defects or reduced viability (Portman et al.  2010; Ralston 
et al.  2008).   
The second explanation for these common findings could be that this terminal 
phenotype is common to BSF RNAi mutants in general, where a wide range of 
cellular defects cause cells to accumulate at a critical cell cycle checkpoint, 
independent of flagellar function.  Either way it points to MCA4 playing a role in 
maintaining flagellar function as opposed to a direct involvement in cytokinesis.      
The severe RNAi phenotype implied MCA4 was an essential gene for BSF T. brucei 
and was likely to be refractory to genetic deletion.  However, MCA2, MCA3 and 
MCA5 displayed collective essentiality when downregulated by RNAi but were 
open to genetic deletion (Helms et al.  2006).  Similarly, it was possible to delete 
the MCA4 ORF by targeted replacement of both alleles with drug resistance 
cassettes.  The severity of the MCA4 phenotype can perhaps be attributed to the 
rapid depletion of MCA4 occurring before parasite adaptation, whereas the 
sequential replacement of each MCA4 allele provided sufficient time for 
adjustment to diminishing MCA4 levels.  Whether the contrasting RNAi and 
knockout phenotypes is specific only for the MCAs is unknown; attempting to 
knock out other BSF flagellar proteins previously shown to be essential by RNAi 
(Broadhead et al.  2006) could shed light on this interesting finding.     
The ∆mca4 cells were verified by Southern and western blotting, which 
confirmed the correct integration of the knockout constructs and the subsequent 
deletion of the MCA4 gene and protein from BSF 427 T. brucei.  Analysis of cell 
growth in vitro revealed a reduced growth rate compared to the parental wild 
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type line, which could have been caused by a reduction in 1N2K cell types.  
However, unlike the RNAi phenotype no defects in cytokinesis were detected in 
∆mca4 cells, with cells appearing to divide normally.  One crucial aspect of 
flagellum function that was amenable to quantitative analysis was motility.  Live 
∆mca4 cells appeared morphological similar to wild type cells and sedimentation 
assays showed no apparent defects in flagellar motility.  Although it is possible 
more sensitive analytical techniques could reveal subtle defects.        
As MCA4 expression was only detected in BSF cells we speculated it could be 
involved in mediating mammalian infectivity. Indeed infection of mice with wild 
type and ∆mca4 cells revealed strikingly different patterns of infection.  The 
parasitemia of ∆mca4 cells was subject to periods where parasites were 
undetectable as well as consecutive days with stable reduced parasite burdens.  
This contributed to prolonged mouse survival and revealed a role for MCA4 in 
parasite virulence within the mammalian host.  Interestingly several other T. 
brucei flagellar proteins have been shown to influence parasitemia in mice.  The 
deletion of the GPI-PLC created a prolonged infection in mice (although 
extended compared to ∆mca4 parasites), that was accompanied by multiple 
peaks and troughs of parasitemia (Webb et al. 1997).  In addition in vivo RNAi 
silencing of the calflagins (Tb17, Tb24 and Tb44) prolonged mouse survival by 
attenuating parasite growth (Emmer et al. 2010b).  The infection was 
characterised by waves of parasitemia associated with the expression of 
alternative VSGs (Emmer et al.  2010b).      
It has yet to be determined whether the waves of ∆mca4 parasitemia were 
accompanied by a VSG switch but it seems likely the reduced virulence allowed 
the mouse immune system more time to clear the original infection before the 
re-emergence of a second wave of parasitemia of cells with a different VSG 
type.  Whether prolonged mouse survival was directly linked to the loss of MCA4 
reducing parasite virulence or arose from a MCA4 dependent interaction with the 
host is yet to be determined.  Either way the identification of proteins such as 
MCA4 that influence the mammalian infection process is an important step in 
identifying new target for future therapeutic development. 
The importance of MCA4 to BSF T. brucei has been demonstrated by RNAi and 
genetic knockout.  The precise physiological role is still unclear but depends on 
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the catalytic activity of the protein.  This was demonstrated by the re-
expression of mutant MCA4 (no nucleophile in active site, MCA4C218G,S219G) in the 
∆mca4 background.  Successful expression of the protein was confirmed by 
western blot, however it failed to rescue the growth of phenotype of ∆mca4 
parasites in mice, confirming the necessity of enzymatic activity for MCA4 
function. 
In the absence of a confirmed physiological substrate(s) for MCA4, we can only 
speculate what roles the protein might play, some of which are discussed below.   
4.4.4 Is MCA4 part of a signalling cascade?  
One interesting finding that could have functional implications was the 
identification of two phosphorylation sites in MCA4.  The two different sites of  
phosphorylation were identified as threonine 56 or 58 (Nett et al.  2009) and 
serine 341 (our experiments and Nett et al. 2009).  The phosphorylation of 
peptidases is a wide spread phenomenon with diverse roles potentially 
influencing protein localisation and substrate specificity, as well as controlling 
catalytic activation and inactivation (Lopez-Otin et al.  2010). 
One well characterised example of phosphorylation dependent peptidase activity 
is caspase-9.  This heavily phosphorylated peptidase is subject to numerous 
phosphorylation events, one of which confers crucial regulation to the catalytic 
activity of this initiator caspase serving to control its role in apoptosis (Allan et 
al. 2009).  The phosphorylation of threonine-125 inhibits caspase-9 proteolytic 
activation and consequently inhibits its ability to activate downstream targets 
(Allan et al. 2003).  Threonine-125 is located in the flexible linker region 
between the caspase recruitment domain (CARD) and the large subunit of the 
processed enzyme.  However, in the absence of structural data for the region 
surrounding threonine-125, the exact mechanism of inhibition is unknown.  
However, once phosphorylated at threonine-125, caspase-9 can still associate 
with apoptotic protease activating factor 1 (Apaf1, a key component of the 
apoptosome) which suggested that either phosphorylation blocked a 
conformational change required for activation or created a dominant negative 
effect inhibiting further activation of other caspase-9 associated with Apaf1 
(Allan et al.  2009).  Furthermore phosphorylation of serine-348, located between 
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the large and small subunit of murine caspase-9 protected aspartate-358 from 
caspase-8 mediated cleavage ensuring the protein remained inactive (McDonnell 
et al. 2008).   
Further work is required to characterise the consequences of the MCA4 
phosphorylation.  Although the close proximity of a phosphorylation site 
(threonine-56 and/or threonine-58) to one of the identified locations of 
proteolytic processing (lysine-64) (Figure 4-21), raises the interesting possibility 
of phosphorylation regulating processing and thus activity.  Another potential 
function of MCA4 phosphorylation could involve control of cellular trafficking, 
acting as a secondary signal facilitating flagellar targeting.  The identification of 
the kinases and phosphatases responsible for controlling the phosphorylation 
status of MCA4 will no doubt be extremely important in helping to define the 
role of the protein.       
Conversely the MCA4 proteolytic activity could be required to participate in 
specific signalling cascades.  Recent work linking the human kinome (total kinase 
genes) and degradome (total peptidase genes) revealed that more than 100 of 
the 518 kinases are specifically regulated by peptidases (Lopez-Otin et al.  2010).  
This could involve kinase activation through the proteolytic cleavage of an 
inhibitory kinase domain or inactivation by degradation, well demonstrated by 
the many interactions between caspases and kinases (Kurokawa et al. 2009).    
The flagellar membrane represents an interface between the parasite and the 
host environment.  Flagellar proteins of other organisms are known to serve an 
important sensory and signal transduction role.  For example the flagellate 
protozoan Chlamydomonas reinhardtii relies on flagellar cAMP signalling to 
mediate fusion of gametes and zygote formation.  In response to nitrogen 
starvation vegetative cells differentiate into gametes of two opposite mating 
types (Pan et al. 2000).  Flagellar adhesion of gametes from opposing mating 
type stimulates relocalisation of a flagellar membrane cyclic GMP-dependent 
protein kinase (PKG) (Wang et al. 2006).  Calcium mediated activation of PKG 
stimulates adenyl cyclase activity and drastically increases flagellar cAMP levels, 
which then permeate the cell body and facilitates cell fusion (Pan et al.  2000). 
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Interestingly many potential components of calcium and cyclic nucleotide 
signalling pathways have been identified in the T. brucei flagellar: the calflagins 
(Tb17, Tb24 and Tb44) a family of calcium binding proteins (Emmer et al.  2009; 
Tyler et al.  2009); an adenylate cyclase (expression site associated gene 4, 
ESAG.4) an enzyme that catalyses the conversion of ATP to cAMP in a calcium 
dependent fashion (Paindavoine et al. 1992); and two phosphodiesterases 
(TbPDEB1 and TbPDEB2) proteins associated with cAMP degradation and 
homeostasis (Oberholzer et al.  2007).  This strongly suggests the presence of 
functional signalling cascades operating within the flagellum and it is possible 
MCA4 activity is required for some form of flagellar signal transduction. 
It would seem unlikely that MCA4 is a primary activator protein because the 
recombinant enzyme required processing for activity.  Therefore it could 
operate within a signalling cascade, responding to proteolytic activation from a 
calflagin-like protein or subtilisin –like peptidase, before processing downstream 
targets.   
4.4.5 Is MCA4 involved in T. brucei flagellar metabolism? 
The maintenance of flagellum function requires high levels of ATP and diffusion 
alone is unlikely to meet this demand, leading to potential ATP starvation in 
distal regions of the flagellum.  Consequently flagellar specific metabolic 
networks are proposed to maintain ATP levels (Ginger et al. 2008).  In C. 
reinhardtii the last three reactions of the glycolytic pathway were identified in 
the isolated flagellar and proposed to help provide ATP to maintain flagellar 
function (Mitchell et al. 2005).  In T. brucei two adenyl kinases have been 
localised to the length of the flagellum and proposed to function in a 
phosphotransfer relay, delivering ATP and removing ADP as required in the 
flagellar (Pullen et al. 2004).  Immunoprecipitation of MCA4 also surprisingly co-
precipitated glycerol-3-phosphate dehydrogenase, an enzyme known to function 
in the in glycosome helping to maintain the redox balance (Michels et al.  2006).  
Given the abundance of many glycolytic enzymes non-specific 
contamination/interaction cannot yet be ruled out.  However, interestingly 
glycerol-3-phosphate dehydrogenase has also been identified in the PCF flagellar 
proteome, thus adding tentative support to the co-immunoprecipitation result 
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(Hart et al.  2009).  However the significance of such and interaction between 
MCA4 and glycerol-3-phosphate is not obviously explained. 
4.4.6 Does MCA4 interact with the host following secretion? 
Recently MCA4 was identified in the secretome (total secreted proteins) of two 
different T. brucei gambiense strains (Geiger et al. 2010).  Proteins identified in 
several trypanosomatid secretomes were analysed in silico for the presence of 
classical N-terminal signal peptides.  Those proteins predicted to contain 
eukaryotic signal peptides without any transmembrane domains were deemed to 
utilise the classic pathway for secretion.  Using this bioinformatic approach only 
14% of proteins in the L. donovani secretome were found to contain an N-
terminal classical secretion signal sequence (Silverman et al. 2008) and similarly 
only 7% of the T. brucei gambiense secretome were identified accordingly 
(Geiger et al.  2010).  Thus it seems likely that trypanosomatids utilise novel 
mechanisms for protein secretion, with two possible models suggested. 
Recent experimental evidence revealed the presence of exosomes (30-100 nm 
vesicles released by many mammalian cell types) budding off the Leishmania 
cell body membrane and flagellar pocket (Silverman et al.  2008; Silverman et al. 
2010).  Proteomic characterisation of purified exosomes revealed they contained 
52% of the total secretome suggesting it is prominent mechanism for delivery of 
proteins to the environment (Silverman et al.  2010).  Additionally Emmer et al 
speculate that the flagellar membrane itself could also be involved in vesicle 
shedding and release (Emmer et al.  2010a).  This prediction stems in part from 
the identification of T. cruzi flagellar protein FCaBP in vesicles shed from the 
cell combined with the TEM and SEM evidence depicting vesicle budding and 
release from the tip of the C. reinhardtii flagellar (Bergman et al. 1975).  
However, recent evidence has been presented showing the budding of vesicles 
from undefined areas of the T. brucei cell membrane (Geiger et al.  2010). 
Although this process has only been visualised by TEM so further analysis is 
required.    
Alternatively MCA4 could be actively secreted out of the flagellar pocket.  This 
would presumably require release from the flagellar membrane, occurring either 
via the reversal of palmitoylation (catalysed by a PAT protein) to diminish 
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membrane association or by proteolytic cleavage to separate the activated form 
of MCA4 from the N-terminal portion left in the flagellar membrane.  
Irrespective of the secretion mechanism used, MCA4 was detected as part of the 
secretome (Geiger et al.  2010) which raises very interesting questions regarding 
its potential functions.  Initial attempts to detect MCA4 in the serum of T. brucei 
infected mice by western blotting were inconclusive, however further 
investigation is clearly warranted to enable a more comprehensive definition of 
MCA4 function. 
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Figure 4-21 Alignments of select metacaspase proteins 
Selected regions of Vector NTI protein sequence alignment of MCA proteins, tritrypDB and 
accession numbers in brackets: LmMCA (LmjF35.1580), TbMCA5 (Tb09.211.4760), Atmc1 
(AAP44514.1), Yca1 (NP_014840.2), Atmc9 (NP_196040.1), TbMCA2 (Tb927.6.940), 
TbMCA3.(Tb927.6.930), TbMCA1 (Tb11.02.0730) and TbMCA4 (Tb927.10.2440).  Sequences 
aligned using Clustal W algorithm of the Align X program.  Identical and conserved amino acids are 
highlighted yellow and blue respectively.  Blocks of similar sequences are highlighted in green and 
green coloured text indicates weak conservation.  Numbers in brackets indicate the position of the 
first amino acid in the linear polypeptide in the section of each protein analysed.  The red and grey 
arrows indicate the position of the canonical metacaspase active site histidine and cysteine 
residues, respectively.  The back arrows indicate additional cysteine with potential catalytic activity.  
The blue arrowheads label the aspartic acid residues predicted to comprise the enzyme S1 pocket.  
Red asterisks above alignment indicate MCA2 and MCA4 processing sites, with P1 residue 
coloured red.  MCA4 phosphorylation sites identified in this study and by (Nett et al.  2009), marked 
beneath the alignment with purple ovals.     
 
179 
5 General discussion 
 
5.1.1 Autophagy in T. brucei – future perspective 
Using fluorescently labelled ATG8 proteins expressed in T. brucei it was possible 
to monitor the formation of autophagosomes and provide direct evidence of a 
functional autophagy system.  As expected autophagy in PCF T. brucei is 
upregulated in response to nutrient starvation and inhibited by the classical 
autophagy inhibitor wortmannin.  Furthermore, an increased autophagic 
response is induced in BSF cells following treatment with the neuropeptide VIP.     
This work has characterised specific components of the T. brucei autophagy 
pathway and revealed that autophagy plays a role in responding to stress.  
However to provide a more thorough understanding of autophagy in T. brucei, 
future work could be developed pursing two main themes: physiological 
functions and molecular machinery.   
To characterise the molecular machinery of autophagy RNAi downregulation 
represents a quick and effective method of targeting and studying select 
proteins.  To facilitate future investigations constructs expressing YFP-ATG8.2 
and YFP-ATG8.3 have been created and integrated into PCF (13 -29) RNAi cell 
lines (Wirtz et al.  1999).  These parasites cell lines are intended to act as 
autophagosome reporter lines for use with RNAi based screens.  This should 
serve to validate the action of known autophagy orthologues and crucially help 
in the discovery of new proteins involved in the pathway. 
Having successfully validated the use of YFP-tagging to monitor autophagy in 
monomorphic T. brucei, similar tools could be developed for pleiomorphic fly 
transmissible strains.  This would allow for thorough investigation of autophagy 
in all forms of the parasite in both the mammalian and insect hosts, providing 
crucial insights into differentiation processes.   
This investigation has begun to expand the known roles of autophagy through the 
targeted downregulation of a key component of the autophagy pathway (ATG3).  
This reduced PCF growth, however it is currently unclear whether this stemmed 
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from inhibition of autophagy or interference with another cellular function of 
the ATG3 protein.  If downregulation of ATG3 does indeed block autophagy then 
silencing ATG3 by RNAi could be used to identify further physiological processes 
requiring a functional autophagy system.     
5.1.2 MCA4 – proposed model of activation  
The research carried out on MCA4 provided some interesting and surprising 
findings.  Drawing all the data generated together and including concepts 
covered in the discussion of section 4.4, we have developed a proposed model 
for the regulation and activation of MCA4 (Figure 5-1).   
We hypothesise that following synthesis of MCA4, the protein is trafficked to the 
flagellar membrane where it is anchored in position by N-terminal dual 
acylation.  Full length MCA4 remains associated to the flagellar membrane as an 
inactive peptidase and the autolytic activation of MCA4 is restricted by serine-
219.   
To activate MCA4 a proteolytic cleavage event, potentially occurring at lysine-
64, is performed by an upstream peptidase.  The exact process used to convert 
the MCA4 zymogen is unknown, however by extrapolating from established 
systems of peptidase inhibition and activation we can predict potential 
mechanisms.  Effector caspases require proteolytic cleavage to reorganise the 
active site of the dimerized P10 and P20 subunits (Fuentes-Prior et al.  2004).  It 
is possible proteolytic cleavage of the MCA4 zymogen causes a conformational 
change favouring activity (perhaps similar to the conformational change 
prediction for Atmc9, as discussed in section 4.1.10), however the release of 
P10-like and P20-like subunits was not detected for MCA4.  An alternative 
activation hypothesis centres on a possible inhibitory effect of the MCA4 N-
terminal region.  This is a common mechanism used to control enzyme activity 
and has been well characterised for the cathepsins (clan CA, family C1), where 
the N-terminal propeptide occupies the active site preventing substrate access 
(Groves et al. 1998).  Accordingly it is possible that proteolytic cleavage at 
lysine-64 serves to separate the mature MCA4 from the inhibitory properties of 
the N-terminal region.   
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In our model a further level of regulation is added by phosphorylation of 
threonine-56 and threonine-58, a modification that serves to protect the lysine 
from proteolytic activity of the activating peptidase. Therefore following the 
appropriate signals MCA4 is dephosphorylated and activated by an unknown 
flagellar peptidase which releases MCA4 from the flagellar membrane.  
Alternatively palmitoylation could be reversed by the activity of a flagellar 
localised palmitoyl acyltransferase and MCA4 released for subsequent activation 
by proteolytic reorganisation of the active site.   
The activated MCA4 is then either able to interact with proteins in the flagellum 
or is secreted from T. brucei for interaction with the host. 
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Figure 5-1 Model for MCA4 activation.  
Schematic representation of inactive MCA4 attached to the flagellar membrane and subsequent 
release of active MCA4 following proteolytic cleavage.  MCA4 protein depicted in green boxes with 
select amino acids in black depicting: the N-terminal region; phosphorylated residues threonine-
56/58 and serine-341 labelled with purple circles and site of proteolytic cleavage lysine-64.  
Predicted active site residues coloured in red.  N-myristoylation of glycine-2 indicated with blue bar 
and palmitoylation of cysteine-4 indicated with purple bar.   
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5.1.3 Interplay between autophagy and MCAs 
The two main topics covered in this work appear to represent different and 
distinct aspects of cell biology.  However recent work in yeast has revealed a 
link between the autophagic degradation of protein aggregates and the yeast 
MCA (Yca1) (Lee et al. 2010).  In mammalian cells it is well known that 
autophagy plays a critical role in mediating the turnover of proteins prone to 
aggregate formation.  In fact the accumulation of such protein aggregates in 
neuronal cells has been associated with several neurodegenerative diseases, 
including Alzheimers, Parkinsons and Huntingdons (Levine et al.  2008; Mizushima 
et al.  2008).    
As part of continuing efforts to characterise potential non cell death functions of 
Yca1, it was discovered that deletion or inactivation of this protein changed 
progression of the cell cycle by elongating G1 phase and disrupting a G2/M 
checkpoint (discussed in section 4.1.9) (Lee et al.  2008).  Further evidence for a 
role of Yca1 promoting cell viability was provided by proteomic analysis of Yca1 
cells.  This revealed an increased level of stress response chaperones and 
proteins involved in vacuolar degradation, suggesting activation of compensating 
stress pathways (Lee et al.  2010).  The specific cellular stress induced by Yca1 
deletion was identified as the accumulation of protein aggregates.  Indeed 
following the artificial induction of protein aggregate formation (heat shock at 
42oC), fluorescently labelled Yca1 translocated from the cytoplasm and 
colocalised with aggregate remodelling chaperones and insoluble protein 
aggregates (Lee et al.  2010).  Interestingly, both deletion and inactivation of 
Yca1 lead to an accumulation of protein aggregates in yeast cells, however the 
effect was partly reduced by proteolytic activation (Lee et al.  2010).  
Importantly the targeting of Yca1 to insoluble aggregates was controlled by the 
prodomain region (Lee et al.  2010).  This region of Yca1 is rich in glutamine and 
asparagine repeats and is predicted to possess prion-like functions (Nemecek et 
al. 2009).  Indeed removal of the prodomain region caused mislocalisation and 
spontaneous autolytic processing of Yca1 (Lee et al.  2010).   
Based on these findings Lee and co-workers proposed a model where Yca1 
targets and facilitates the clearance of protein aggregates, either directly by 
184 
proteolytic degradation or through the formation of a Yca1 scaffold that serves 
to facilitate the enzymatic activity of other aggregate processing enzymes (Lee 
et al.  2010).  Thus in the absence of Yca1, the autophagic pathway is up-
regulated to help clear aggregated proteins (Lee et al.  2010).  This shows that 
MCAs and autophagy both play vital roles in maintaining cellular equilibrium.  In 
T. brucei this is perhaps most relevant to MCA2, MCA3 and MCA5.  These three 
MCAs possess N-terminal prodomains (of unknown function) and have all been 
shown to localise to RAB11 positive recycling endosomes (Helms et al.  2006).  To 
date the role of these MCA associated RAB11 endosomes is unknown, but it is 
tempting to speculate they may be involved in the removal of unwanted protein 
aggregates.  
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